| ENSG00000088970.11 |
Avagacestat |
Bladder urothelial carcinoma |
0.027846272 |
Resistant |
| ENSG00000118412.8 |
Avagacestat |
Bladder urothelial carcinoma |
0.023586883 |
Resistant |
| ENSG00000185837.3 |
Avagacestat |
Bladder urothelial carcinoma |
0.032498749 |
Resistant |
| ENSG00000188206.5 |
Avagacestat |
Bladder urothelial carcinoma |
0.038995886 |
Resistant |
| ENSG00000203327.2 |
Avagacestat |
Bladder urothelial carcinoma |
0.020342206 |
Resistant |
| ENSG00000204837.2 |
Avagacestat |
Bladder urothelial carcinoma |
0.032289449 |
Resistant |
| ENSG00000204934.6 |
Avagacestat |
Bladder urothelial carcinoma |
0.02360456 |
Resistant |
| ENSG00000205662.2 |
Avagacestat |
Bladder urothelial carcinoma |
0.017302373 |
Resistant |
| ENSG00000205663.5 |
Avagacestat |
Bladder urothelial carcinoma |
0.012138997 |
Resistant |
| ENSG00000223734.2 |
Avagacestat |
Bladder urothelial carcinoma |
0.019217454 |
Resistant |
| ENSG00000224046.1 |
Avagacestat |
Bladder urothelial carcinoma |
0.004927548 |
Resistant |
| ENSG00000224914.2 |
Avagacestat |
Bladder urothelial carcinoma |
0.012464239 |
Resistant |
| ENSG00000226386.1 |
Avagacestat |
Bladder urothelial carcinoma |
0.028545897 |
Resistant |
| ENSG00000228061.1 |
Avagacestat |
Bladder urothelial carcinoma |
0.042451719 |
Resistant |
| ENSG00000228369.2 |
Avagacestat |
Bladder urothelial carcinoma |
0.032427633 |
Resistant |
| ENSG00000228779.1 |
Avagacestat |
Bladder urothelial carcinoma |
0.000941034 |
Resistant |
| ENSG00000229589.1 |
Avagacestat |
Bladder urothelial carcinoma |
0.038282362 |
Resistant |
| ENSG00000230082.1 |
Avagacestat |
Bladder urothelial carcinoma |
0.029698373 |
Resistant |
| ENSG00000230530.1 |
Avagacestat |
Bladder urothelial carcinoma |
0.030173721 |
Resistant |
| ENSG00000230699.2 |
Avagacestat |
Bladder urothelial carcinoma |
0.044192563 |
Resistant |
| ENSG00000231125.2 |
Avagacestat |
Bladder urothelial carcinoma |
0.039972396 |
Resistant |
| ENSG00000231154.1 |
Avagacestat |
Bladder urothelial carcinoma |
0.046094808 |
Resistant |
| ENSG00000232098.2 |
Avagacestat |
Bladder urothelial carcinoma |
0.003618656 |
Resistant |
| ENSG00000232712.2 |
Avagacestat |
Bladder urothelial carcinoma |
0.037611684 |
Resistant |
| ENSG00000232940.1 |
Avagacestat |
Bladder urothelial carcinoma |
0.035618409 |
Resistant |
| ENSG00000233220.3 |
Avagacestat |
Bladder urothelial carcinoma |
0.031589895 |
Resistant |
| ENSG00000233654.1 |
Avagacestat |
Bladder urothelial carcinoma |
0.041124658 |
Resistant |
| ENSG00000234913.1 |
Avagacestat |
Bladder urothelial carcinoma |
0.039651124 |
Resistant |
| ENSG00000235159.1 |
Avagacestat |
Bladder urothelial carcinoma |
0.03689727 |
Resistant |
| ENSG00000235530.2 |
Avagacestat |
Bladder urothelial carcinoma |
0.00605372 |
Resistant |
| ENSG00000235806.1 |
Avagacestat |
Bladder urothelial carcinoma |
0.039054292 |
Resistant |
| ENSG00000236519.1 |
Avagacestat |
Bladder urothelial carcinoma |
0.02563727 |
Resistant |
| ENSG00000237424.1 |
Avagacestat |
Bladder urothelial carcinoma |
0.034078751 |
Resistant |
| ENSG00000237489.2 |
Avagacestat |
Bladder urothelial carcinoma |
0.021535883 |
Resistant |
| ENSG00000239569.2 |
Avagacestat |
Bladder urothelial carcinoma |
0.027819628 |
Resistant |
| ENSG00000241180.1 |
Avagacestat |
Bladder urothelial carcinoma |
0.049855648 |
Resistant |
| ENSG00000242282.2 |
Avagacestat |
Bladder urothelial carcinoma |
0.0153813 |
Resistant |
| ENSG00000244879.3 |
Avagacestat |
Bladder urothelial carcinoma |
0.007080365 |
Resistant |
| ENSG00000245498.2 |
Avagacestat |
Bladder urothelial carcinoma |
0.028201177 |
Resistant |
| ENSG00000247199.3 |
Avagacestat |
Bladder urothelial carcinoma |
0.036068565 |
Resistant |
| ENSG00000247877.2 |
Avagacestat |
Bladder urothelial carcinoma |
0.010480405 |
Resistant |
| ENSG00000248367.1 |
Avagacestat |
Bladder urothelial carcinoma |
0.018135514 |
Resistant |
| ENSG00000248445.1 |
Avagacestat |
Bladder urothelial carcinoma |
0.009739966 |
Resistant |
| ENSG00000250057.1 |
Avagacestat |
Bladder urothelial carcinoma |
0.031748747 |
Resistant |
| ENSG00000250326.1 |
Avagacestat |
Bladder urothelial carcinoma |
0.009102872 |
Resistant |
| ENSG00000250900.2 |
Avagacestat |
Bladder urothelial carcinoma |
0.028949493 |
Resistant |
| ENSG00000254028.1 |
Avagacestat |
Bladder urothelial carcinoma |
0.006004687 |
Resistant |
| ENSG00000254341.1 |
Avagacestat |
Bladder urothelial carcinoma |
0.011431315 |
Resistant |
| ENSG00000255100.1 |
Avagacestat |
Bladder urothelial carcinoma |
0.004406881 |
Resistant |
| ENSG00000255153.1 |
Avagacestat |
Bladder urothelial carcinoma |
0.022996581 |
Resistant |
| ENSG00000255234.1 |
Avagacestat |
Bladder urothelial carcinoma |
0.023672082 |
Resistant |
| ENSG00000255559.1 |
Avagacestat |
Bladder urothelial carcinoma |
0.012948148 |
Resistant |
| ENSG00000256705.3 |
Avagacestat |
Bladder urothelial carcinoma |
0.033821348 |
Resistant |
| ENSG00000257815.1 |
Avagacestat |
Bladder urothelial carcinoma |
0.009525199 |
Resistant |
| ENSG00000258731.1 |
Avagacestat |
Bladder urothelial carcinoma |
0.019302676 |
Resistant |
| ENSG00000259215.1 |
Avagacestat |
Bladder urothelial carcinoma |
0.03577955 |
Resistant |
| ENSG00000259891.1 |
Avagacestat |
Bladder urothelial carcinoma |
0.001328222 |
Resistant |
| ENSG00000260231.1 |
Avagacestat |
Bladder urothelial carcinoma |
0.033675253 |
Resistant |
| ENSG00000260285.1 |
Avagacestat |
Bladder urothelial carcinoma |
0.038785338 |
Resistant |
| ENSG00000260526.1 |
Avagacestat |
Bladder urothelial carcinoma |
0.002356216 |
Resistant |
| ENSG00000260563.2 |
Avagacestat |
Bladder urothelial carcinoma |
0.023552004 |
Resistant |
| ENSG00000260766.1 |
Avagacestat |
Bladder urothelial carcinoma |
0.016167376 |
Resistant |
| ENSG00000261187.1 |
Avagacestat |
Bladder urothelial carcinoma |
0.027142908 |
Resistant |
| ENSG00000261251.1 |
Avagacestat |
Bladder urothelial carcinoma |
0.027561562 |
Resistant |
| ENSG00000261360.1 |
Avagacestat |
Bladder urothelial carcinoma |
0.009090247 |
Resistant |
| ENSG00000261433.1 |
Avagacestat |
Bladder urothelial carcinoma |
0.028794509 |
Resistant |
| ENSG00000261526.1 |
Avagacestat |
Bladder urothelial carcinoma |
0.046600165 |
Resistant |
| ENSG00000261610.1 |
Avagacestat |
Bladder urothelial carcinoma |
0.000594496 |
Resistant |
| ENSG00000262165.1 |
Avagacestat |
Bladder urothelial carcinoma |
0.037868141 |
Resistant |
| ENSG00000262202.3 |
Avagacestat |
Bladder urothelial carcinoma |
0.02782614 |
Resistant |
| ENSG00000262319.1 |
Avagacestat |
Bladder urothelial carcinoma |
0.025390863 |
Resistant |
| ENSG00000262362.1 |
Avagacestat |
Bladder urothelial carcinoma |
0.028098541 |
Resistant |
| ENSG00000263766.1 |
Avagacestat |
Bladder urothelial carcinoma |
0.026191164 |
Resistant |
| ENSG00000265912.1 |
Avagacestat |
Bladder urothelial carcinoma |
0.001381827 |
Resistant |
| ENSG00000266289.1 |
Avagacestat |
Bladder urothelial carcinoma |
0.021434027 |
Resistant |
| ENSG00000266983.1 |
Avagacestat |
Bladder urothelial carcinoma |
0.016752796 |
Resistant |
| ENSG00000267138.1 |
Avagacestat |
Bladder urothelial carcinoma |
0.019453017 |
Resistant |
| ENSG00000267213.3 |
Avagacestat |
Bladder urothelial carcinoma |
0.030624167 |
Resistant |
| ENSG00000267232.1 |
Avagacestat |
Bladder urothelial carcinoma |
0.049129776 |
Resistant |
| ENSG00000267786.1 |
Avagacestat |
Bladder urothelial carcinoma |
0.011460483 |
Resistant |
| ENSG00000267838.1 |
Avagacestat |
Bladder urothelial carcinoma |
0.028505734 |
Resistant |
| ENSG00000268230.1 |
Avagacestat |
Bladder urothelial carcinoma |
0.038423263 |
Resistant |
| ENSG00000268530.1 |
Avagacestat |
Bladder urothelial carcinoma |
0.020947285 |
Resistant |
| ENSG00000268584.1 |
Avagacestat |
Bladder urothelial carcinoma |
0.022629174 |
Resistant |
| ENSG00000268683.1 |
Avagacestat |
Bladder urothelial carcinoma |
0.03216664 |
Resistant |
| ENSG00000269161.1 |
Avagacestat |
Bladder urothelial carcinoma |
0.049474768 |
Resistant |
| ENSG00000269423.1 |
Avagacestat |
Bladder urothelial carcinoma |
0.023404032 |
Resistant |
| ENSG00000269534.1 |
Avagacestat |
Bladder urothelial carcinoma |
0.038233596 |
Resistant |
| ENSG00000269814.1 |
Avagacestat |
Bladder urothelial carcinoma |
0.036787492 |
Resistant |
| ENSG00000269815.1 |
Avagacestat |
Bladder urothelial carcinoma |
0.00776341 |
Resistant |
| ENSG00000270048.1 |
Avagacestat |
Bladder urothelial carcinoma |
0.024387071 |
Resistant |
| ENSG00000270419.1 |
Avagacestat |
Bladder urothelial carcinoma |
0.045968815 |
Resistant |
| ENSG00000270964.1 |
Avagacestat |
Bladder urothelial carcinoma |
0.046097654 |
Resistant |
| ENSG00000271327.1 |
Avagacestat |
Bladder urothelial carcinoma |
0.026553776 |
Resistant |
| ENSG00000271659.1 |
Avagacestat |
Bladder urothelial carcinoma |
0.016172447 |
Resistant |
| ENSG00000271755.1 |
Avagacestat |
Bladder urothelial carcinoma |
0.010774884 |
Resistant |
| ENSG00000271825.1 |
Avagacestat |
Bladder urothelial carcinoma |
0.009238003 |
Resistant |
| ENSG00000271835.1 |
Avagacestat |
Bladder urothelial carcinoma |
0.028309899 |
Resistant |
| ENSG00000271869.1 |
Avagacestat |
Bladder urothelial carcinoma |
0.00845573 |
Resistant |
| ENSG00000271991.1 |
Avagacestat |
Bladder urothelial carcinoma |
0.03914754 |
Resistant |
| ENSG00000271993.1 |
Avagacestat |
Bladder urothelial carcinoma |
0.011179007 |
Resistant |
| ENSG00000272205.1 |
Avagacestat |
Bladder urothelial carcinoma |
0.038147948 |
Resistant |
| ENSG00000272225.1 |
Avagacestat |
Bladder urothelial carcinoma |
0.013911714 |
Resistant |
| ENSG00000272417.1 |
Avagacestat |
Bladder urothelial carcinoma |
0.025563247 |
Resistant |
| ENSG00000272438.1 |
Avagacestat |
Bladder urothelial carcinoma |
0.038859432 |
Resistant |
| ENSG00000272444.1 |
Avagacestat |
Bladder urothelial carcinoma |
0.001972605 |
Resistant |
| ENSG00000272447.1 |
Avagacestat |
Bladder urothelial carcinoma |
0.040744282 |
Resistant |
| ENSG00000272459.1 |
Avagacestat |
Bladder urothelial carcinoma |
0.032124615 |
Resistant |
| ENSG00000272524.1 |
Avagacestat |
Bladder urothelial carcinoma |
0.048168498 |
Resistant |
| ENSG00000272525.1 |
Avagacestat |
Bladder urothelial carcinoma |
0.022100365 |
Resistant |
| ENSG00000272631.1 |
Avagacestat |
Bladder urothelial carcinoma |
0.029970927 |
Resistant |
| ENSG00000272795.1 |
Avagacestat |
Bladder urothelial carcinoma |
0.012414462 |
Resistant |
| ENSG00000272892.1 |
Avagacestat |
Bladder urothelial carcinoma |
0.018164378 |
Resistant |
| ENSG00000272953.1 |
Avagacestat |
Bladder urothelial carcinoma |
0.029603398 |
Resistant |
| ENSG00000272977.1 |
Avagacestat |
Bladder urothelial carcinoma |
0.039651569 |
Resistant |
| ENSG00000273116.1 |
Avagacestat |
Bladder urothelial carcinoma |
0.022088141 |
Resistant |
| ENSG00000273162.1 |
Avagacestat |
Bladder urothelial carcinoma |
0.021048527 |
Resistant |
| ENSG00000273329.1 |
Avagacestat |
Bladder urothelial carcinoma |
0.031160505 |
Resistant |
| ENSG00000273355.1 |
Avagacestat |
Bladder urothelial carcinoma |
0.047652094 |
Resistant |
| ENSG00000273374.1 |
Avagacestat |
Bladder urothelial carcinoma |
0.045421738 |
Resistant |
| ENSG00000273424.1 |
Avagacestat |
Bladder urothelial carcinoma |
0.043560404 |
Resistant |
| ENSG00000189223.9 |
Avagacestat |
Breast invasive carcinoma |
0.026091343 |
Resistant |
| ENSG00000223956.1 |
Avagacestat |
Breast invasive carcinoma |
0.04965347 |
Resistant |
| ENSG00000228423.2 |
Avagacestat |
Breast invasive carcinoma |
0.031889465 |
Resistant |
| ENSG00000231054.1 |
Avagacestat |
Breast invasive carcinoma |
0.047025155 |
Resistant |
| ENSG00000236467.3 |
Avagacestat |
Breast invasive carcinoma |
0.031541325 |
Resistant |
| ENSG00000257496.1 |
Avagacestat |
Breast invasive carcinoma |
0.005474056 |
Resistant |
| ENSG00000259542.1 |
Avagacestat |
Breast invasive carcinoma |
0.046128423 |
Resistant |
| ENSG00000260643.1 |
Avagacestat |
Breast invasive carcinoma |
0.045477122 |
Resistant |
| ENSG00000263718.2 |
Avagacestat |
Breast invasive carcinoma |
0.032680648 |
Resistant |
| ENSG00000267159.1 |
Avagacestat |
Breast invasive carcinoma |
0.003484429 |
Resistant |
| ENSG00000267751.1 |
Avagacestat |
Breast invasive carcinoma |
0.032898181 |
Resistant |
| ENSG00000273143.1 |
Avagacestat |
Breast invasive carcinoma |
0.026382642 |
Resistant |
| ENSG00000181798.2 |
Avagacestat |
Colon adenocarcinoma |
0.031980947 |
Resistant |
| ENSG00000212978.5 |
Avagacestat |
Colon adenocarcinoma |
0.049721937 |
Resistant |
| ENSG00000224863.1 |
Avagacestat |
Colon adenocarcinoma |
0.004938362 |
Resistant |
| ENSG00000234509.1 |
Avagacestat |
Colon adenocarcinoma |
0.027467318 |
Resistant |
| ENSG00000248596.2 |
Avagacestat |
Colon adenocarcinoma |
0.021996917 |
Resistant |
| ENSG00000249996.1 |
Avagacestat |
Colon adenocarcinoma |
0.048627677 |
Resistant |
| ENSG00000253695.1 |
Avagacestat |
Colon adenocarcinoma |
0.040134419 |
Resistant |
| ENSG00000227373.1 |
Avagacestat |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.020537224 |
Resistant |
| ENSG00000227811.2 |
Avagacestat |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.036760202 |
Resistant |
| ENSG00000228084.1 |
Avagacestat |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.037997007 |
Resistant |
| ENSG00000237438.2 |
Avagacestat |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.035642606 |
Resistant |
| ENSG00000237605.1 |
Avagacestat |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.028428648 |
Resistant |
| ENSG00000260132.1 |
Avagacestat |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.04107868 |
Resistant |
| ENSG00000260648.2 |
Avagacestat |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.037027719 |
Resistant |
| ENSG00000270168.1 |
Avagacestat |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.005690393 |
Resistant |
| ENSG00000214407.3 |
Avagacestat |
Esophageal cancer |
0.019258974 |
Resistant |
| ENSG00000223571.1 |
Avagacestat |
Esophageal cancer |
0.027995245 |
Resistant |
| ENSG00000231255.1 |
Avagacestat |
Esophageal cancer |
0.049534774 |
Resistant |
| ENSG00000234665.4 |
Avagacestat |
Esophageal cancer |
0.029488772 |
Resistant |
| ENSG00000237862.1 |
Avagacestat |
Esophageal cancer |
0.005511827 |
Resistant |
| ENSG00000240922.1 |
Avagacestat |
Esophageal cancer |
0.04108338 |
Resistant |
| ENSG00000241280.1 |
Avagacestat |
Esophageal cancer |
0.019117842 |
Resistant |
| ENSG00000247925.2 |
Avagacestat |
Esophageal cancer |
0.022503282 |
Resistant |
| ENSG00000005206.12 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.010958589 |
Resistant |
| ENSG00000170590.4 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.042100416 |
Resistant |
| ENSG00000177406.4 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.035109803 |
Resistant |
| ENSG00000179818.9 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.004157857 |
Resistant |
| ENSG00000185495.6 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.015459465 |
Resistant |
| ENSG00000185837.3 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.000352455 |
Resistant |
| ENSG00000186369.5 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.002152655 |
Resistant |
| ENSG00000197934.4 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.004335905 |
Resistant |
| ENSG00000203321.2 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.04985897 |
Resistant |
| ENSG00000203999.4 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.026266572 |
Resistant |
| ENSG00000205041.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.031449054 |
Resistant |
| ENSG00000214719.7 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.038154167 |
Resistant |
| ENSG00000214773.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.039375024 |
Resistant |
| ENSG00000223374.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.027738163 |
Resistant |
| ENSG00000223522.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.042066187 |
Resistant |
| ENSG00000223809.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.034006576 |
Resistant |
| ENSG00000223813.2 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.018405316 |
Resistant |
| ENSG00000224046.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.022904562 |
Resistant |
| ENSG00000224078.8 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.012712562 |
Resistant |
| ENSG00000224100.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.01314298 |
Resistant |
| ENSG00000224281.4 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.007485716 |
Resistant |
| ENSG00000224376.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.03347613 |
Resistant |
| ENSG00000224505.2 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.017918421 |
Resistant |
| ENSG00000224660.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.042635013 |
Resistant |
| ENSG00000224855.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.008628188 |
Resistant |
| ENSG00000224975.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.019987789 |
Resistant |
| ENSG00000225096.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.01725445 |
Resistant |
| ENSG00000225234.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.007800271 |
Resistant |
| ENSG00000225377.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.003040261 |
Resistant |
| ENSG00000225721.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.003881857 |
Resistant |
| ENSG00000225744.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.041710642 |
Resistant |
| ENSG00000225767.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.003442366 |
Resistant |
| ENSG00000225868.2 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.028841387 |
Resistant |
| ENSG00000225891.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.012667984 |
Resistant |
| ENSG00000225956.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.012444847 |
Resistant |
| ENSG00000226245.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.01486584 |
Resistant |
| ENSG00000226276.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.018264982 |
Resistant |
| ENSG00000226310.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.020751657 |
Resistant |
| ENSG00000226416.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.021620234 |
Resistant |
| ENSG00000227017.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.025557913 |
Resistant |
| ENSG00000227083.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.041316297 |
Resistant |
| ENSG00000227215.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.022020533 |
Resistant |
| ENSG00000227492.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.029473046 |
Resistant |
| ENSG00000227508.2 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.005107884 |
Resistant |
| ENSG00000227527.2 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.000000299 |
Resistant |
| ENSG00000228084.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.045045127 |
Resistant |
| ENSG00000228109.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.023089953 |
Resistant |
| ENSG00000228126.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.008864138 |
Resistant |
| ENSG00000228223.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.012333189 |
Resistant |
| ENSG00000228323.2 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.006039037 |
Resistant |
| ENSG00000228327.2 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.008129517 |
Resistant |
| ENSG00000228386.2 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.019148319 |
Resistant |
| ENSG00000228393.3 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.042648082 |
Resistant |
| ENSG00000228404.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.009118074 |
Resistant |
| ENSG00000228614.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.024654964 |
Resistant |
| ENSG00000228791.3 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.016147495 |
Resistant |
| ENSG00000228839.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.001236851 |
Resistant |
| ENSG00000229021.2 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.001387744 |
Resistant |
| ENSG00000229122.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.018327109 |
Resistant |
| ENSG00000229539.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.00032954 |
Resistant |
| ENSG00000229660.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.043987524 |
Resistant |
| ENSG00000229728.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.009267755 |
Resistant |
| ENSG00000229832.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.042975945 |
Resistant |
| ENSG00000229986.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.03135891 |
Resistant |
| ENSG00000230065.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.01869896 |
Resistant |
| ENSG00000230155.2 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.003607359 |
Resistant |
| ENSG00000230177.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.042554761 |
Resistant |
| ENSG00000230289.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.02113388 |
Resistant |
| ENSG00000230613.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.036063966 |
Resistant |
| ENSG00000230724.5 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.001457894 |
Resistant |
| ENSG00000230817.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.004044229 |
Resistant |
| ENSG00000231064.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.035349931 |
Resistant |
| ENSG00000231704.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.011318789 |
Resistant |
| ENSG00000231734.4 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.019947513 |
Resistant |
| ENSG00000232295.3 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.011792564 |
Resistant |
| ENSG00000232298.2 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.006802929 |
Resistant |
| ENSG00000232401.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.012008562 |
Resistant |
| ENSG00000232458.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.020812495 |
Resistant |
| ENSG00000232519.2 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.042561093 |
Resistant |
| ENSG00000232545.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.007680039 |
Resistant |
| ENSG00000232586.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.041899826 |
Resistant |
| ENSG00000232645.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.003387883 |
Resistant |
| ENSG00000232650.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.045592559 |
Resistant |
| ENSG00000232686.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.010781603 |
Resistant |
| ENSG00000232712.2 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.009726429 |
Resistant |
| ENSG00000232814.2 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.036922825 |
Resistant |
| ENSG00000232940.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.008518106 |
Resistant |
| ENSG00000232973.7 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.017565141 |
Resistant |
| ENSG00000233077.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.02850851 |
Resistant |
| ENSG00000233221.2 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.049323932 |
Resistant |
| ENSG00000233483.2 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.01247155 |
Resistant |
| ENSG00000233509.2 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.044427605 |
Resistant |
| ENSG00000233602.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.024971969 |
Resistant |
| ENSG00000233651.2 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.028150704 |
Resistant |
| ENSG00000233799.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.017483162 |
Resistant |
| ENSG00000233967.2 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.0353842 |
Resistant |
| ENSG00000234160.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.030787603 |
Resistant |
| ENSG00000234535.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.002094015 |
Resistant |
| ENSG00000234614.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.049416931 |
Resistant |
| ENSG00000234617.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.007967939 |
Resistant |
| ENSG00000234684.2 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.012849773 |
Resistant |
| ENSG00000234694.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.042806833 |
Resistant |
| ENSG00000234722.3 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.025090806 |
Resistant |
| ENSG00000234753.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.041737316 |
Resistant |
| ENSG00000234917.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.020998585 |
Resistant |
| ENSG00000234936.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.006314738 |
Resistant |
| ENSG00000234943.2 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.006386054 |
Resistant |
| ENSG00000235079.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.038476578 |
Resistant |
| ENSG00000235138.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.003303447 |
Resistant |
| ENSG00000235236.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.029352966 |
Resistant |
| ENSG00000235245.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.005101944 |
Resistant |
| ENSG00000235314.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.016930927 |
Resistant |
| ENSG00000235373.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.00606158 |
Resistant |
| ENSG00000235501.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.019962176 |
Resistant |
| ENSG00000235726.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.004514248 |
Resistant |
| ENSG00000235919.3 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.006558319 |
Resistant |
| ENSG00000236308.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.023490774 |
Resistant |
| ENSG00000236337.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.013921627 |
Resistant |
| ENSG00000236438.2 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.012122143 |
Resistant |
| ENSG00000236861.2 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.025014741 |
Resistant |
| ENSG00000236896.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.010656599 |
Resistant |
| ENSG00000237015.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.049299617 |
Resistant |
| ENSG00000237017.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.019651909 |
Resistant |
| ENSG00000237094.7 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.001319606 |
Resistant |
| ENSG00000237167.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.029842112 |
Resistant |
| ENSG00000237343.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.021194047 |
Resistant |
| ENSG00000237491.4 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.018983524 |
Resistant |
| ENSG00000237502.2 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.000640905 |
Resistant |
| ENSG00000237718.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.040441811 |
Resistant |
| ENSG00000237772.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.036324296 |
Resistant |
| ENSG00000237886.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.01119856 |
Resistant |
| ENSG00000238035.4 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.028091539 |
Resistant |
| ENSG00000239569.2 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.016531993 |
Resistant |
| ENSG00000239608.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.000756518 |
Resistant |
| ENSG00000239906.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.001199131 |
Resistant |
| ENSG00000240207.2 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.040746407 |
Resistant |
| ENSG00000240498.2 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.009189707 |
Resistant |
| ENSG00000240618.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.042781659 |
Resistant |
| ENSG00000241288.3 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.028669537 |
Resistant |
| ENSG00000241732.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.047238836 |
Resistant |
| ENSG00000241769.3 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.048956684 |
Resistant |
| ENSG00000241860.2 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.001868197 |
Resistant |
| ENSG00000242396.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.016453472 |
Resistant |
| ENSG00000242553.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.00916977 |
Resistant |
| ENSG00000242861.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.023824864 |
Resistant |
| ENSG00000244393.3 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.043367109 |
Resistant |
| ENSG00000245571.2 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.007042406 |
Resistant |
| ENSG00000245685.2 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.037269234 |
Resistant |
| ENSG00000245849.2 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.008467409 |
Resistant |
| ENSG00000246863.2 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.012350494 |
Resistant |
| ENSG00000247228.2 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.025192437 |
Resistant |
| ENSG00000247373.2 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.001509474 |
Resistant |
| ENSG00000247765.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.035591016 |
Resistant |
| ENSG00000247950.2 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.016624203 |
Resistant |
| ENSG00000248240.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.031372576 |
Resistant |
| ENSG00000248367.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.04373421 |
Resistant |
| ENSG00000248607.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.026959432 |
Resistant |
| ENSG00000248758.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.043252243 |
Resistant |
| ENSG00000249572.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.01200835 |
Resistant |
| ENSG00000249655.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.018674799 |
Resistant |
| ENSG00000250133.2 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.041948752 |
Resistant |
| ENSG00000250286.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.002999759 |
Resistant |
| ENSG00000250893.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.015740521 |
Resistant |
| ENSG00000250899.3 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.046094353 |
Resistant |
| ENSG00000250950.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.026712572 |
Resistant |
| ENSG00000250988.3 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.03076899 |
Resistant |
| ENSG00000250990.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.00053721 |
Resistant |
| ENSG00000251611.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.00495047 |
Resistant |
| ENSG00000251661.3 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.003766519 |
Resistant |
| ENSG00000251666.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.033456821 |
Resistant |
| ENSG00000253167.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.021750791 |
Resistant |
| ENSG00000253854.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.004349459 |
Resistant |
| ENSG00000253898.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.032355182 |
Resistant |
| ENSG00000253921.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.03267632 |
Resistant |
| ENSG00000253948.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.026519764 |
Resistant |
| ENSG00000254003.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.045213103 |
Resistant |
| ENSG00000254208.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.022270341 |
Resistant |
| ENSG00000254226.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.009818921 |
Resistant |
| ENSG00000254248.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.030510129 |
Resistant |
| ENSG00000254267.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.006181657 |
Resistant |
| ENSG00000254340.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.000723119 |
Resistant |
| ENSG00000254370.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.048384618 |
Resistant |
| ENSG00000254428.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.0211618 |
Resistant |
| ENSG00000254461.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.041121845 |
Resistant |
| ENSG00000254551.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.011925255 |
Resistant |
| ENSG00000254756.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.04656519 |
Resistant |
| ENSG00000254854.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.037300309 |
Resistant |
| ENSG00000254859.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.047510153 |
Resistant |
| ENSG00000254862.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.016336423 |
Resistant |
| ENSG00000254985.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.010496553 |
Resistant |
| ENSG00000255135.3 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.0280191 |
Resistant |
| ENSG00000255142.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.037672832 |
Resistant |
| ENSG00000255310.2 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.01305035 |
Resistant |
| ENSG00000255313.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.023774097 |
Resistant |
| ENSG00000255409.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.013909805 |
Resistant |
| ENSG00000255421.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.00077283 |
Resistant |
| ENSG00000255449.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.028879571 |
Resistant |
| ENSG00000255571.2 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.005794403 |
Resistant |
| ENSG00000255670.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.005849917 |
Resistant |
| ENSG00000255871.2 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.04054859 |
Resistant |
| ENSG00000255933.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.009075946 |
Resistant |
| ENSG00000256278.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.001027234 |
Resistant |
| ENSG00000256448.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.024624448 |
Resistant |
| ENSG00000256576.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.044934033 |
Resistant |
| ENSG00000257151.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.0415952 |
Resistant |
| ENSG00000257474.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.024606071 |
Resistant |
| ENSG00000257488.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.039251109 |
Resistant |
| ENSG00000257496.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.047538492 |
Resistant |
| ENSG00000258301.2 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.014714433 |
Resistant |
| ENSG00000258302.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.017766034 |
Resistant |
| ENSG00000258515.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.001069155 |
Resistant |
| ENSG00000258545.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.011908287 |
Resistant |
| ENSG00000258548.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.027927995 |
Resistant |
| ENSG00000258593.2 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.046886818 |
Resistant |
| ENSG00000258603.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.037524165 |
Resistant |
| ENSG00000258623.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.014934451 |
Resistant |
| ENSG00000258704.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.004571743 |
Resistant |
| ENSG00000259138.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.011151726 |
Resistant |
| ENSG00000259218.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.014689628 |
Resistant |
| ENSG00000259244.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.007728024 |
Resistant |
| ENSG00000259341.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.005385942 |
Resistant |
| ENSG00000259416.2 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.041616268 |
Resistant |
| ENSG00000259424.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.001897464 |
Resistant |
| ENSG00000259447.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.030070208 |
Resistant |
| ENSG00000259617.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.022566149 |
Resistant |
| ENSG00000259623.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.004410937 |
Resistant |
| ENSG00000259644.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.042448323 |
Resistant |
| ENSG00000259654.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.003979002 |
Resistant |
| ENSG00000259673.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.029868845 |
Resistant |
| ENSG00000259755.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.000465822 |
Resistant |
| ENSG00000259783.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.012264592 |
Resistant |
| ENSG00000259793.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.041932091 |
Resistant |
| ENSG00000259826.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.021108987 |
Resistant |
| ENSG00000259933.2 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.03125821 |
Resistant |
| ENSG00000259972.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.01191576 |
Resistant |
| ENSG00000260051.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.000805561 |
Resistant |
| ENSG00000260316.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.030033329 |
Resistant |
| ENSG00000260336.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.045401566 |
Resistant |
| ENSG00000260367.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.008596276 |
Resistant |
| ENSG00000260377.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.041190333 |
Resistant |
| ENSG00000260400.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.028729717 |
Resistant |
| ENSG00000260409.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.029344506 |
Resistant |
| ENSG00000260534.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.027422214 |
Resistant |
| ENSG00000260586.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.021541041 |
Resistant |
| ENSG00000260635.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.033199478 |
Resistant |
| ENSG00000260637.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.032187866 |
Resistant |
| ENSG00000260711.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.031702038 |
Resistant |
| ENSG00000260735.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.006591283 |
Resistant |
| ENSG00000260773.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.00082666 |
Resistant |
| ENSG00000260884.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.04875982 |
Resistant |
| ENSG00000260891.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.029424223 |
Resistant |
| ENSG00000261000.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.036062013 |
Resistant |
| ENSG00000261098.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.042536322 |
Resistant |
| ENSG00000261114.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.017700287 |
Resistant |
| ENSG00000261123.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.036691894 |
Resistant |
| ENSG00000261124.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.002734538 |
Resistant |
| ENSG00000261186.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.007668653 |
Resistant |
| ENSG00000261200.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.045307059 |
Resistant |
| ENSG00000261251.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.005293158 |
Resistant |
| ENSG00000261360.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.025798304 |
Resistant |
| ENSG00000261437.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.013789796 |
Resistant |
| ENSG00000261468.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.001853756 |
Resistant |
| ENSG00000261474.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.040915489 |
Resistant |
| ENSG00000261478.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.034171999 |
Resistant |
| ENSG00000261669.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.025628279 |
Resistant |
| ENSG00000261690.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.007902598 |
Resistant |
| ENSG00000261695.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.009176799 |
Resistant |
| ENSG00000261799.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.030936888 |
Resistant |
| ENSG00000261916.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.031195246 |
Resistant |
| ENSG00000262136.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.001935857 |
Resistant |
| ENSG00000262152.2 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.019588104 |
Resistant |
| ENSG00000262194.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.000239537 |
Resistant |
| ENSG00000262372.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.02570832 |
Resistant |
| ENSG00000262681.2 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.005192421 |
Resistant |
| ENSG00000262837.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.020470154 |
Resistant |
| ENSG00000262979.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.041814596 |
Resistant |
| ENSG00000263063.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.000876615 |
Resistant |
| ENSG00000263182.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.018359572 |
Resistant |
| ENSG00000263214.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.033023732 |
Resistant |
| ENSG00000263272.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.025170042 |
Resistant |
| ENSG00000263307.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.038724368 |
Resistant |
| ENSG00000263325.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.047234667 |
Resistant |
| ENSG00000263412.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.002230492 |
Resistant |
| ENSG00000263612.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.043552622 |
Resistant |
| ENSG00000263982.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.035788839 |
Resistant |
| ENSG00000264304.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.007628685 |
Resistant |
| ENSG00000264456.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.027583661 |
Resistant |
| ENSG00000264486.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.010431499 |
Resistant |
| ENSG00000264608.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.017629049 |
Resistant |
| ENSG00000264672.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.00179853 |
Resistant |
| ENSG00000264937.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.02542378 |
Resistant |
| ENSG00000265443.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.037386169 |
Resistant |
| ENSG00000265474.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.029762433 |
Resistant |
| ENSG00000265511.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.042552458 |
Resistant |
| ENSG00000265845.2 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.043830459 |
Resistant |
| ENSG00000266053.2 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.026932012 |
Resistant |
| ENSG00000266521.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.001183582 |
Resistant |
| ENSG00000266805.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.002702812 |
Resistant |
| ENSG00000266912.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.012740363 |
Resistant |
| ENSG00000267002.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.001439715 |
Resistant |
| ENSG00000267025.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.015135125 |
Resistant |
| ENSG00000267064.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.005017406 |
Resistant |
| ENSG00000267080.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.002966507 |
Resistant |
| ENSG00000267150.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.008433906 |
Resistant |
| ENSG00000267167.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.00113544 |
Resistant |
| ENSG00000267274.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.028597552 |
Resistant |
| ENSG00000267325.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.022619515 |
Resistant |
| ENSG00000267419.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.019273395 |
Resistant |
| ENSG00000267481.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.047632408 |
Resistant |
| ENSG00000267560.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.024739928 |
Resistant |
| ENSG00000267568.2 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.017440987 |
Resistant |
| ENSG00000267682.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.009222645 |
Resistant |
| ENSG00000267709.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.000338972 |
Resistant |
| ENSG00000267715.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.015013205 |
Resistant |
| ENSG00000267838.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.024306444 |
Resistant |
| ENSG00000268204.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.012654334 |
Resistant |
| ENSG00000268605.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.007632962 |
Resistant |
| ENSG00000269054.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.012405011 |
Resistant |
| ENSG00000269202.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.017314547 |
Resistant |
| ENSG00000269481.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.041843795 |
Resistant |
| ENSG00000269609.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.008985143 |
Resistant |
| ENSG00000269815.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.042818236 |
Resistant |
| ENSG00000269951.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.016884819 |
Resistant |
| ENSG00000270001.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.02949242 |
Resistant |
| ENSG00000270015.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.049790306 |
Resistant |
| ENSG00000270116.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.029152669 |
Resistant |
| ENSG00000270130.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.015189861 |
Resistant |
| ENSG00000270154.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.013815655 |
Resistant |
| ENSG00000270168.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.000839938 |
Resistant |
| ENSG00000270190.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.021473459 |
Resistant |
| ENSG00000270210.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.009202182 |
Resistant |
| ENSG00000270580.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.011096906 |
Resistant |
| ENSG00000270599.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.046578884 |
Resistant |
| ENSG00000270640.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.012765582 |
Resistant |
| ENSG00000270704.2 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.004787549 |
Resistant |
| ENSG00000270720.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.022159669 |
Resistant |
| ENSG00000270820.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.002843247 |
Resistant |
| ENSG00000270876.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.030975985 |
Resistant |
| ENSG00000271185.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.011950522 |
Resistant |
| ENSG00000271199.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.000457516 |
Resistant |
| ENSG00000271533.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.011460696 |
Resistant |
| ENSG00000271659.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.026418264 |
Resistant |
| ENSG00000271752.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.015080922 |
Resistant |
| ENSG00000271757.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.013801768 |
Resistant |
| ENSG00000271778.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.043696131 |
Resistant |
| ENSG00000271789.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.008480205 |
Resistant |
| ENSG00000271843.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.007526229 |
Resistant |
| ENSG00000271888.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.012467548 |
Resistant |
| ENSG00000271943.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.015407303 |
Resistant |
| ENSG00000271971.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.007860963 |
Resistant |
| ENSG00000272065.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.007529069 |
Resistant |
| ENSG00000272076.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.006934355 |
Resistant |
| ENSG00000272181.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.045828091 |
Resistant |
| ENSG00000272216.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.007546845 |
Resistant |
| ENSG00000272225.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.045389492 |
Resistant |
| ENSG00000272248.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.03192428 |
Resistant |
| ENSG00000272320.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.040066391 |
Resistant |
| ENSG00000272389.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.024834513 |
Resistant |
| ENSG00000272463.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.018635758 |
Resistant |
| ENSG00000272529.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.031922722 |
Resistant |
| ENSG00000272562.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.029677427 |
Resistant |
| ENSG00000272583.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.004450097 |
Resistant |
| ENSG00000272631.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.013894668 |
Resistant |
| ENSG00000272650.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.025067246 |
Resistant |
| ENSG00000272692.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.006442666 |
Resistant |
| ENSG00000272760.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.031409944 |
Resistant |
| ENSG00000272764.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.017236223 |
Resistant |
| ENSG00000272769.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.028525083 |
Resistant |
| ENSG00000272795.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.014165089 |
Resistant |
| ENSG00000272829.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.015747942 |
Resistant |
| ENSG00000272836.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.032541892 |
Resistant |
| ENSG00000272858.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.00156761 |
Resistant |
| ENSG00000273035.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.014399679 |
Resistant |
| ENSG00000273091.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.028812422 |
Resistant |
| ENSG00000273104.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.032767253 |
Resistant |
| ENSG00000273117.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.007987077 |
Resistant |
| ENSG00000273145.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.00056932 |
Resistant |
| ENSG00000273162.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.005898422 |
Resistant |
| ENSG00000273248.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.014865482 |
Resistant |
| ENSG00000273249.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.018211047 |
Resistant |
| ENSG00000273253.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.024736866 |
Resistant |
| ENSG00000273306.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.01753214 |
Resistant |
| ENSG00000273355.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.011355754 |
Resistant |
| ENSG00000273381.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.010266154 |
Resistant |
| ENSG00000273399.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.045481671 |
Resistant |
| ENSG00000273424.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.044542537 |
Resistant |
| ENSG00000167912.5 |
Avagacestat |
Kidney renal clear cell carcinoma |
0.020959819 |
Resistant |
| ENSG00000186594.8 |
Avagacestat |
Kidney renal clear cell carcinoma |
0.017024017 |
Resistant |
| ENSG00000187229.3 |
Avagacestat |
Kidney renal clear cell carcinoma |
0.033669935 |
Resistant |
| ENSG00000188660.3 |
Avagacestat |
Kidney renal clear cell carcinoma |
0.009319586 |
Resistant |
| ENSG00000203706.4 |
Avagacestat |
Kidney renal clear cell carcinoma |
0.030711848 |
Resistant |
| ENSG00000205266.5 |
Avagacestat |
Kidney renal clear cell carcinoma |
0.034899087 |
Resistant |
| ENSG00000214146.2 |
Avagacestat |
Kidney renal clear cell carcinoma |
0.034150812 |
Resistant |
| ENSG00000223528.3 |
Avagacestat |
Kidney renal clear cell carcinoma |
0.008572008 |
Resistant |
| ENSG00000223829.1 |
Avagacestat |
Kidney renal clear cell carcinoma |
0.011056157 |
Resistant |
| ENSG00000223975.1 |
Avagacestat |
Kidney renal clear cell carcinoma |
0.046251686 |
Resistant |
| ENSG00000224020.1 |
Avagacestat |
Kidney renal clear cell carcinoma |
0.006469296 |
Resistant |
| ENSG00000224189.2 |
Avagacestat |
Kidney renal clear cell carcinoma |
0.047250583 |
Resistant |
| ENSG00000224592.1 |
Avagacestat |
Kidney renal clear cell carcinoma |
0.005828344 |
Resistant |
| ENSG00000225764.1 |
Avagacestat |
Kidney renal clear cell carcinoma |
0.014532409 |
Resistant |
| ENSG00000226471.2 |
Avagacestat |
Kidney renal clear cell carcinoma |
0.003324709 |
Resistant |
| ENSG00000226965.1 |
Avagacestat |
Kidney renal clear cell carcinoma |
0.008839024 |
Resistant |
| ENSG00000227908.3 |
Avagacestat |
Kidney renal clear cell carcinoma |
0.040617674 |
Resistant |
| ENSG00000228063.1 |
Avagacestat |
Kidney renal clear cell carcinoma |
0.017934193 |
Resistant |
| ENSG00000228643.1 |
Avagacestat |
Kidney renal clear cell carcinoma |
0.040378159 |
Resistant |
| ENSG00000228649.4 |
Avagacestat |
Kidney renal clear cell carcinoma |
0.025531198 |
Resistant |
| ENSG00000228719.1 |
Avagacestat |
Kidney renal clear cell carcinoma |
0.006320447 |
Resistant |
| ENSG00000228838.1 |
Avagacestat |
Kidney renal clear cell carcinoma |
0.032353779 |
Resistant |
| ENSG00000229153.1 |
Avagacestat |
Kidney renal clear cell carcinoma |
0.039351246 |
Resistant |
| ENSG00000229291.1 |
Avagacestat |
Kidney renal clear cell carcinoma |
0.006460729 |
Resistant |
| ENSG00000229368.1 |
Avagacestat |
Kidney renal clear cell carcinoma |
0.029153235 |
Resistant |
| ENSG00000229647.1 |
Avagacestat |
Kidney renal clear cell carcinoma |
0.033317241 |
Resistant |
| ENSG00000230417.6 |
Avagacestat |
Kidney renal clear cell carcinoma |
0.02632597 |
Resistant |
| ENSG00000230479.1 |
Avagacestat |
Kidney renal clear cell carcinoma |
0.00092042 |
Resistant |
| ENSG00000230825.1 |
Avagacestat |
Kidney renal clear cell carcinoma |
0.01029462 |
Resistant |
| ENSG00000231563.1 |
Avagacestat |
Kidney renal clear cell carcinoma |
0.012291651 |
Resistant |
| ENSG00000232388.2 |
Avagacestat |
Kidney renal clear cell carcinoma |
0.003575215 |
Resistant |
| ENSG00000232633.3 |
Avagacestat |
Kidney renal clear cell carcinoma |
0.00618693 |
Resistant |
| ENSG00000233393.1 |
Avagacestat |
Kidney renal clear cell carcinoma |
0.049270977 |
Resistant |
| ENSG00000233621.1 |
Avagacestat |
Kidney renal clear cell carcinoma |
0.043838483 |
Resistant |
| ENSG00000233818.1 |
Avagacestat |
Kidney renal clear cell carcinoma |
0.00233048 |
Resistant |
| ENSG00000233922.1 |
Avagacestat |
Kidney renal clear cell carcinoma |
0.038831822 |
Resistant |
| ENSG00000234380.1 |
Avagacestat |
Kidney renal clear cell carcinoma |
0.04905381 |
Resistant |
| ENSG00000234428.2 |
Avagacestat |
Kidney renal clear cell carcinoma |
0.045149095 |
Resistant |
| ENSG00000235091.1 |
Avagacestat |
Kidney renal clear cell carcinoma |
0.041302794 |
Resistant |
| ENSG00000235934.1 |
Avagacestat |
Kidney renal clear cell carcinoma |
0.038158355 |
Resistant |
| ENSG00000237184.1 |
Avagacestat |
Kidney renal clear cell carcinoma |
0.043016454 |
Resistant |
| ENSG00000237187.4 |
Avagacestat |
Kidney renal clear cell carcinoma |
0.043104589 |
Resistant |
| ENSG00000237689.1 |
Avagacestat |
Kidney renal clear cell carcinoma |
0.008479182 |
Resistant |
| ENSG00000242082.1 |
Avagacestat |
Kidney renal clear cell carcinoma |
0.04097168 |
Resistant |
| ENSG00000246731.2 |
Avagacestat |
Kidney renal clear cell carcinoma |
0.018751146 |
Resistant |
| ENSG00000249304.1 |
Avagacestat |
Kidney renal clear cell carcinoma |
0.042189888 |
Resistant |
| ENSG00000249550.2 |
Avagacestat |
Kidney renal clear cell carcinoma |
0.003918635 |
Resistant |
| ENSG00000249650.1 |
Avagacestat |
Kidney renal clear cell carcinoma |
0.010105307 |
Resistant |
| ENSG00000250988.3 |
Avagacestat |
Kidney renal clear cell carcinoma |
0.010949766 |
Resistant |
| ENSG00000251161.2 |
Avagacestat |
Kidney renal clear cell carcinoma |
0.03721356 |
Resistant |
| ENSG00000251179.1 |
Avagacestat |
Kidney renal clear cell carcinoma |
0.013661661 |
Resistant |
| ENSG00000251279.1 |
Avagacestat |
Kidney renal clear cell carcinoma |
0.013514763 |
Resistant |
| ENSG00000251405.2 |
Avagacestat |
Kidney renal clear cell carcinoma |
0.035783526 |
Resistant |
| ENSG00000251532.1 |
Avagacestat |
Kidney renal clear cell carcinoma |
0.017848073 |
Resistant |
| ENSG00000254226.1 |
Avagacestat |
Kidney renal clear cell carcinoma |
0.011509953 |
Resistant |
| ENSG00000255227.1 |
Avagacestat |
Kidney renal clear cell carcinoma |
0.039460204 |
Resistant |
| ENSG00000255446.1 |
Avagacestat |
Kidney renal clear cell carcinoma |
0.026560554 |
Resistant |
| ENSG00000257391.1 |
Avagacestat |
Kidney renal clear cell carcinoma |
0.035863923 |
Resistant |
| ENSG00000257563.1 |
Avagacestat |
Kidney renal clear cell carcinoma |
0.012737597 |
Resistant |
| ENSG00000257815.1 |
Avagacestat |
Kidney renal clear cell carcinoma |
0.026068503 |
Resistant |
| ENSG00000259867.1 |
Avagacestat |
Kidney renal clear cell carcinoma |
0.00033329 |
Resistant |
| ENSG00000260209.1 |
Avagacestat |
Kidney renal clear cell carcinoma |
0.019006486 |
Resistant |
| ENSG00000260626.1 |
Avagacestat |
Kidney renal clear cell carcinoma |
0.011621848 |
Resistant |
| ENSG00000260877.1 |
Avagacestat |
Kidney renal clear cell carcinoma |
0.031853899 |
Resistant |
| ENSG00000260992.1 |
Avagacestat |
Kidney renal clear cell carcinoma |
0.016914132 |
Resistant |
| ENSG00000261105.1 |
Avagacestat |
Kidney renal clear cell carcinoma |
0.043314785 |
Resistant |
| ENSG00000261188.1 |
Avagacestat |
Kidney renal clear cell carcinoma |
0.007020433 |
Resistant |
| ENSG00000261490.1 |
Avagacestat |
Kidney renal clear cell carcinoma |
0.012296222 |
Resistant |
| ENSG00000262171.1 |
Avagacestat |
Kidney renal clear cell carcinoma |
0.026859047 |
Resistant |
| ENSG00000262454.1 |
Avagacestat |
Kidney renal clear cell carcinoma |
0.034953118 |
Resistant |
| ENSG00000262979.1 |
Avagacestat |
Kidney renal clear cell carcinoma |
0.030085502 |
Resistant |
| ENSG00000263718.2 |
Avagacestat |
Kidney renal clear cell carcinoma |
0.049396636 |
Resistant |
| ENSG00000265478.1 |
Avagacestat |
Kidney renal clear cell carcinoma |
0.007160649 |
Resistant |
| ENSG00000266903.1 |
Avagacestat |
Kidney renal clear cell carcinoma |
0.044580967 |
Resistant |
| ENSG00000267243.1 |
Avagacestat |
Kidney renal clear cell carcinoma |
0.031644618 |
Resistant |
| ENSG00000267405.1 |
Avagacestat |
Kidney renal clear cell carcinoma |
0.028210076 |
Resistant |
| ENSG00000267439.1 |
Avagacestat |
Kidney renal clear cell carcinoma |
0.0237027 |
Resistant |
| ENSG00000267582.1 |
Avagacestat |
Kidney renal clear cell carcinoma |
0.04278053 |
Resistant |
| ENSG00000268001.1 |
Avagacestat |
Kidney renal clear cell carcinoma |
0.006221404 |
Resistant |
| ENSG00000269202.1 |
Avagacestat |
Kidney renal clear cell carcinoma |
0.035162351 |
Resistant |
| ENSG00000269487.1 |
Avagacestat |
Kidney renal clear cell carcinoma |
0.046066938 |
Resistant |
| ENSG00000270031.1 |
Avagacestat |
Kidney renal clear cell carcinoma |
0.020709752 |
Resistant |
| ENSG00000270164.1 |
Avagacestat |
Kidney renal clear cell carcinoma |
0.037612707 |
Resistant |
| ENSG00000271778.1 |
Avagacestat |
Kidney renal clear cell carcinoma |
0.004031564 |
Resistant |
| ENSG00000271874.1 |
Avagacestat |
Kidney renal clear cell carcinoma |
0.00316923 |
Resistant |
| ENSG00000272191.1 |
Avagacestat |
Kidney renal clear cell carcinoma |
0.011870728 |
Resistant |
| ENSG00000272523.1 |
Avagacestat |
Kidney renal clear cell carcinoma |
0.024797257 |
Resistant |
| ENSG00000272630.1 |
Avagacestat |
Kidney renal clear cell carcinoma |
0.02426359 |
Resistant |
| ENSG00000272657.1 |
Avagacestat |
Kidney renal clear cell carcinoma |
0.030880829 |
Resistant |
| ENSG00000273058.1 |
Avagacestat |
Kidney renal clear cell carcinoma |
0.000649195 |
Resistant |
| ENSG00000273102.1 |
Avagacestat |
Kidney renal clear cell carcinoma |
0.049835385 |
Resistant |
| ENSG00000223882.1 |
Avagacestat |
Chronic Lymphocytic Leukemia |
0.030927472 |
Resistant |
| ENSG00000223901.1 |
Avagacestat |
Chronic Lymphocytic Leukemia |
0.022677936 |
Resistant |
| ENSG00000224441.1 |
Avagacestat |
Chronic Lymphocytic Leukemia |
0.008657747 |
Resistant |
| ENSG00000224609.2 |
Avagacestat |
Chronic Lymphocytic Leukemia |
0.037784212 |
Resistant |
| ENSG00000225138.3 |
Avagacestat |
Chronic Lymphocytic Leukemia |
0.021072186 |
Resistant |
| ENSG00000226853.2 |
Avagacestat |
Chronic Lymphocytic Leukemia |
0.012439996 |
Resistant |
| ENSG00000227375.1 |
Avagacestat |
Chronic Lymphocytic Leukemia |
0.034508238 |
Resistant |
| ENSG00000227946.1 |
Avagacestat |
Chronic Lymphocytic Leukemia |
0.03759042 |
Resistant |
| ENSG00000228065.6 |
Avagacestat |
Chronic Lymphocytic Leukemia |
0.025140278 |
Resistant |
| ENSG00000229874.2 |
Avagacestat |
Chronic Lymphocytic Leukemia |
0.011985113 |
Resistant |
| ENSG00000231842.1 |
Avagacestat |
Chronic Lymphocytic Leukemia |
0.026740302 |
Resistant |
| ENSG00000232811.1 |
Avagacestat |
Chronic Lymphocytic Leukemia |
0.036523898 |
Resistant |
| ENSG00000233220.3 |
Avagacestat |
Chronic Lymphocytic Leukemia |
0.025614059 |
Resistant |
| ENSG00000233509.2 |
Avagacestat |
Chronic Lymphocytic Leukemia |
0.042177231 |
Resistant |
| ENSG00000233613.1 |
Avagacestat |
Chronic Lymphocytic Leukemia |
0.03969272 |
Resistant |
| ENSG00000233725.3 |
Avagacestat |
Chronic Lymphocytic Leukemia |
0.001879082 |
Resistant |
| ENSG00000233797.1 |
Avagacestat |
Chronic Lymphocytic Leukemia |
0.031983217 |
Resistant |
| ENSG00000234902.2 |
Avagacestat |
Chronic Lymphocytic Leukemia |
0.028500776 |
Resistant |
| ENSG00000235245.1 |
Avagacestat |
Chronic Lymphocytic Leukemia |
0.018192262 |
Resistant |
| ENSG00000236199.1 |
Avagacestat |
Chronic Lymphocytic Leukemia |
0.027496578 |
Resistant |
| ENSG00000236753.1 |
Avagacestat |
Chronic Lymphocytic Leukemia |
0.028313164 |
Resistant |
| ENSG00000236933.1 |
Avagacestat |
Chronic Lymphocytic Leukemia |
0.027712168 |
Resistant |
| ENSG00000237188.3 |
Avagacestat |
Chronic Lymphocytic Leukemia |
0.02428267 |
Resistant |
| ENSG00000240440.1 |
Avagacestat |
Chronic Lymphocytic Leukemia |
0.043249665 |
Resistant |
| ENSG00000242791.2 |
Avagacestat |
Chronic Lymphocytic Leukemia |
0.033863603 |
Resistant |
| ENSG00000246863.2 |
Avagacestat |
Chronic Lymphocytic Leukemia |
0.023717443 |
Resistant |
| ENSG00000249348.1 |
Avagacestat |
Chronic Lymphocytic Leukemia |
0.02693737 |
Resistant |
| ENSG00000250748.2 |
Avagacestat |
Chronic Lymphocytic Leukemia |
0.035299432 |
Resistant |
| ENSG00000251396.2 |
Avagacestat |
Chronic Lymphocytic Leukemia |
0.007051641 |
Resistant |
| ENSG00000253174.2 |
Avagacestat |
Chronic Lymphocytic Leukemia |
0.040029455 |
Resistant |
| ENSG00000253399.1 |
Avagacestat |
Chronic Lymphocytic Leukemia |
0.044199283 |
Resistant |
| ENSG00000254699.1 |
Avagacestat |
Chronic Lymphocytic Leukemia |
0.030648275 |
Resistant |
| ENSG00000255050.1 |
Avagacestat |
Chronic Lymphocytic Leukemia |
0.001064395 |
Resistant |
| ENSG00000255165.1 |
Avagacestat |
Chronic Lymphocytic Leukemia |
0.003320644 |
Resistant |
| ENSG00000256482.1 |
Avagacestat |
Chronic Lymphocytic Leukemia |
0.002866843 |
Resistant |
| ENSG00000257808.1 |
Avagacestat |
Chronic Lymphocytic Leukemia |
0.032037892 |
Resistant |
| ENSG00000258821.1 |
Avagacestat |
Chronic Lymphocytic Leukemia |
0.032811253 |
Resistant |
| ENSG00000258922.1 |
Avagacestat |
Chronic Lymphocytic Leukemia |
0.032151987 |
Resistant |
| ENSG00000259967.1 |
Avagacestat |
Chronic Lymphocytic Leukemia |
0.031955206 |
Resistant |
| ENSG00000260190.1 |
Avagacestat |
Chronic Lymphocytic Leukemia |
0.047883656 |
Resistant |
| ENSG00000260394.2 |
Avagacestat |
Chronic Lymphocytic Leukemia |
0.013777643 |
Resistant |
| ENSG00000260651.1 |
Avagacestat |
Chronic Lymphocytic Leukemia |
0.049354277 |
Resistant |
| ENSG00000260661.1 |
Avagacestat |
Chronic Lymphocytic Leukemia |
0.008144083 |
Resistant |
| ENSG00000261069.2 |
Avagacestat |
Chronic Lymphocytic Leukemia |
0.044183039 |
Resistant |
| ENSG00000261663.1 |
Avagacestat |
Chronic Lymphocytic Leukemia |
0.003771354 |
Resistant |
| ENSG00000266176.1 |
Avagacestat |
Chronic Lymphocytic Leukemia |
0.043412709 |
Resistant |
| ENSG00000267778.1 |
Avagacestat |
Chronic Lymphocytic Leukemia |
0.048221348 |
Resistant |
| ENSG00000267927.1 |
Avagacestat |
Chronic Lymphocytic Leukemia |
0.029371045 |
Resistant |
| ENSG00000268204.1 |
Avagacestat |
Chronic Lymphocytic Leukemia |
0.002994984 |
Resistant |
| ENSG00000269653.1 |
Avagacestat |
Chronic Lymphocytic Leukemia |
0.043873734 |
Resistant |
| ENSG00000269973.1 |
Avagacestat |
Chronic Lymphocytic Leukemia |
0.032233365 |
Resistant |
| ENSG00000269996.1 |
Avagacestat |
Chronic Lymphocytic Leukemia |
0.039693123 |
Resistant |
| ENSG00000270015.1 |
Avagacestat |
Chronic Lymphocytic Leukemia |
0.007350558 |
Resistant |
| ENSG00000270055.1 |
Avagacestat |
Chronic Lymphocytic Leukemia |
0.044038794 |
Resistant |
| ENSG00000270571.2 |
Avagacestat |
Chronic Lymphocytic Leukemia |
0.035777653 |
Resistant |
| ENSG00000271327.1 |
Avagacestat |
Chronic Lymphocytic Leukemia |
0.039988382 |
Resistant |
| ENSG00000272172.1 |
Avagacestat |
Chronic Lymphocytic Leukemia |
0.023368954 |
Resistant |
| ENSG00000272183.1 |
Avagacestat |
Chronic Lymphocytic Leukemia |
0.046181897 |
Resistant |
| ENSG00000272217.1 |
Avagacestat |
Chronic Lymphocytic Leukemia |
0.002217215 |
Resistant |
| ENSG00000215692.2 |
Avagacestat |
Brain lower grade glioma |
0.013206411 |
Resistant |
| ENSG00000223561.2 |
Avagacestat |
Brain lower grade glioma |
0.046330934 |
Resistant |
| ENSG00000223799.1 |
Avagacestat |
Brain lower grade glioma |
0.012973772 |
Resistant |
| ENSG00000224969.1 |
Avagacestat |
Brain lower grade glioma |
0.01849612 |
Resistant |
| ENSG00000225138.3 |
Avagacestat |
Brain lower grade glioma |
0.023932832 |
Resistant |
| ENSG00000226089.2 |
Avagacestat |
Brain lower grade glioma |
0.037328275 |
Resistant |
| ENSG00000232192.1 |
Avagacestat |
Brain lower grade glioma |
0.040270959 |
Resistant |
| ENSG00000232973.7 |
Avagacestat |
Brain lower grade glioma |
0.024285998 |
Resistant |
| ENSG00000232986.1 |
Avagacestat |
Brain lower grade glioma |
0.01085279 |
Resistant |
| ENSG00000235049.1 |
Avagacestat |
Brain lower grade glioma |
0.00567761 |
Resistant |
| ENSG00000236051.2 |
Avagacestat |
Brain lower grade glioma |
0.041393911 |
Resistant |
| ENSG00000236708.1 |
Avagacestat |
Brain lower grade glioma |
0.047475004 |
Resistant |
| ENSG00000236886.2 |
Avagacestat |
Brain lower grade glioma |
0.029820878 |
Resistant |
| ENSG00000248479.1 |
Avagacestat |
Brain lower grade glioma |
0.012076284 |
Resistant |
| ENSG00000249309.1 |
Avagacestat |
Brain lower grade glioma |
0.0427769 |
Resistant |
| ENSG00000250846.2 |
Avagacestat |
Brain lower grade glioma |
0.015439578 |
Resistant |
| ENSG00000253733.2 |
Avagacestat |
Brain lower grade glioma |
0.048199222 |
Resistant |
| ENSG00000253864.1 |
Avagacestat |
Brain lower grade glioma |
0.039206692 |
Resistant |
| ENSG00000254031.1 |
Avagacestat |
Brain lower grade glioma |
0.025187847 |
Resistant |
| ENSG00000254281.1 |
Avagacestat |
Brain lower grade glioma |
0.032569264 |
Resistant |
| ENSG00000255314.1 |
Avagacestat |
Brain lower grade glioma |
0.041486314 |
Resistant |
| ENSG00000255476.1 |
Avagacestat |
Brain lower grade glioma |
0.039673685 |
Resistant |
| ENSG00000255790.1 |
Avagacestat |
Brain lower grade glioma |
0.011156527 |
Resistant |
| ENSG00000256025.1 |
Avagacestat |
Brain lower grade glioma |
0.042905665 |
Resistant |
| ENSG00000256824.1 |
Avagacestat |
Brain lower grade glioma |
0.032480496 |
Resistant |
| ENSG00000259372.1 |
Avagacestat |
Brain lower grade glioma |
0.033693965 |
Resistant |
| ENSG00000260619.1 |
Avagacestat |
Brain lower grade glioma |
0.038064238 |
Resistant |
| ENSG00000260744.1 |
Avagacestat |
Brain lower grade glioma |
0.036165123 |
Resistant |
| ENSG00000261888.1 |
Avagacestat |
Brain lower grade glioma |
0.016403466 |
Resistant |
| ENSG00000262434.1 |
Avagacestat |
Brain lower grade glioma |
0.02764429 |
Resistant |
| ENSG00000262585.1 |
Avagacestat |
Brain lower grade glioma |
0.045453111 |
Resistant |
| ENSG00000267414.1 |
Avagacestat |
Brain lower grade glioma |
0.038448286 |
Resistant |
| ENSG00000272519.1 |
Avagacestat |
Brain lower grade glioma |
0.031256887 |
Resistant |
| ENSG00000272970.1 |
Avagacestat |
Brain lower grade glioma |
0.025192811 |
Resistant |
| ENSG00000177406.4 |
Avagacestat |
Lung squamous cell carcinoma |
0.032626358 |
Resistant |
| ENSG00000180458.2 |
Avagacestat |
Lung squamous cell carcinoma |
0.026236722 |
Resistant |
| ENSG00000215533.4 |
Avagacestat |
Lung squamous cell carcinoma |
0.028987945 |
Resistant |
| ENSG00000223811.1 |
Avagacestat |
Lung squamous cell carcinoma |
0.021576678 |
Resistant |
| ENSG00000224995.1 |
Avagacestat |
Lung squamous cell carcinoma |
0.015013756 |
Resistant |
| ENSG00000225063.1 |
Avagacestat |
Lung squamous cell carcinoma |
0.045629412 |
Resistant |
| ENSG00000225187.1 |
Avagacestat |
Lung squamous cell carcinoma |
0.005737247 |
Resistant |
| ENSG00000225760.1 |
Avagacestat |
Lung squamous cell carcinoma |
0.015298502 |
Resistant |
| ENSG00000225850.2 |
Avagacestat |
Lung squamous cell carcinoma |
0.037722611 |
Resistant |
| ENSG00000226277.1 |
Avagacestat |
Lung squamous cell carcinoma |
0.049923546 |
Resistant |
| ENSG00000226363.3 |
Avagacestat |
Lung squamous cell carcinoma |
0.012667874 |
Resistant |
| ENSG00000226954.1 |
Avagacestat |
Lung squamous cell carcinoma |
0.033333426 |
Resistant |
| ENSG00000227060.2 |
Avagacestat |
Lung squamous cell carcinoma |
0.015703089 |
Resistant |
| ENSG00000227128.3 |
Avagacestat |
Lung squamous cell carcinoma |
0.036359491 |
Resistant |
| ENSG00000227252.1 |
Avagacestat |
Lung squamous cell carcinoma |
0.036521894 |
Resistant |
| ENSG00000227533.1 |
Avagacestat |
Lung squamous cell carcinoma |
0.04529959 |
Resistant |
| ENSG00000228063.1 |
Avagacestat |
Lung squamous cell carcinoma |
0.049542448 |
Resistant |
| ENSG00000228072.1 |
Avagacestat |
Lung squamous cell carcinoma |
0.03636853 |
Resistant |
| ENSG00000228313.3 |
Avagacestat |
Lung squamous cell carcinoma |
0.047519436 |
Resistant |
| ENSG00000229153.1 |
Avagacestat |
Lung squamous cell carcinoma |
0.024060787 |
Resistant |
| ENSG00000231272.1 |
Avagacestat |
Lung squamous cell carcinoma |
0.036150761 |
Resistant |
| ENSG00000231367.1 |
Avagacestat |
Lung squamous cell carcinoma |
0.048273793 |
Resistant |
| ENSG00000231424.2 |
Avagacestat |
Lung squamous cell carcinoma |
0.0473239 |
Resistant |
| ENSG00000232053.2 |
Avagacestat |
Lung squamous cell carcinoma |
0.024949169 |
Resistant |
| ENSG00000232415.1 |
Avagacestat |
Lung squamous cell carcinoma |
0.027303354 |
Resistant |
| ENSG00000232613.2 |
Avagacestat |
Lung squamous cell carcinoma |
0.027486547 |
Resistant |
| ENSG00000232807.2 |
Avagacestat |
Lung squamous cell carcinoma |
0.04316929 |
Resistant |
| ENSG00000233191.1 |
Avagacestat |
Lung squamous cell carcinoma |
0.037872354 |
Resistant |
| ENSG00000234380.1 |
Avagacestat |
Lung squamous cell carcinoma |
0.023050304 |
Resistant |
| ENSG00000234779.1 |
Avagacestat |
Lung squamous cell carcinoma |
0.049879522 |
Resistant |
| ENSG00000235096.1 |
Avagacestat |
Lung squamous cell carcinoma |
0.033920296 |
Resistant |
| ENSG00000235501.1 |
Avagacestat |
Lung squamous cell carcinoma |
0.035513205 |
Resistant |
| ENSG00000236390.1 |
Avagacestat |
Lung squamous cell carcinoma |
0.01328392 |
Resistant |
| ENSG00000236510.1 |
Avagacestat |
Lung squamous cell carcinoma |
0.045561869 |
Resistant |
| ENSG00000236977.1 |
Avagacestat |
Lung squamous cell carcinoma |
0.022107273 |
Resistant |
| ENSG00000237234.2 |
Avagacestat |
Lung squamous cell carcinoma |
0.032505004 |
Resistant |
| ENSG00000237352.2 |
Avagacestat |
Lung squamous cell carcinoma |
0.015780712 |
Resistant |
| ENSG00000237803.1 |
Avagacestat |
Lung squamous cell carcinoma |
0.03946651 |
Resistant |
| ENSG00000238186.1 |
Avagacestat |
Lung squamous cell carcinoma |
0.002700411 |
Resistant |
| ENSG00000238224.1 |
Avagacestat |
Lung squamous cell carcinoma |
0.040989267 |
Resistant |
| ENSG00000238287.1 |
Avagacestat |
Lung squamous cell carcinoma |
0.023534136 |
Resistant |
| ENSG00000239519.1 |
Avagacestat |
Lung squamous cell carcinoma |
0.043505773 |
Resistant |
| ENSG00000241679.2 |
Avagacestat |
Lung squamous cell carcinoma |
0.041855933 |
Resistant |
| ENSG00000243055.1 |
Avagacestat |
Lung squamous cell carcinoma |
0.011740227 |
Resistant |
| ENSG00000244137.1 |
Avagacestat |
Lung squamous cell carcinoma |
0.02482141 |
Resistant |
| ENSG00000246763.2 |
Avagacestat |
Lung squamous cell carcinoma |
0.028891077 |
Resistant |
| ENSG00000246859.2 |
Avagacestat |
Lung squamous cell carcinoma |
0.010061923 |
Resistant |
| ENSG00000248265.1 |
Avagacestat |
Lung squamous cell carcinoma |
0.039387544 |
Resistant |
| ENSG00000248664.1 |
Avagacestat |
Lung squamous cell carcinoma |
0.004577469 |
Resistant |
| ENSG00000249094.2 |
Avagacestat |
Lung squamous cell carcinoma |
0.023436026 |
Resistant |
| ENSG00000249483.1 |
Avagacestat |
Lung squamous cell carcinoma |
0.006868232 |
Resistant |
| ENSG00000250240.1 |
Avagacestat |
Lung squamous cell carcinoma |
0.021494112 |
Resistant |
| ENSG00000250432.1 |
Avagacestat |
Lung squamous cell carcinoma |
0.047688819 |
Resistant |
| ENSG00000250708.1 |
Avagacestat |
Lung squamous cell carcinoma |
0.037784639 |
Resistant |
| ENSG00000251309.1 |
Avagacestat |
Lung squamous cell carcinoma |
0.030521734 |
Resistant |
| ENSG00000251314.2 |
Avagacestat |
Lung squamous cell carcinoma |
0.016250018 |
Resistant |
| ENSG00000251523.1 |
Avagacestat |
Lung squamous cell carcinoma |
0.015706334 |
Resistant |
| ENSG00000253978.1 |
Avagacestat |
Lung squamous cell carcinoma |
0.037141108 |
Resistant |
| ENSG00000254427.1 |
Avagacestat |
Lung squamous cell carcinoma |
0.043638475 |
Resistant |
| ENSG00000254460.1 |
Avagacestat |
Lung squamous cell carcinoma |
0.04880457 |
Resistant |
| ENSG00000255029.1 |
Avagacestat |
Lung squamous cell carcinoma |
0.04821284 |
Resistant |
| ENSG00000255440.1 |
Avagacestat |
Lung squamous cell carcinoma |
0.049104704 |
Resistant |
| ENSG00000255652.2 |
Avagacestat |
Lung squamous cell carcinoma |
0.017754897 |
Resistant |
| ENSG00000256101.1 |
Avagacestat |
Lung squamous cell carcinoma |
0.047567238 |
Resistant |
| ENSG00000257126.1 |
Avagacestat |
Lung squamous cell carcinoma |
0.026790056 |
Resistant |
| ENSG00000258414.1 |
Avagacestat |
Lung squamous cell carcinoma |
0.039471118 |
Resistant |
| ENSG00000258983.1 |
Avagacestat |
Lung squamous cell carcinoma |
0.010368434 |
Resistant |
| ENSG00000259372.1 |
Avagacestat |
Lung squamous cell carcinoma |
0.043910603 |
Resistant |
| ENSG00000260306.1 |
Avagacestat |
Lung squamous cell carcinoma |
0.019207933 |
Resistant |
| ENSG00000260331.1 |
Avagacestat |
Lung squamous cell carcinoma |
0.039164661 |
Resistant |
| ENSG00000260400.1 |
Avagacestat |
Lung squamous cell carcinoma |
0.02894508 |
Resistant |
| ENSG00000261801.1 |
Avagacestat |
Lung squamous cell carcinoma |
0.044618451 |
Resistant |
| ENSG00000263063.1 |
Avagacestat |
Lung squamous cell carcinoma |
0.02176734 |
Resistant |
| ENSG00000264365.1 |
Avagacestat |
Lung squamous cell carcinoma |
0.013782212 |
Resistant |
| ENSG00000264666.1 |
Avagacestat |
Lung squamous cell carcinoma |
0.02849011 |
Resistant |
| ENSG00000266916.1 |
Avagacestat |
Lung squamous cell carcinoma |
0.008348641 |
Resistant |
| ENSG00000266918.1 |
Avagacestat |
Lung squamous cell carcinoma |
0.028944475 |
Resistant |
| ENSG00000267058.1 |
Avagacestat |
Lung squamous cell carcinoma |
0.04538575 |
Resistant |
| ENSG00000267470.1 |
Avagacestat |
Lung squamous cell carcinoma |
0.012707288 |
Resistant |
| ENSG00000267547.1 |
Avagacestat |
Lung squamous cell carcinoma |
0.022236925 |
Resistant |
| ENSG00000267563.1 |
Avagacestat |
Lung squamous cell carcinoma |
0.032645461 |
Resistant |
| ENSG00000267711.1 |
Avagacestat |
Lung squamous cell carcinoma |
0.013072811 |
Resistant |
| ENSG00000267761.2 |
Avagacestat |
Lung squamous cell carcinoma |
0.009365369 |
Resistant |
| ENSG00000267927.1 |
Avagacestat |
Lung squamous cell carcinoma |
0.012330104 |
Resistant |
| ENSG00000268601.1 |
Avagacestat |
Lung squamous cell carcinoma |
0.022335562 |
Resistant |
| ENSG00000269834.1 |
Avagacestat |
Lung squamous cell carcinoma |
0.011301425 |
Resistant |
| ENSG00000270237.1 |
Avagacestat |
Lung squamous cell carcinoma |
0.04278912 |
Resistant |
| ENSG00000270346.1 |
Avagacestat |
Lung squamous cell carcinoma |
0.025338395 |
Resistant |
| ENSG00000271782.1 |
Avagacestat |
Lung squamous cell carcinoma |
0.007630871 |
Resistant |
| ENSG00000271815.1 |
Avagacestat |
Lung squamous cell carcinoma |
0.008804154 |
Resistant |
| ENSG00000271916.1 |
Avagacestat |
Lung squamous cell carcinoma |
0.02848034 |
Resistant |
| ENSG00000272320.1 |
Avagacestat |
Lung squamous cell carcinoma |
0.01719717 |
Resistant |
| ENSG00000272330.1 |
Avagacestat |
Lung squamous cell carcinoma |
0.049102203 |
Resistant |
| ENSG00000272479.1 |
Avagacestat |
Lung squamous cell carcinoma |
0.030348185 |
Resistant |
| ENSG00000272931.1 |
Avagacestat |
Lung squamous cell carcinoma |
0.010538351 |
Resistant |
| ENSG00000273017.1 |
Avagacestat |
Lung squamous cell carcinoma |
0.004735907 |
Resistant |
| ENSG00000273372.1 |
Avagacestat |
Lung squamous cell carcinoma |
0.023983969 |
Resistant |
| ENSG00000178412.4 |
Avagacestat |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.017891983 |
Resistant |
| ENSG00000179935.5 |
Avagacestat |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.048824052 |
Resistant |
| ENSG00000196559.3 |
Avagacestat |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.049353703 |
Resistant |
| ENSG00000203325.3 |
Avagacestat |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.020435872 |
Resistant |
| ENSG00000203709.5 |
Avagacestat |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.031132348 |
Resistant |
| ENSG00000214837.4 |
Avagacestat |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.02746562 |
Resistant |
| ENSG00000215374.5 |
Avagacestat |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.009953502 |
Resistant |
| ENSG00000215908.5 |
Avagacestat |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.015273517 |
Resistant |
| ENSG00000224533.3 |
Avagacestat |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.006560672 |
Resistant |
| ENSG00000224888.3 |
Avagacestat |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.021937714 |
Resistant |
| ENSG00000225725.4 |
Avagacestat |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.018052681 |
Resistant |
| ENSG00000225798.1 |
Avagacestat |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.006539544 |
Resistant |
| ENSG00000226312.3 |
Avagacestat |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.048336486 |
Resistant |
| ENSG00000226690.2 |
Avagacestat |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.01019237 |
Resistant |
| ENSG00000227388.2 |
Avagacestat |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.002593246 |
Resistant |
| ENSG00000227398.3 |
Avagacestat |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.039984647 |
Resistant |
| ENSG00000228028.2 |
Avagacestat |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.046622967 |
Resistant |
| ENSG00000228302.2 |
Avagacestat |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.022273707 |
Resistant |
| ENSG00000228363.2 |
Avagacestat |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.016500544 |
Resistant |
| ENSG00000228389.1 |
Avagacestat |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.001699284 |
Resistant |
| ENSG00000228544.1 |
Avagacestat |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.032973739 |
Resistant |
| ENSG00000228838.1 |
Avagacestat |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.00800503 |
Resistant |
| ENSG00000229180.4 |
Avagacestat |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.011459233 |
Resistant |
| ENSG00000229512.1 |
Avagacestat |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.026598921 |
Resistant |
| ENSG00000229587.2 |
Avagacestat |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.013345758 |
Resistant |
| ENSG00000229841.1 |
Avagacestat |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.020586967 |
Resistant |
| ENSG00000231393.1 |
Avagacestat |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.015711915 |
Resistant |
| ENSG00000231595.1 |
Avagacestat |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.011833995 |
Resistant |
| ENSG00000231646.1 |
Avagacestat |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.035689778 |
Resistant |
| ENSG00000231993.1 |
Avagacestat |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.03579206 |
Resistant |
| ENSG00000232116.2 |
Avagacestat |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.043299442 |
Resistant |
| ENSG00000232656.3 |
Avagacestat |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.019622695 |
Resistant |
| ENSG00000233527.4 |
Avagacestat |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.043983432 |
Resistant |
| ENSG00000233602.1 |
Avagacestat |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.031122045 |
Resistant |
| ENSG00000234185.2 |
Avagacestat |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.049900044 |
Resistant |
| ENSG00000234232.2 |
Avagacestat |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.030772634 |
Resistant |
| ENSG00000234630.1 |
Avagacestat |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.018645707 |
Resistant |
| ENSG00000234789.1 |
Avagacestat |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.028641342 |
Resistant |
| ENSG00000235298.1 |
Avagacestat |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.007137026 |
Resistant |
| ENSG00000235499.1 |
Avagacestat |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.014489378 |
Resistant |
| ENSG00000235897.1 |
Avagacestat |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.043036869 |
Resistant |
| ENSG00000235908.1 |
Avagacestat |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.029504513 |
Resistant |
| ENSG00000236498.1 |
Avagacestat |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.00545285 |
Resistant |
| ENSG00000236601.1 |
Avagacestat |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.026988971 |
Resistant |
| ENSG00000236869.1 |
Avagacestat |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.007934916 |
Resistant |
| ENSG00000237200.1 |
Avagacestat |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.034845783 |
Resistant |
| ENSG00000237248.3 |
Avagacestat |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.044817478 |
Resistant |
| ENSG00000237529.1 |
Avagacestat |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.027900156 |
Resistant |
| ENSG00000238039.1 |
Avagacestat |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.02042647 |
Resistant |
| ENSG00000238045.5 |
Avagacestat |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.043054964 |
Resistant |
| ENSG00000239377.1 |
Avagacestat |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.042405452 |
Resistant |
| ENSG00000240137.1 |
Avagacestat |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.025672973 |
Resistant |
| ENSG00000241014.1 |
Avagacestat |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.034099985 |
Resistant |
| ENSG00000242288.6 |
Avagacestat |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.017991113 |
Resistant |
| ENSG00000245060.2 |
Avagacestat |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.042350078 |
Resistant |
| ENSG00000245149.3 |
Avagacestat |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.037013551 |
Resistant |
| ENSG00000246898.1 |
Avagacestat |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.014978952 |
Resistant |
| ENSG00000247199.3 |
Avagacestat |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.000231504 |
Resistant |
| ENSG00000247572.3 |
Avagacestat |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.048158909 |
Resistant |
| ENSG00000247982.2 |
Avagacestat |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.01388383 |
Resistant |
| ENSG00000248019.2 |
Avagacestat |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.0356124 |
Resistant |
| ENSG00000248514.1 |
Avagacestat |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.045568155 |
Resistant |
| ENSG00000248925.1 |
Avagacestat |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.040743642 |
Resistant |
| ENSG00000248936.1 |
Avagacestat |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.030164484 |
Resistant |
| ENSG00000249476.1 |
Avagacestat |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.032808951 |
Resistant |
| ENSG00000249637.1 |
Avagacestat |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.011305284 |
Resistant |
| ENSG00000249655.1 |
Avagacestat |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.018605703 |
Resistant |
| ENSG00000249685.1 |
Avagacestat |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.011369691 |
Resistant |
| ENSG00000249898.3 |
Avagacestat |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.00801925 |
Resistant |
| ENSG00000250116.2 |
Avagacestat |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.020412951 |
Resistant |
| ENSG00000250131.1 |
Avagacestat |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.006567991 |
Resistant |
| ENSG00000250900.2 |
Avagacestat |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.045893091 |
Resistant |
| ENSG00000250938.1 |
Avagacestat |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.020595752 |
Resistant |
| ENSG00000253476.1 |
Avagacestat |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.015517174 |
Resistant |
| ENSG00000253636.1 |
Avagacestat |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.042548951 |
Resistant |
| ENSG00000253641.1 |
Avagacestat |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.019557556 |
Resistant |
| ENSG00000254694.1 |
Avagacestat |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.042806726 |
Resistant |
| ENSG00000255449.1 |
Avagacestat |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.00502382 |
Resistant |
| ENSG00000255651.2 |
Avagacestat |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.026657258 |
Resistant |
| ENSG00000259209.1 |
Avagacestat |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.005852339 |
Resistant |
| ENSG00000259212.1 |
Avagacestat |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.000249272 |
Resistant |
| ENSG00000259322.1 |
Avagacestat |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.027958039 |
Resistant |
| ENSG00000259366.1 |
Avagacestat |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.010769816 |
Resistant |
| ENSG00000259408.1 |
Avagacestat |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.04955196 |
Resistant |
| ENSG00000259488.1 |
Avagacestat |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.004583119 |
Resistant |
| ENSG00000259709.1 |
Avagacestat |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.036988147 |
Resistant |
| ENSG00000259797.1 |
Avagacestat |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.002958133 |
Resistant |
| ENSG00000259877.1 |
Avagacestat |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.014218475 |
Resistant |
| ENSG00000259972.1 |
Avagacestat |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.022647514 |
Resistant |
| ENSG00000260038.1 |
Avagacestat |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.021912055 |
Resistant |
| ENSG00000260279.1 |
Avagacestat |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.025769693 |
Resistant |
| ENSG00000260296.1 |
Avagacestat |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.029779704 |
Resistant |
| ENSG00000260316.1 |
Avagacestat |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.040879903 |
Resistant |
| ENSG00000260591.1 |
Avagacestat |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.036473737 |
Resistant |
| ENSG00000260693.1 |
Avagacestat |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.049727949 |
Resistant |
| ENSG00000260927.1 |
Avagacestat |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.006597319 |
Resistant |
| ENSG00000261135.1 |
Avagacestat |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.028244388 |
Resistant |
| ENSG00000261267.1 |
Avagacestat |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.008964769 |
Resistant |
| ENSG00000261337.1 |
Avagacestat |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.042037333 |
Resistant |
| ENSG00000261396.1 |
Avagacestat |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.005122152 |
Resistant |
| ENSG00000261574.1 |
Avagacestat |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.039934121 |
Resistant |
| ENSG00000261592.1 |
Avagacestat |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.02706045 |
Resistant |
| ENSG00000262089.1 |
Avagacestat |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.0259081 |
Resistant |
| ENSG00000262115.1 |
Avagacestat |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.033762544 |
Resistant |
| ENSG00000262228.1 |
Avagacestat |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.015159075 |
Resistant |
| ENSG00000262663.1 |
Avagacestat |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.023688381 |
Resistant |
| ENSG00000262952.1 |
Avagacestat |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.019145714 |
Resistant |
| ENSG00000263393.1 |
Avagacestat |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.012770402 |
Resistant |
| ENSG00000263847.1 |
Avagacestat |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.026020927 |
Resistant |
| ENSG00000264885.1 |
Avagacestat |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.017380325 |
Resistant |
| ENSG00000265242.1 |
Avagacestat |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.00469792 |
Resistant |
| ENSG00000265625.1 |
Avagacestat |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.016346585 |
Resistant |
| ENSG00000267167.1 |
Avagacestat |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.005465621 |
Resistant |
| ENSG00000267244.1 |
Avagacestat |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.037496875 |
Resistant |
| ENSG00000267347.1 |
Avagacestat |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.04229201 |
Resistant |
| ENSG00000268093.1 |
Avagacestat |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.009766974 |
Resistant |
| ENSG00000268471.3 |
Avagacestat |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.002649665 |
Resistant |
| ENSG00000268670.1 |
Avagacestat |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.038809814 |
Resistant |
| ENSG00000269444.1 |
Avagacestat |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.032537545 |
Resistant |
| ENSG00000269951.1 |
Avagacestat |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.02903951 |
Resistant |
| ENSG00000269979.1 |
Avagacestat |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.019726404 |
Resistant |
| ENSG00000269999.1 |
Avagacestat |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.020590014 |
Resistant |
| ENSG00000270055.1 |
Avagacestat |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.007241368 |
Resistant |
| ENSG00000270060.1 |
Avagacestat |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.030887209 |
Resistant |
| ENSG00000270074.1 |
Avagacestat |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.019187844 |
Resistant |
| ENSG00000270095.1 |
Avagacestat |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.032032994 |
Resistant |
| ENSG00000270184.1 |
Avagacestat |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.014871993 |
Resistant |
| ENSG00000270246.2 |
Avagacestat |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.047571941 |
Resistant |
| ENSG00000270346.1 |
Avagacestat |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.04984358 |
Resistant |
| ENSG00000271816.1 |
Avagacestat |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.028867483 |
Resistant |
| ENSG00000271963.1 |
Avagacestat |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.022716542 |
Resistant |
| ENSG00000272040.1 |
Avagacestat |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.031705907 |
Resistant |
| ENSG00000272077.1 |
Avagacestat |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.025361778 |
Resistant |
| ENSG00000272425.1 |
Avagacestat |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.037308011 |
Resistant |
| ENSG00000272520.1 |
Avagacestat |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.044939811 |
Resistant |
| ENSG00000272800.1 |
Avagacestat |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.001177145 |
Resistant |
| ENSG00000272812.1 |
Avagacestat |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.019191808 |
Resistant |
| ENSG00000273183.1 |
Avagacestat |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.021882466 |
Resistant |
| ENSG00000273353.1 |
Avagacestat |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.018408058 |
Resistant |
| ENSG00000273488.1 |
Avagacestat |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.015085209 |
Resistant |
| ENSG00000223784.1 |
Avagacestat |
Pancreatic adenocarcinoma |
0.017931404 |
Resistant |
| ENSG00000224000.1 |
Avagacestat |
Pancreatic adenocarcinoma |
0.014645965 |
Resistant |
| ENSG00000226950.2 |
Avagacestat |
Pancreatic adenocarcinoma |
0.046452333 |
Resistant |
| ENSG00000229124.2 |
Avagacestat |
Pancreatic adenocarcinoma |
0.04159696 |
Resistant |
| ENSG00000231073.1 |
Avagacestat |
Pancreatic adenocarcinoma |
0.035012794 |
Resistant |
| ENSG00000234630.1 |
Avagacestat |
Pancreatic adenocarcinoma |
0.033472018 |
Resistant |
| ENSG00000235903.3 |
Avagacestat |
Pancreatic adenocarcinoma |
0.019520818 |
Resistant |
| ENSG00000237187.4 |
Avagacestat |
Pancreatic adenocarcinoma |
0.041730978 |
Resistant |
| ENSG00000249476.1 |
Avagacestat |
Pancreatic adenocarcinoma |
0.047274432 |
Resistant |
| ENSG00000253414.2 |
Avagacestat |
Pancreatic adenocarcinoma |
0.003576819 |
Resistant |
| ENSG00000253837.1 |
Avagacestat |
Pancreatic adenocarcinoma |
0.002039274 |
Resistant |
| ENSG00000255090.1 |
Avagacestat |
Pancreatic adenocarcinoma |
0.006153353 |
Resistant |
| ENSG00000255176.1 |
Avagacestat |
Pancreatic adenocarcinoma |
0.046349219 |
Resistant |
| ENSG00000257137.1 |
Avagacestat |
Pancreatic adenocarcinoma |
0.026333881 |
Resistant |
| ENSG00000258904.1 |
Avagacestat |
Pancreatic adenocarcinoma |
0.031008298 |
Resistant |
| ENSG00000259563.1 |
Avagacestat |
Pancreatic adenocarcinoma |
0.019388957 |
Resistant |
| ENSG00000260475.1 |
Avagacestat |
Pancreatic adenocarcinoma |
0.003896584 |
Resistant |
| ENSG00000262147.1 |
Avagacestat |
Pancreatic adenocarcinoma |
0.010599686 |
Resistant |
| ENSG00000267446.1 |
Avagacestat |
Pancreatic adenocarcinoma |
0.044104407 |
Resistant |
| ENSG00000269893.2 |
Avagacestat |
Pancreatic adenocarcinoma |
0.047547998 |
Resistant |
| ENSG00000270097.1 |
Avagacestat |
Pancreatic adenocarcinoma |
0.034500333 |
Resistant |
| ENSG00000272695.1 |
Avagacestat |
Pancreatic adenocarcinoma |
0.01686484 |
Resistant |
| ENSG00000170161.6 |
Avagacestat |
Sarcoma |
0.039300437 |
Resistant |
| ENSG00000177757.1 |
Avagacestat |
Sarcoma |
0.024461657 |
Resistant |
| ENSG00000179743.2 |
Avagacestat |
Sarcoma |
0.003993841 |
Resistant |
| ENSG00000185186.4 |
Avagacestat |
Sarcoma |
0.007955246 |
Resistant |
| ENSG00000203706.4 |
Avagacestat |
Sarcoma |
0.018105623 |
Resistant |
| ENSG00000204802.3 |
Avagacestat |
Sarcoma |
0.038038844 |
Resistant |
| ENSG00000215863.2 |
Avagacestat |
Sarcoma |
0.023125563 |
Resistant |
| ENSG00000222041.6 |
Avagacestat |
Sarcoma |
0.015756707 |
Resistant |
| ENSG00000223725.2 |
Avagacestat |
Sarcoma |
0.028602054 |
Resistant |
| ENSG00000223759.2 |
Avagacestat |
Sarcoma |
0.042075188 |
Resistant |
| ENSG00000223804.1 |
Avagacestat |
Sarcoma |
0.015278356 |
Resistant |
| ENSG00000226007.2 |
Avagacestat |
Sarcoma |
0.02184299 |
Resistant |
| ENSG00000226067.2 |
Avagacestat |
Sarcoma |
0.023593463 |
Resistant |
| ENSG00000227036.2 |
Avagacestat |
Sarcoma |
0.040420552 |
Resistant |
| ENSG00000227258.1 |
Avagacestat |
Sarcoma |
0.005999771 |
Resistant |
| ENSG00000227308.2 |
Avagacestat |
Sarcoma |
0.017139998 |
Resistant |
| ENSG00000227704.1 |
Avagacestat |
Sarcoma |
0.029402589 |
Resistant |
| ENSG00000229017.2 |
Avagacestat |
Sarcoma |
0.014541078 |
Resistant |
| ENSG00000229589.1 |
Avagacestat |
Sarcoma |
0.044471513 |
Resistant |
| ENSG00000229647.1 |
Avagacestat |
Sarcoma |
0.02463351 |
Resistant |
| ENSG00000232284.3 |
Avagacestat |
Sarcoma |
0.048005045 |
Resistant |
| ENSG00000232342.3 |
Avagacestat |
Sarcoma |
0.004456076 |
Resistant |
| ENSG00000233154.1 |
Avagacestat |
Sarcoma |
0.044539376 |
Resistant |
| ENSG00000233237.2 |
Avagacestat |
Sarcoma |
0.017612911 |
Resistant |
| ENSG00000233368.2 |
Avagacestat |
Sarcoma |
0.018080798 |
Resistant |
| ENSG00000233532.1 |
Avagacestat |
Sarcoma |
0.025749247 |
Resistant |
| ENSG00000234665.4 |
Avagacestat |
Sarcoma |
0.009933289 |
Resistant |
| ENSG00000235319.1 |
Avagacestat |
Sarcoma |
0.020573219 |
Resistant |
| ENSG00000235398.4 |
Avagacestat |
Sarcoma |
0.027501766 |
Resistant |
| ENSG00000235641.3 |
Avagacestat |
Sarcoma |
0.035835943 |
Resistant |
| ENSG00000235843.1 |
Avagacestat |
Sarcoma |
0.008589059 |
Resistant |
| ENSG00000235999.1 |
Avagacestat |
Sarcoma |
0.034005453 |
Resistant |
| ENSG00000236234.1 |
Avagacestat |
Sarcoma |
0.007865392 |
Resistant |
| ENSG00000236772.1 |
Avagacestat |
Sarcoma |
0.034456326 |
Resistant |
| ENSG00000236943.2 |
Avagacestat |
Sarcoma |
0.037504814 |
Resistant |
| ENSG00000237686.2 |
Avagacestat |
Sarcoma |
0.042774881 |
Resistant |
| ENSG00000240050.1 |
Avagacestat |
Sarcoma |
0.030819972 |
Resistant |
| ENSG00000240571.1 |
Avagacestat |
Sarcoma |
0.020238548 |
Resistant |
| ENSG00000242242.1 |
Avagacestat |
Sarcoma |
0.027099593 |
Resistant |
| ENSG00000245060.2 |
Avagacestat |
Sarcoma |
0.04995948 |
Resistant |
| ENSG00000245311.2 |
Avagacestat |
Sarcoma |
0.018847462 |
Resistant |
| ENSG00000247853.2 |
Avagacestat |
Sarcoma |
0.041917378 |
Resistant |
| ENSG00000249328.2 |
Avagacestat |
Sarcoma |
0.037254065 |
Resistant |
| ENSG00000251323.2 |
Avagacestat |
Sarcoma |
0.032140059 |
Resistant |
| ENSG00000254907.1 |
Avagacestat |
Sarcoma |
0.036579778 |
Resistant |
| ENSG00000258458.1 |
Avagacestat |
Sarcoma |
0.037500201 |
Resistant |
| ENSG00000258526.1 |
Avagacestat |
Sarcoma |
0.030315176 |
Resistant |
| ENSG00000258825.1 |
Avagacestat |
Sarcoma |
0.030212089 |
Resistant |
| ENSG00000259640.1 |
Avagacestat |
Sarcoma |
0.039324272 |
Resistant |
| ENSG00000259709.1 |
Avagacestat |
Sarcoma |
0.044754607 |
Resistant |
| ENSG00000260277.1 |
Avagacestat |
Sarcoma |
0.040871241 |
Resistant |
| ENSG00000260409.1 |
Avagacestat |
Sarcoma |
0.013737296 |
Resistant |
| ENSG00000260604.1 |
Avagacestat |
Sarcoma |
0.021736593 |
Resistant |
| ENSG00000260949.1 |
Avagacestat |
Sarcoma |
0.028293567 |
Resistant |
| ENSG00000260953.1 |
Avagacestat |
Sarcoma |
0.04720289 |
Resistant |
| ENSG00000260977.1 |
Avagacestat |
Sarcoma |
0.043684565 |
Resistant |
| ENSG00000260992.1 |
Avagacestat |
Sarcoma |
0.033196805 |
Resistant |
| ENSG00000261634.2 |
Avagacestat |
Sarcoma |
0.021836793 |
Resistant |
| ENSG00000262905.1 |
Avagacestat |
Sarcoma |
0.049238944 |
Resistant |
| ENSG00000263624.1 |
Avagacestat |
Sarcoma |
0.01938575 |
Resistant |
| ENSG00000263753.2 |
Avagacestat |
Sarcoma |
0.017555835 |
Resistant |
| ENSG00000263843.1 |
Avagacestat |
Sarcoma |
0.021146666 |
Resistant |
| ENSG00000264575.1 |
Avagacestat |
Sarcoma |
0.01614732 |
Resistant |
| ENSG00000265091.1 |
Avagacestat |
Sarcoma |
0.018543426 |
Resistant |
| ENSG00000266709.1 |
Avagacestat |
Sarcoma |
0.017578613 |
Resistant |
| ENSG00000268362.1 |
Avagacestat |
Sarcoma |
0.041815747 |
Resistant |
| ENSG00000269966.1 |
Avagacestat |
Sarcoma |
0.017603165 |
Resistant |
| ENSG00000269983.1 |
Avagacestat |
Sarcoma |
0.048170985 |
Resistant |
| ENSG00000270419.1 |
Avagacestat |
Sarcoma |
0.009350303 |
Resistant |
| ENSG00000270557.1 |
Avagacestat |
Sarcoma |
0.03214456 |
Resistant |
| ENSG00000270562.1 |
Avagacestat |
Sarcoma |
0.024009054 |
Resistant |
| ENSG00000270951.1 |
Avagacestat |
Sarcoma |
0.02266018 |
Resistant |
| ENSG00000271826.1 |
Avagacestat |
Sarcoma |
0.034058731 |
Resistant |
| ENSG00000272403.1 |
Avagacestat |
Sarcoma |
0.001584442 |
Resistant |
| ENSG00000272444.1 |
Avagacestat |
Sarcoma |
0.023810863 |
Resistant |
| ENSG00000272462.2 |
Avagacestat |
Sarcoma |
0.048819462 |
Resistant |
| ENSG00000272735.1 |
Avagacestat |
Sarcoma |
0.030469169 |
Resistant |
| ENSG00000272810.1 |
Avagacestat |
Sarcoma |
0.019438453 |
Resistant |
| ENSG00000273017.1 |
Avagacestat |
Sarcoma |
0.031553836 |
Resistant |
| ENSG00000273264.1 |
Avagacestat |
Sarcoma |
0.04584138 |
Resistant |
| ENSG00000273374.1 |
Avagacestat |
Sarcoma |
0.038557333 |
Resistant |
| ENSG00000273443.1 |
Avagacestat |
Sarcoma |
0.01765285 |
Resistant |
| ENSG00000171889.3 |
Avagacestat |
Skin cutaneous melanoma |
0.020772051 |
Resistant |
| ENSG00000180139.10 |
Avagacestat |
Skin cutaneous melanoma |
0.01851712 |
Resistant |
| ENSG00000188825.9 |
Avagacestat |
Skin cutaneous melanoma |
0.031977153 |
Resistant |
| ENSG00000196810.4 |
Avagacestat |
Skin cutaneous melanoma |
0.029323556 |
Resistant |
| ENSG00000197332.7 |
Avagacestat |
Skin cutaneous melanoma |
0.040004243 |
Resistant |
| ENSG00000215190.4 |
Avagacestat |
Skin cutaneous melanoma |
0.002262669 |
Resistant |
| ENSG00000215424.5 |
Avagacestat |
Skin cutaneous melanoma |
0.015531521 |
Resistant |
| ENSG00000217576.7 |
Avagacestat |
Skin cutaneous melanoma |
0.031992791 |
Resistant |
| ENSG00000223685.1 |
Avagacestat |
Skin cutaneous melanoma |
0.043821245 |
Resistant |
| ENSG00000223697.2 |
Avagacestat |
Skin cutaneous melanoma |
0.009413773 |
Resistant |
| ENSG00000223799.1 |
Avagacestat |
Skin cutaneous melanoma |
0.001210736 |
Resistant |
| ENSG00000224621.1 |
Avagacestat |
Skin cutaneous melanoma |
0.009254595 |
Resistant |
| ENSG00000225300.1 |
Avagacestat |
Skin cutaneous melanoma |
0.009616117 |
Resistant |
| ENSG00000225335.2 |
Avagacestat |
Skin cutaneous melanoma |
0.040491192 |
Resistant |
| ENSG00000225675.2 |
Avagacestat |
Skin cutaneous melanoma |
0.029792014 |
Resistant |
| ENSG00000225791.2 |
Avagacestat |
Skin cutaneous melanoma |
0.001971794 |
Resistant |
| ENSG00000225969.1 |
Avagacestat |
Skin cutaneous melanoma |
0.02999125 |
Resistant |
| ENSG00000226904.1 |
Avagacestat |
Skin cutaneous melanoma |
0.014198613 |
Resistant |
| ENSG00000227963.1 |
Avagacestat |
Skin cutaneous melanoma |
0.003209975 |
Resistant |
| ENSG00000228124.1 |
Avagacestat |
Skin cutaneous melanoma |
0.001906417 |
Resistant |
| ENSG00000228470.1 |
Avagacestat |
Skin cutaneous melanoma |
0.04630349 |
Resistant |
| ENSG00000229137.2 |
Avagacestat |
Skin cutaneous melanoma |
0.037863877 |
Resistant |
| ENSG00000229852.2 |
Avagacestat |
Skin cutaneous melanoma |
0.026639623 |
Resistant |
| ENSG00000229956.5 |
Avagacestat |
Skin cutaneous melanoma |
0.004063402 |
Resistant |
| ENSG00000230366.5 |
Avagacestat |
Skin cutaneous melanoma |
0.044808533 |
Resistant |
| ENSG00000230555.2 |
Avagacestat |
Skin cutaneous melanoma |
0.035507102 |
Resistant |
| ENSG00000230561.3 |
Avagacestat |
Skin cutaneous melanoma |
0.002973074 |
Resistant |
| ENSG00000231530.1 |
Avagacestat |
Skin cutaneous melanoma |
0.006588438 |
Resistant |
| ENSG00000232487.1 |
Avagacestat |
Skin cutaneous melanoma |
0.039427329 |
Resistant |
| ENSG00000232694.2 |
Avagacestat |
Skin cutaneous melanoma |
0.035971437 |
Resistant |
| ENSG00000232814.2 |
Avagacestat |
Skin cutaneous melanoma |
0.046642365 |
Resistant |
| ENSG00000233509.2 |
Avagacestat |
Skin cutaneous melanoma |
0.027473856 |
Resistant |
| ENSG00000233901.1 |
Avagacestat |
Skin cutaneous melanoma |
0.027310027 |
Resistant |
| ENSG00000234509.1 |
Avagacestat |
Skin cutaneous melanoma |
0.035919099 |
Resistant |
| ENSG00000234617.1 |
Avagacestat |
Skin cutaneous melanoma |
0.027433694 |
Resistant |
| ENSG00000234772.1 |
Avagacestat |
Skin cutaneous melanoma |
0.029041778 |
Resistant |
| ENSG00000234817.2 |
Avagacestat |
Skin cutaneous melanoma |
0.019055209 |
Resistant |
| ENSG00000235079.1 |
Avagacestat |
Skin cutaneous melanoma |
0.029550199 |
Resistant |
| ENSG00000235138.1 |
Avagacestat |
Skin cutaneous melanoma |
0.024469706 |
Resistant |
| ENSG00000235609.4 |
Avagacestat |
Skin cutaneous melanoma |
0.033245841 |
Resistant |
| ENSG00000236140.1 |
Avagacestat |
Skin cutaneous melanoma |
0.023489933 |
Resistant |
| ENSG00000236423.1 |
Avagacestat |
Skin cutaneous melanoma |
0.027568163 |
Resistant |
| ENSG00000237126.4 |
Avagacestat |
Skin cutaneous melanoma |
0.019364793 |
Resistant |
| ENSG00000237356.1 |
Avagacestat |
Skin cutaneous melanoma |
0.042789974 |
Resistant |
| ENSG00000239335.4 |
Avagacestat |
Skin cutaneous melanoma |
0.022017498 |
Resistant |
| ENSG00000240057.1 |
Avagacestat |
Skin cutaneous melanoma |
0.0106322 |
Resistant |
| ENSG00000240859.1 |
Avagacestat |
Skin cutaneous melanoma |
0.005786367 |
Resistant |
| ENSG00000241316.2 |
Avagacestat |
Skin cutaneous melanoma |
0.039965951 |
Resistant |
| ENSG00000241544.1 |
Avagacestat |
Skin cutaneous melanoma |
0.044909537 |
Resistant |
| ENSG00000242474.1 |
Avagacestat |
Skin cutaneous melanoma |
0.000330522 |
Resistant |
| ENSG00000245213.2 |
Avagacestat |
Skin cutaneous melanoma |
0.039555911 |
Resistant |
| ENSG00000245571.2 |
Avagacestat |
Skin cutaneous melanoma |
0.012745725 |
Resistant |
| ENSG00000247081.3 |
Avagacestat |
Skin cutaneous melanoma |
0.034360568 |
Resistant |
| ENSG00000247416.2 |
Avagacestat |
Skin cutaneous melanoma |
0.035706221 |
Resistant |
| ENSG00000248559.1 |
Avagacestat |
Skin cutaneous melanoma |
0.047279655 |
Resistant |
| ENSG00000248677.1 |
Avagacestat |
Skin cutaneous melanoma |
0.005663012 |
Resistant |
| ENSG00000248866.1 |
Avagacestat |
Skin cutaneous melanoma |
0.0105848 |
Resistant |
| ENSG00000248927.1 |
Avagacestat |
Skin cutaneous melanoma |
0.028872439 |
Resistant |
| ENSG00000249304.1 |
Avagacestat |
Skin cutaneous melanoma |
0.022314631 |
Resistant |
| ENSG00000250012.1 |
Avagacestat |
Skin cutaneous melanoma |
0.029335258 |
Resistant |
| ENSG00000250786.1 |
Avagacestat |
Skin cutaneous melanoma |
0.040302627 |
Resistant |
| ENSG00000250938.1 |
Avagacestat |
Skin cutaneous melanoma |
0.022520734 |
Resistant |
| ENSG00000251867.2 |
Avagacestat |
Skin cutaneous melanoma |
0.046289914 |
Resistant |
| ENSG00000253559.1 |
Avagacestat |
Skin cutaneous melanoma |
0.015802569 |
Resistant |
| ENSG00000253854.1 |
Avagacestat |
Skin cutaneous melanoma |
0.014899289 |
Resistant |
| ENSG00000254477.1 |
Avagacestat |
Skin cutaneous melanoma |
0.046218122 |
Resistant |
| ENSG00000254635.1 |
Avagacestat |
Skin cutaneous melanoma |
0.019489588 |
Resistant |
| ENSG00000254929.2 |
Avagacestat |
Skin cutaneous melanoma |
0.017006536 |
Resistant |
| ENSG00000255164.1 |
Avagacestat |
Skin cutaneous melanoma |
0.030922339 |
Resistant |
| ENSG00000255343.1 |
Avagacestat |
Skin cutaneous melanoma |
0.022357273 |
Resistant |
| ENSG00000256196.1 |
Avagacestat |
Skin cutaneous melanoma |
0.042248346 |
Resistant |
| ENSG00000257354.1 |
Avagacestat |
Skin cutaneous melanoma |
0.012842887 |
Resistant |
| ENSG00000257366.1 |
Avagacestat |
Skin cutaneous melanoma |
0.03527363 |
Resistant |
| ENSG00000257391.1 |
Avagacestat |
Skin cutaneous melanoma |
0.042713922 |
Resistant |
| ENSG00000259310.1 |
Avagacestat |
Skin cutaneous melanoma |
0.015170369 |
Resistant |
| ENSG00000259327.1 |
Avagacestat |
Skin cutaneous melanoma |
0.020765789 |
Resistant |
| ENSG00000259426.1 |
Avagacestat |
Skin cutaneous melanoma |
0.013219024 |
Resistant |
| ENSG00000259563.1 |
Avagacestat |
Skin cutaneous melanoma |
0.005332326 |
Resistant |
| ENSG00000260037.1 |
Avagacestat |
Skin cutaneous melanoma |
0.005765629 |
Resistant |
| ENSG00000260136.1 |
Avagacestat |
Skin cutaneous melanoma |
0.026347034 |
Resistant |
| ENSG00000260233.2 |
Avagacestat |
Skin cutaneous melanoma |
0.025410214 |
Resistant |
| ENSG00000260361.1 |
Avagacestat |
Skin cutaneous melanoma |
0.01929662 |
Resistant |
| ENSG00000260572.1 |
Avagacestat |
Skin cutaneous melanoma |
0.011871114 |
Resistant |
| ENSG00000260841.1 |
Avagacestat |
Skin cutaneous melanoma |
0.014264613 |
Resistant |
| ENSG00000260891.1 |
Avagacestat |
Skin cutaneous melanoma |
0.008081888 |
Resistant |
| ENSG00000260931.1 |
Avagacestat |
Skin cutaneous melanoma |
0.007719184 |
Resistant |
| ENSG00000260954.1 |
Avagacestat |
Skin cutaneous melanoma |
0.037749847 |
Resistant |
| ENSG00000260978.1 |
Avagacestat |
Skin cutaneous melanoma |
0.038795837 |
Resistant |
| ENSG00000261186.1 |
Avagacestat |
Skin cutaneous melanoma |
0.024199652 |
Resistant |
| ENSG00000261758.1 |
Avagacestat |
Skin cutaneous melanoma |
0.031065688 |
Resistant |
| ENSG00000262686.1 |
Avagacestat |
Skin cutaneous melanoma |
0.025148266 |
Resistant |
| ENSG00000263069.1 |
Avagacestat |
Skin cutaneous melanoma |
0.035513203 |
Resistant |
| ENSG00000263327.2 |
Avagacestat |
Skin cutaneous melanoma |
0.014921574 |
Resistant |
| ENSG00000264188.1 |
Avagacestat |
Skin cutaneous melanoma |
0.047431067 |
Resistant |
| ENSG00000264247.1 |
Avagacestat |
Skin cutaneous melanoma |
0.011735556 |
Resistant |
| ENSG00000264635.1 |
Avagacestat |
Skin cutaneous melanoma |
0.009178861 |
Resistant |
| ENSG00000265519.1 |
Avagacestat |
Skin cutaneous melanoma |
0.002363648 |
Resistant |
| ENSG00000265688.1 |
Avagacestat |
Skin cutaneous melanoma |
0.00302338 |
Resistant |
| ENSG00000265750.1 |
Avagacestat |
Skin cutaneous melanoma |
0.025756596 |
Resistant |
| ENSG00000265971.1 |
Avagacestat |
Skin cutaneous melanoma |
0.029118076 |
Resistant |
| ENSG00000266010.1 |
Avagacestat |
Skin cutaneous melanoma |
0.047777689 |
Resistant |
| ENSG00000267010.1 |
Avagacestat |
Skin cutaneous melanoma |
0.042612308 |
Resistant |
| ENSG00000267249.1 |
Avagacestat |
Skin cutaneous melanoma |
0.030369896 |
Resistant |
| ENSG00000267476.1 |
Avagacestat |
Skin cutaneous melanoma |
0.009009971 |
Resistant |
| ENSG00000267501.1 |
Avagacestat |
Skin cutaneous melanoma |
0.018505515 |
Resistant |
| ENSG00000268001.1 |
Avagacestat |
Skin cutaneous melanoma |
0.045321124 |
Resistant |
| ENSG00000268049.1 |
Avagacestat |
Skin cutaneous melanoma |
0.033941537 |
Resistant |
| ENSG00000269425.1 |
Avagacestat |
Skin cutaneous melanoma |
0.028301595 |
Resistant |
| ENSG00000269961.1 |
Avagacestat |
Skin cutaneous melanoma |
0.008337886 |
Resistant |
| ENSG00000269973.1 |
Avagacestat |
Skin cutaneous melanoma |
0.029226079 |
Resistant |
| ENSG00000270141.2 |
Avagacestat |
Skin cutaneous melanoma |
0.016656966 |
Resistant |
| ENSG00000271009.2 |
Avagacestat |
Skin cutaneous melanoma |
0.03806476 |
Resistant |
| ENSG00000271551.1 |
Avagacestat |
Skin cutaneous melanoma |
0.016822655 |
Resistant |
| ENSG00000271659.1 |
Avagacestat |
Skin cutaneous melanoma |
0.020254124 |
Resistant |
| ENSG00000271971.1 |
Avagacestat |
Skin cutaneous melanoma |
0.041980342 |
Resistant |
| ENSG00000272263.1 |
Avagacestat |
Skin cutaneous melanoma |
0.043951864 |
Resistant |
| ENSG00000272282.1 |
Avagacestat |
Skin cutaneous melanoma |
0.048919706 |
Resistant |
| ENSG00000272373.1 |
Avagacestat |
Skin cutaneous melanoma |
0.028410721 |
Resistant |
| ENSG00000272377.1 |
Avagacestat |
Skin cutaneous melanoma |
0.006030307 |
Resistant |
| ENSG00000272389.1 |
Avagacestat |
Skin cutaneous melanoma |
0.02134018 |
Resistant |
| ENSG00000272782.1 |
Avagacestat |
Skin cutaneous melanoma |
0.019300742 |
Resistant |
| ENSG00000273007.1 |
Avagacestat |
Skin cutaneous melanoma |
0.014120124 |
Resistant |
| ENSG00000273038.1 |
Avagacestat |
Skin cutaneous melanoma |
0.028026222 |
Resistant |
| ENSG00000273081.1 |
Avagacestat |
Skin cutaneous melanoma |
0.023552555 |
Resistant |
| ENSG00000273437.1 |
Avagacestat |
Skin cutaneous melanoma |
0.045231515 |
Resistant |
| ENSG00000224621.1 |
Avagacestat |
Thyroid carcinoma |
0.039609385 |
Resistant |
| ENSG00000232564.1 |
Avagacestat |
Thyroid carcinoma |
0.030630565 |
Resistant |
| ENSG00000245146.2 |
Avagacestat |
Thyroid carcinoma |
0.012305021 |
Resistant |
| ENSG00000249084.1 |
Avagacestat |
Thyroid carcinoma |
0.020038608 |
Resistant |
| ENSG00000251031.1 |
Avagacestat |
Thyroid carcinoma |
0.001584741 |
Resistant |
| ENSG00000254094.1 |
Avagacestat |
Thyroid carcinoma |
0.039221302 |
Resistant |
| ENSG00000257740.1 |
Avagacestat |
Thyroid carcinoma |
0.009025269 |
Resistant |
| ENSG00000258441.1 |
Avagacestat |
Thyroid carcinoma |
0.046804089 |
Resistant |
| ENSG00000258525.1 |
Avagacestat |
Thyroid carcinoma |
0.046959426 |
Resistant |
| ENSG00000259116.1 |
Avagacestat |
Thyroid carcinoma |
0.044432573 |
Resistant |
| ENSG00000259364.1 |
Avagacestat |
Thyroid carcinoma |
0.015103662 |
Resistant |
| ENSG00000259678.1 |
Avagacestat |
Thyroid carcinoma |
0.034348681 |
Resistant |
| ENSG00000260936.1 |
Avagacestat |
Thyroid carcinoma |
0.001522386 |
Resistant |
| ENSG00000261039.1 |
Avagacestat |
Thyroid carcinoma |
0.028023088 |
Resistant |
| ENSG00000268362.1 |
Avagacestat |
Thyroid carcinoma |
0.040511266 |
Resistant |
| ENSG00000269397.1 |
Avagacestat |
Thyroid carcinoma |
0.012937379 |
Resistant |
| ENSG00000272029.1 |
Avagacestat |
Thyroid carcinoma |
0.010795895 |
Resistant |
| ENSG00000272221.1 |
Avagacestat |
Thyroid carcinoma |
0.047671232 |
Resistant |
| ENSG00000223478.1 |
Avagacestat |
Bladder urothelial carcinoma |
0.009049554 |
Sensitive |
| ENSG00000225111.1 |
Avagacestat |
Bladder urothelial carcinoma |
0.035422955 |
Sensitive |
| ENSG00000225434.2 |
Avagacestat |
Bladder urothelial carcinoma |
0.005749215 |
Sensitive |
| ENSG00000228809.1 |
Avagacestat |
Bladder urothelial carcinoma |
0.038795361 |
Sensitive |
| ENSG00000230285.1 |
Avagacestat |
Bladder urothelial carcinoma |
0.037084949 |
Sensitive |
| ENSG00000235419.1 |
Avagacestat |
Bladder urothelial carcinoma |
0.008576693 |
Sensitive |
| ENSG00000235427.1 |
Avagacestat |
Bladder urothelial carcinoma |
0.003800484 |
Sensitive |
| ENSG00000244268.1 |
Avagacestat |
Bladder urothelial carcinoma |
0.024291391 |
Sensitive |
| ENSG00000251361.1 |
Avagacestat |
Bladder urothelial carcinoma |
0.046296831 |
Sensitive |
| ENSG00000254275.2 |
Avagacestat |
Bladder urothelial carcinoma |
0.039949808 |
Sensitive |
| ENSG00000254756.1 |
Avagacestat |
Bladder urothelial carcinoma |
0.016734381 |
Sensitive |
| ENSG00000255345.1 |
Avagacestat |
Bladder urothelial carcinoma |
0.009818015 |
Sensitive |
| ENSG00000255421.1 |
Avagacestat |
Bladder urothelial carcinoma |
0.042927497 |
Sensitive |
| ENSG00000259345.1 |
Avagacestat |
Bladder urothelial carcinoma |
0.024947653 |
Sensitive |
| ENSG00000260588.1 |
Avagacestat |
Bladder urothelial carcinoma |
0.012133602 |
Sensitive |
| ENSG00000263874.1 |
Avagacestat |
Bladder urothelial carcinoma |
0.045973565 |
Sensitive |
| ENSG00000267230.1 |
Avagacestat |
Bladder urothelial carcinoma |
0.012528478 |
Sensitive |
| ENSG00000268894.2 |
Avagacestat |
Bladder urothelial carcinoma |
0.040349985 |
Sensitive |
| ENSG00000272707.1 |
Avagacestat |
Bladder urothelial carcinoma |
0.044259017 |
Sensitive |
| ENSG00000149656.4 |
Avagacestat |
Breast invasive carcinoma |
0.007045028 |
Sensitive |
| ENSG00000170590.4 |
Avagacestat |
Breast invasive carcinoma |
0.0069763 |
Sensitive |
| ENSG00000178412.4 |
Avagacestat |
Breast invasive carcinoma |
0.046392495 |
Sensitive |
| ENSG00000188693.7 |
Avagacestat |
Breast invasive carcinoma |
0.028273884 |
Sensitive |
| ENSG00000204054.7 |
Avagacestat |
Breast invasive carcinoma |
0.044289258 |
Sensitive |
| ENSG00000204685.5 |
Avagacestat |
Breast invasive carcinoma |
0.001195137 |
Sensitive |
| ENSG00000211683.3 |
Avagacestat |
Breast invasive carcinoma |
0.005008187 |
Sensitive |
| ENSG00000214770.2 |
Avagacestat |
Breast invasive carcinoma |
0.048756386 |
Sensitive |
| ENSG00000214773.1 |
Avagacestat |
Breast invasive carcinoma |
0.047686199 |
Sensitive |
| ENSG00000215022.3 |
Avagacestat |
Breast invasive carcinoma |
0.043654089 |
Sensitive |
| ENSG00000215386.6 |
Avagacestat |
Breast invasive carcinoma |
0.029143927 |
Sensitive |
| ENSG00000222035.2 |
Avagacestat |
Breast invasive carcinoma |
0.044402605 |
Sensitive |
| ENSG00000223692.1 |
Avagacestat |
Breast invasive carcinoma |
0.036965798 |
Sensitive |
| ENSG00000223923.1 |
Avagacestat |
Breast invasive carcinoma |
0.049940728 |
Sensitive |
| ENSG00000223935.1 |
Avagacestat |
Breast invasive carcinoma |
0.037626916 |
Sensitive |
| ENSG00000224888.3 |
Avagacestat |
Breast invasive carcinoma |
0.04229726 |
Sensitive |
| ENSG00000224905.2 |
Avagacestat |
Breast invasive carcinoma |
0.018752828 |
Sensitive |
| ENSG00000225076.1 |
Avagacestat |
Breast invasive carcinoma |
0.015918846 |
Sensitive |
| ENSG00000225092.2 |
Avagacestat |
Breast invasive carcinoma |
0.010686211 |
Sensitive |
| ENSG00000225218.1 |
Avagacestat |
Breast invasive carcinoma |
0.008143748 |
Sensitive |
| ENSG00000225703.1 |
Avagacestat |
Breast invasive carcinoma |
0.039409821 |
Sensitive |
| ENSG00000226954.1 |
Avagacestat |
Breast invasive carcinoma |
0.04300184 |
Sensitive |
| ENSG00000227039.2 |
Avagacestat |
Breast invasive carcinoma |
0.014006955 |
Sensitive |
| ENSG00000227256.1 |
Avagacestat |
Breast invasive carcinoma |
0.008596778 |
Sensitive |
| ENSG00000227258.1 |
Avagacestat |
Breast invasive carcinoma |
0.045124296 |
Sensitive |
| ENSG00000227407.1 |
Avagacestat |
Breast invasive carcinoma |
0.048757004 |
Sensitive |
| ENSG00000227409.1 |
Avagacestat |
Breast invasive carcinoma |
0.033081327 |
Sensitive |
| ENSG00000227630.2 |
Avagacestat |
Breast invasive carcinoma |
0.042313842 |
Sensitive |
| ENSG00000227698.1 |
Avagacestat |
Breast invasive carcinoma |
0.034995878 |
Sensitive |
| ENSG00000227741.1 |
Avagacestat |
Breast invasive carcinoma |
0.011477233 |
Sensitive |
| ENSG00000228137.1 |
Avagacestat |
Breast invasive carcinoma |
0.044244293 |
Sensitive |
| ENSG00000228141.2 |
Avagacestat |
Breast invasive carcinoma |
0.000252935 |
Sensitive |
| ENSG00000228237.1 |
Avagacestat |
Breast invasive carcinoma |
0.041835521 |
Sensitive |
| ENSG00000228315.7 |
Avagacestat |
Breast invasive carcinoma |
0.007960375 |
Sensitive |
| ENSG00000228352.2 |
Avagacestat |
Breast invasive carcinoma |
0.026188533 |
Sensitive |
| ENSG00000228393.3 |
Avagacestat |
Breast invasive carcinoma |
0.003204677 |
Sensitive |
| ENSG00000228452.1 |
Avagacestat |
Breast invasive carcinoma |
0.039333775 |
Sensitive |
| ENSG00000228701.1 |
Avagacestat |
Breast invasive carcinoma |
0.047010363 |
Sensitive |
| ENSG00000228791.3 |
Avagacestat |
Breast invasive carcinoma |
0.042888627 |
Sensitive |
| ENSG00000228817.3 |
Avagacestat |
Breast invasive carcinoma |
0.025207344 |
Sensitive |
| ENSG00000228917.1 |
Avagacestat |
Breast invasive carcinoma |
0.02189506 |
Sensitive |
| ENSG00000229180.4 |
Avagacestat |
Breast invasive carcinoma |
0.044292928 |
Sensitive |
| ENSG00000229321.1 |
Avagacestat |
Breast invasive carcinoma |
0.011190605 |
Sensitive |
| ENSG00000229539.1 |
Avagacestat |
Breast invasive carcinoma |
0.0335026 |
Sensitive |
| ENSG00000229728.1 |
Avagacestat |
Breast invasive carcinoma |
0.035878215 |
Sensitive |
| ENSG00000230289.1 |
Avagacestat |
Breast invasive carcinoma |
0.014803581 |
Sensitive |
| ENSG00000230736.2 |
Avagacestat |
Breast invasive carcinoma |
0.020754916 |
Sensitive |
| ENSG00000230914.2 |
Avagacestat |
Breast invasive carcinoma |
0.036885629 |
Sensitive |
| ENSG00000231407.1 |
Avagacestat |
Breast invasive carcinoma |
0.031233277 |
Sensitive |
| ENSG00000231595.1 |
Avagacestat |
Breast invasive carcinoma |
0.042137859 |
Sensitive |
| ENSG00000231865.1 |
Avagacestat |
Breast invasive carcinoma |
0.027983162 |
Sensitive |
| ENSG00000232118.1 |
Avagacestat |
Breast invasive carcinoma |
0.023244636 |
Sensitive |
| ENSG00000232762.1 |
Avagacestat |
Breast invasive carcinoma |
0.022006824 |
Sensitive |
| ENSG00000232909.1 |
Avagacestat |
Breast invasive carcinoma |
0.04208398 |
Sensitive |
| ENSG00000232931.1 |
Avagacestat |
Breast invasive carcinoma |
0.025246323 |
Sensitive |
| ENSG00000233081.1 |
Avagacestat |
Breast invasive carcinoma |
0.034429817 |
Sensitive |
| ENSG00000234019.1 |
Avagacestat |
Breast invasive carcinoma |
0.043705385 |
Sensitive |
| ENSG00000234174.1 |
Avagacestat |
Breast invasive carcinoma |
0.043222141 |
Sensitive |
| ENSG00000234684.2 |
Avagacestat |
Breast invasive carcinoma |
0.008440325 |
Sensitive |
| ENSG00000234917.1 |
Avagacestat |
Breast invasive carcinoma |
0.013481166 |
Sensitive |
| ENSG00000235072.1 |
Avagacestat |
Breast invasive carcinoma |
0.02841057 |
Sensitive |
| ENSG00000235423.4 |
Avagacestat |
Breast invasive carcinoma |
0.049431495 |
Sensitive |
| ENSG00000235445.1 |
Avagacestat |
Breast invasive carcinoma |
0.040513265 |
Sensitive |
| ENSG00000235475.1 |
Avagacestat |
Breast invasive carcinoma |
0.044912462 |
Sensitive |
| ENSG00000235499.1 |
Avagacestat |
Breast invasive carcinoma |
0.041070824 |
Sensitive |
| ENSG00000235958.1 |
Avagacestat |
Breast invasive carcinoma |
0.026712862 |
Sensitive |
| ENSG00000236013.1 |
Avagacestat |
Breast invasive carcinoma |
0.040771583 |
Sensitive |
| ENSG00000236299.3 |
Avagacestat |
Breast invasive carcinoma |
0.017143809 |
Sensitive |
| ENSG00000236519.1 |
Avagacestat |
Breast invasive carcinoma |
0.002092758 |
Sensitive |
| ENSG00000236772.1 |
Avagacestat |
Breast invasive carcinoma |
0.039179487 |
Sensitive |
| ENSG00000236861.2 |
Avagacestat |
Breast invasive carcinoma |
0.029516515 |
Sensitive |
| ENSG00000237126.4 |
Avagacestat |
Breast invasive carcinoma |
0.00322025 |
Sensitive |
| ENSG00000237481.1 |
Avagacestat |
Breast invasive carcinoma |
0.028702225 |
Sensitive |
| ENSG00000237718.1 |
Avagacestat |
Breast invasive carcinoma |
0.037954154 |
Sensitive |
| ENSG00000237742.2 |
Avagacestat |
Breast invasive carcinoma |
0.047441531 |
Sensitive |
| ENSG00000238045.5 |
Avagacestat |
Breast invasive carcinoma |
0.017995605 |
Sensitive |
| ENSG00000239377.1 |
Avagacestat |
Breast invasive carcinoma |
0.019652611 |
Sensitive |
| ENSG00000240449.1 |
Avagacestat |
Breast invasive carcinoma |
0.018888551 |
Sensitive |
| ENSG00000241954.1 |
Avagacestat |
Breast invasive carcinoma |
0.044908619 |
Sensitive |
| ENSG00000243107.1 |
Avagacestat |
Breast invasive carcinoma |
0.007391435 |
Sensitive |
| ENSG00000244055.1 |
Avagacestat |
Breast invasive carcinoma |
0.042860843 |
Sensitive |
| ENSG00000244198.1 |
Avagacestat |
Breast invasive carcinoma |
0.020805071 |
Sensitive |
| ENSG00000244327.1 |
Avagacestat |
Breast invasive carcinoma |
0.000456527 |
Sensitive |
| ENSG00000244332.1 |
Avagacestat |
Breast invasive carcinoma |
0.046856367 |
Sensitive |
| ENSG00000244479.2 |
Avagacestat |
Breast invasive carcinoma |
0.013277992 |
Sensitive |
| ENSG00000248476.1 |
Avagacestat |
Breast invasive carcinoma |
0.019449141 |
Sensitive |
| ENSG00000250075.1 |
Avagacestat |
Breast invasive carcinoma |
0.046745509 |
Sensitive |
| ENSG00000250999.1 |
Avagacestat |
Breast invasive carcinoma |
0.022424716 |
Sensitive |
| ENSG00000251161.2 |
Avagacestat |
Breast invasive carcinoma |
0.036031975 |
Sensitive |
| ENSG00000251497.2 |
Avagacestat |
Breast invasive carcinoma |
0.005286468 |
Sensitive |
| ENSG00000253539.1 |
Avagacestat |
Breast invasive carcinoma |
0.039272408 |
Sensitive |
| ENSG00000253738.1 |
Avagacestat |
Breast invasive carcinoma |
0.016499184 |
Sensitive |
| ENSG00000254099.1 |
Avagacestat |
Breast invasive carcinoma |
0.04225829 |
Sensitive |
| ENSG00000254162.1 |
Avagacestat |
Breast invasive carcinoma |
0.001990207 |
Sensitive |
| ENSG00000254362.1 |
Avagacestat |
Breast invasive carcinoma |
0.043261898 |
Sensitive |
| ENSG00000254689.1 |
Avagacestat |
Breast invasive carcinoma |
0.047999349 |
Sensitive |
| ENSG00000254718.2 |
Avagacestat |
Breast invasive carcinoma |
0.022715097 |
Sensitive |
| ENSG00000254756.1 |
Avagacestat |
Breast invasive carcinoma |
0.023562302 |
Sensitive |
| ENSG00000254833.1 |
Avagacestat |
Breast invasive carcinoma |
0.032603675 |
Sensitive |
| ENSG00000254847.1 |
Avagacestat |
Breast invasive carcinoma |
0.039247388 |
Sensitive |
| ENSG00000254869.1 |
Avagacestat |
Breast invasive carcinoma |
0.004204038 |
Sensitive |
| ENSG00000255236.2 |
Avagacestat |
Breast invasive carcinoma |
0.013008341 |
Sensitive |
| ENSG00000255651.2 |
Avagacestat |
Breast invasive carcinoma |
0.028889792 |
Sensitive |
| ENSG00000256824.1 |
Avagacestat |
Breast invasive carcinoma |
0.032531238 |
Sensitive |
| ENSG00000257137.1 |
Avagacestat |
Breast invasive carcinoma |
0.019512571 |
Sensitive |
| ENSG00000257381.2 |
Avagacestat |
Breast invasive carcinoma |
0.010903863 |
Sensitive |
| ENSG00000257759.2 |
Avagacestat |
Breast invasive carcinoma |
0.046857283 |
Sensitive |
| ENSG00000258101.1 |
Avagacestat |
Breast invasive carcinoma |
0.026487726 |
Sensitive |
| ENSG00000258260.1 |
Avagacestat |
Breast invasive carcinoma |
0.023279265 |
Sensitive |
| ENSG00000258317.1 |
Avagacestat |
Breast invasive carcinoma |
0.01967723 |
Sensitive |
| ENSG00000258454.1 |
Avagacestat |
Breast invasive carcinoma |
0.033681436 |
Sensitive |
| ENSG00000258520.1 |
Avagacestat |
Breast invasive carcinoma |
0.034244187 |
Sensitive |
| ENSG00000258851.1 |
Avagacestat |
Breast invasive carcinoma |
0.033439225 |
Sensitive |
| ENSG00000258935.1 |
Avagacestat |
Breast invasive carcinoma |
0.02118124 |
Sensitive |
| ENSG00000259039.1 |
Avagacestat |
Breast invasive carcinoma |
0.035571546 |
Sensitive |
| ENSG00000259138.1 |
Avagacestat |
Breast invasive carcinoma |
0.048931333 |
Sensitive |
| ENSG00000259287.1 |
Avagacestat |
Breast invasive carcinoma |
0.033999979 |
Sensitive |
| ENSG00000259336.1 |
Avagacestat |
Breast invasive carcinoma |
0.02481078 |
Sensitive |
| ENSG00000259736.1 |
Avagacestat |
Breast invasive carcinoma |
0.047918199 |
Sensitive |
| ENSG00000259772.2 |
Avagacestat |
Breast invasive carcinoma |
0.005184137 |
Sensitive |
| ENSG00000259806.2 |
Avagacestat |
Breast invasive carcinoma |
0.009537367 |
Sensitive |
| ENSG00000260005.2 |
Avagacestat |
Breast invasive carcinoma |
0.025030236 |
Sensitive |
| ENSG00000260008.1 |
Avagacestat |
Breast invasive carcinoma |
0.032914209 |
Sensitive |
| ENSG00000260132.1 |
Avagacestat |
Breast invasive carcinoma |
0.018098092 |
Sensitive |
| ENSG00000260176.1 |
Avagacestat |
Breast invasive carcinoma |
0.039002304 |
Sensitive |
| ENSG00000260317.1 |
Avagacestat |
Breast invasive carcinoma |
0.021324536 |
Sensitive |
| ENSG00000260423.1 |
Avagacestat |
Breast invasive carcinoma |
0.013470394 |
Sensitive |
| ENSG00000260454.1 |
Avagacestat |
Breast invasive carcinoma |
0.007586618 |
Sensitive |
| ENSG00000260672.1 |
Avagacestat |
Breast invasive carcinoma |
0.015984564 |
Sensitive |
| ENSG00000260884.1 |
Avagacestat |
Breast invasive carcinoma |
0.043975916 |
Sensitive |
| ENSG00000261003.1 |
Avagacestat |
Breast invasive carcinoma |
0.048309282 |
Sensitive |
| ENSG00000261043.2 |
Avagacestat |
Breast invasive carcinoma |
0.049644569 |
Sensitive |
| ENSG00000261083.1 |
Avagacestat |
Breast invasive carcinoma |
0.016674562 |
Sensitive |
| ENSG00000261167.1 |
Avagacestat |
Breast invasive carcinoma |
0.049206438 |
Sensitive |
| ENSG00000261288.1 |
Avagacestat |
Breast invasive carcinoma |
0.019898462 |
Sensitive |
| ENSG00000261305.1 |
Avagacestat |
Breast invasive carcinoma |
0.00698678 |
Sensitive |
| ENSG00000261334.1 |
Avagacestat |
Breast invasive carcinoma |
0.031628331 |
Sensitive |
| ENSG00000261610.1 |
Avagacestat |
Breast invasive carcinoma |
0.025413277 |
Sensitive |
| ENSG00000261634.2 |
Avagacestat |
Breast invasive carcinoma |
0.000820543 |
Sensitive |
| ENSG00000261654.1 |
Avagacestat |
Breast invasive carcinoma |
0.002662407 |
Sensitive |
| ENSG00000262652.1 |
Avagacestat |
Breast invasive carcinoma |
0.035085487 |
Sensitive |
| ENSG00000263860.1 |
Avagacestat |
Breast invasive carcinoma |
0.021984822 |
Sensitive |
| ENSG00000263924.1 |
Avagacestat |
Breast invasive carcinoma |
0.046400263 |
Sensitive |
| ENSG00000265010.1 |
Avagacestat |
Breast invasive carcinoma |
0.046846254 |
Sensitive |
| ENSG00000265349.1 |
Avagacestat |
Breast invasive carcinoma |
0.009124642 |
Sensitive |
| ENSG00000265394.1 |
Avagacestat |
Breast invasive carcinoma |
0.017600369 |
Sensitive |
| ENSG00000265750.1 |
Avagacestat |
Breast invasive carcinoma |
0.03548209 |
Sensitive |
| ENSG00000265791.1 |
Avagacestat |
Breast invasive carcinoma |
0.003185868 |
Sensitive |
| ENSG00000266236.1 |
Avagacestat |
Breast invasive carcinoma |
0.014364466 |
Sensitive |
| ENSG00000266340.1 |
Avagacestat |
Breast invasive carcinoma |
0.01128793 |
Sensitive |
| ENSG00000266850.1 |
Avagacestat |
Breast invasive carcinoma |
0.030508779 |
Sensitive |
| ENSG00000266877.1 |
Avagacestat |
Breast invasive carcinoma |
0.045061116 |
Sensitive |
| ENSG00000266900.1 |
Avagacestat |
Breast invasive carcinoma |
0.046400099 |
Sensitive |
| ENSG00000266947.1 |
Avagacestat |
Breast invasive carcinoma |
0.040314828 |
Sensitive |
| ENSG00000267016.1 |
Avagacestat |
Breast invasive carcinoma |
0.025452622 |
Sensitive |
| ENSG00000267025.1 |
Avagacestat |
Breast invasive carcinoma |
0.01892546 |
Sensitive |
| ENSG00000267167.1 |
Avagacestat |
Breast invasive carcinoma |
0.038549816 |
Sensitive |
| ENSG00000267263.1 |
Avagacestat |
Breast invasive carcinoma |
0.031603521 |
Sensitive |
| ENSG00000267347.1 |
Avagacestat |
Breast invasive carcinoma |
0.03501203 |
Sensitive |
| ENSG00000267374.1 |
Avagacestat |
Breast invasive carcinoma |
0.044213339 |
Sensitive |
| ENSG00000267583.1 |
Avagacestat |
Breast invasive carcinoma |
0.001240632 |
Sensitive |
| ENSG00000267586.2 |
Avagacestat |
Breast invasive carcinoma |
0.049974726 |
Sensitive |
| ENSG00000267804.1 |
Avagacestat |
Breast invasive carcinoma |
0.021334793 |
Sensitive |
| ENSG00000268262.1 |
Avagacestat |
Breast invasive carcinoma |
0.048841485 |
Sensitive |
| ENSG00000268289.1 |
Avagacestat |
Breast invasive carcinoma |
0.02769236 |
Sensitive |
| ENSG00000268707.1 |
Avagacestat |
Breast invasive carcinoma |
0.048298825 |
Sensitive |
| ENSG00000269235.1 |
Avagacestat |
Breast invasive carcinoma |
0.028159033 |
Sensitive |
| ENSG00000269901.1 |
Avagacestat |
Breast invasive carcinoma |
0.048735478 |
Sensitive |
| ENSG00000269951.1 |
Avagacestat |
Breast invasive carcinoma |
0.030688691 |
Sensitive |
| ENSG00000269959.1 |
Avagacestat |
Breast invasive carcinoma |
0.042929713 |
Sensitive |
| ENSG00000269980.1 |
Avagacestat |
Breast invasive carcinoma |
0.049757343 |
Sensitive |
| ENSG00000270062.1 |
Avagacestat |
Breast invasive carcinoma |
0.003354769 |
Sensitive |
| ENSG00000271185.1 |
Avagacestat |
Breast invasive carcinoma |
0.016313489 |
Sensitive |
| ENSG00000271553.1 |
Avagacestat |
Breast invasive carcinoma |
0.032036902 |
Sensitive |
| ENSG00000271921.1 |
Avagacestat |
Breast invasive carcinoma |
0.020046109 |
Sensitive |
| ENSG00000272048.1 |
Avagacestat |
Breast invasive carcinoma |
0.017734555 |
Sensitive |
| ENSG00000272209.1 |
Avagacestat |
Breast invasive carcinoma |
0.029889832 |
Sensitive |
| ENSG00000272604.1 |
Avagacestat |
Breast invasive carcinoma |
0.002505253 |
Sensitive |
| ENSG00000272905.1 |
Avagacestat |
Breast invasive carcinoma |
0.037884711 |
Sensitive |
| ENSG00000273000.1 |
Avagacestat |
Breast invasive carcinoma |
0.011814781 |
Sensitive |
| ENSG00000273216.1 |
Avagacestat |
Breast invasive carcinoma |
0.018140507 |
Sensitive |
| ENSG00000273218.1 |
Avagacestat |
Breast invasive carcinoma |
0.01556181 |
Sensitive |
| ENSG00000273270.1 |
Avagacestat |
Breast invasive carcinoma |
0.047190125 |
Sensitive |
| ENSG00000273373.1 |
Avagacestat |
Breast invasive carcinoma |
0.045159045 |
Sensitive |
| ENSG00000273448.1 |
Avagacestat |
Breast invasive carcinoma |
0.007562061 |
Sensitive |
| ENSG00000088970.11 |
Avagacestat |
Colon adenocarcinoma |
0.035265957 |
Sensitive |
| ENSG00000175701.6 |
Avagacestat |
Colon adenocarcinoma |
0.014326087 |
Sensitive |
| ENSG00000180846.4 |
Avagacestat |
Colon adenocarcinoma |
0.017963283 |
Sensitive |
| ENSG00000185495.6 |
Avagacestat |
Colon adenocarcinoma |
0.04338218 |
Sensitive |
| ENSG00000187979.4 |
Avagacestat |
Colon adenocarcinoma |
0.036848971 |
Sensitive |
| ENSG00000196696.8 |
Avagacestat |
Colon adenocarcinoma |
0.004602039 |
Sensitive |
| ENSG00000205037.2 |
Avagacestat |
Colon adenocarcinoma |
0.014578314 |
Sensitive |
| ENSG00000205500.4 |
Avagacestat |
Colon adenocarcinoma |
0.011435845 |
Sensitive |
| ENSG00000215417.6 |
Avagacestat |
Colon adenocarcinoma |
0.019791775 |
Sensitive |
| ENSG00000215863.2 |
Avagacestat |
Colon adenocarcinoma |
0.017003365 |
Sensitive |
| ENSG00000223380.3 |
Avagacestat |
Colon adenocarcinoma |
0.045324014 |
Sensitive |
| ENSG00000223576.2 |
Avagacestat |
Colon adenocarcinoma |
0.031699153 |
Sensitive |
| ENSG00000223804.1 |
Avagacestat |
Colon adenocarcinoma |
0.040513086 |
Sensitive |
| ENSG00000224844.1 |
Avagacestat |
Colon adenocarcinoma |
0.0000884 |
Sensitive |
| ENSG00000224975.1 |
Avagacestat |
Colon adenocarcinoma |
0.04139764 |
Sensitive |
| ENSG00000224977.1 |
Avagacestat |
Colon adenocarcinoma |
0.035714076 |
Sensitive |
| ENSG00000225489.2 |
Avagacestat |
Colon adenocarcinoma |
0.001809171 |
Sensitive |
| ENSG00000225703.1 |
Avagacestat |
Colon adenocarcinoma |
0.030531985 |
Sensitive |
| ENSG00000225751.2 |
Avagacestat |
Colon adenocarcinoma |
0.005616733 |
Sensitive |
| ENSG00000226149.1 |
Avagacestat |
Colon adenocarcinoma |
0.023955415 |
Sensitive |
| ENSG00000226383.1 |
Avagacestat |
Colon adenocarcinoma |
0.00487862 |
Sensitive |
| ENSG00000226645.1 |
Avagacestat |
Colon adenocarcinoma |
0.025148426 |
Sensitive |
| ENSG00000226920.1 |
Avagacestat |
Colon adenocarcinoma |
0.011972595 |
Sensitive |
| ENSG00000226950.2 |
Avagacestat |
Colon adenocarcinoma |
0.039659873 |
Sensitive |
| ENSG00000227036.2 |
Avagacestat |
Colon adenocarcinoma |
0.00034637 |
Sensitive |
| ENSG00000227200.1 |
Avagacestat |
Colon adenocarcinoma |
0.030310772 |
Sensitive |
| ENSG00000227237.1 |
Avagacestat |
Colon adenocarcinoma |
0.023344253 |
Sensitive |
| ENSG00000227518.2 |
Avagacestat |
Colon adenocarcinoma |
0.005618684 |
Sensitive |
| ENSG00000227627.1 |
Avagacestat |
Colon adenocarcinoma |
0.038754005 |
Sensitive |
| ENSG00000227740.1 |
Avagacestat |
Colon adenocarcinoma |
0.014101187 |
Sensitive |
| ENSG00000227959.1 |
Avagacestat |
Colon adenocarcinoma |
0.028061106 |
Sensitive |
| ENSG00000228204.2 |
Avagacestat |
Colon adenocarcinoma |
0.004017486 |
Sensitive |
| ENSG00000228302.2 |
Avagacestat |
Colon adenocarcinoma |
0.019039097 |
Sensitive |
| ENSG00000228353.1 |
Avagacestat |
Colon adenocarcinoma |
0.026418149 |
Sensitive |
| ENSG00000228737.2 |
Avagacestat |
Colon adenocarcinoma |
0.001899677 |
Sensitive |
| ENSG00000228802.1 |
Avagacestat |
Colon adenocarcinoma |
0.000599544 |
Sensitive |
| ENSG00000228886.1 |
Avagacestat |
Colon adenocarcinoma |
0.046418432 |
Sensitive |
| ENSG00000229005.2 |
Avagacestat |
Colon adenocarcinoma |
0.00342184 |
Sensitive |
| ENSG00000229111.1 |
Avagacestat |
Colon adenocarcinoma |
0.032118535 |
Sensitive |
| ENSG00000229656.2 |
Avagacestat |
Colon adenocarcinoma |
0.036466349 |
Sensitive |
| ENSG00000229672.2 |
Avagacestat |
Colon adenocarcinoma |
0.030374286 |
Sensitive |
| ENSG00000229694.2 |
Avagacestat |
Colon adenocarcinoma |
0.001813125 |
Sensitive |
| ENSG00000229862.1 |
Avagacestat |
Colon adenocarcinoma |
0.004515342 |
Sensitive |
| ENSG00000229951.1 |
Avagacestat |
Colon adenocarcinoma |
0.00118539 |
Sensitive |
| ENSG00000231560.1 |
Avagacestat |
Colon adenocarcinoma |
0.003122695 |
Sensitive |
| ENSG00000231611.1 |
Avagacestat |
Colon adenocarcinoma |
0.00137269 |
Sensitive |
| ENSG00000231817.3 |
Avagacestat |
Colon adenocarcinoma |
0.011995994 |
Sensitive |
| ENSG00000231829.2 |
Avagacestat |
Colon adenocarcinoma |
0.049948707 |
Sensitive |
| ENSG00000231842.1 |
Avagacestat |
Colon adenocarcinoma |
0.022375277 |
Sensitive |
| ENSG00000232412.1 |
Avagacestat |
Colon adenocarcinoma |
0.018230624 |
Sensitive |
| ENSG00000232686.1 |
Avagacestat |
Colon adenocarcinoma |
0.040016106 |
Sensitive |
| ENSG00000232860.3 |
Avagacestat |
Colon adenocarcinoma |
0.031698325 |
Sensitive |
| ENSG00000232931.1 |
Avagacestat |
Colon adenocarcinoma |
0.010690153 |
Sensitive |
| ENSG00000234160.1 |
Avagacestat |
Colon adenocarcinoma |
0.003101722 |
Sensitive |
| ENSG00000234650.1 |
Avagacestat |
Colon adenocarcinoma |
0.028859208 |
Sensitive |
| ENSG00000234705.1 |
Avagacestat |
Colon adenocarcinoma |
0.004898847 |
Sensitive |
| ENSG00000234899.5 |
Avagacestat |
Colon adenocarcinoma |
0.020434933 |
Sensitive |
| ENSG00000235029.1 |
Avagacestat |
Colon adenocarcinoma |
0.03648836 |
Sensitive |
| ENSG00000235381.1 |
Avagacestat |
Colon adenocarcinoma |
0.0000558 |
Sensitive |
| ENSG00000235448.1 |
Avagacestat |
Colon adenocarcinoma |
0.02021225 |
Sensitive |
| ENSG00000235481.2 |
Avagacestat |
Colon adenocarcinoma |
0.004192322 |
Sensitive |
| ENSG00000235884.2 |
Avagacestat |
Colon adenocarcinoma |
0.037817224 |
Sensitive |
| ENSG00000235910.1 |
Avagacestat |
Colon adenocarcinoma |
0.045470815 |
Sensitive |
| ENSG00000236194.2 |
Avagacestat |
Colon adenocarcinoma |
0.016496064 |
Sensitive |
| ENSG00000237877.2 |
Avagacestat |
Colon adenocarcinoma |
0.002811279 |
Sensitive |
| ENSG00000238045.5 |
Avagacestat |
Colon adenocarcinoma |
0.00270562 |
Sensitive |
| ENSG00000238279.1 |
Avagacestat |
Colon adenocarcinoma |
0.015711103 |
Sensitive |
| ENSG00000239300.1 |
Avagacestat |
Colon adenocarcinoma |
0.049227929 |
Sensitive |
| ENSG00000240143.1 |
Avagacestat |
Colon adenocarcinoma |
0.009627846 |
Sensitive |
| ENSG00000243433.1 |
Avagacestat |
Colon adenocarcinoma |
0.011589535 |
Sensitive |
| ENSG00000243485.2 |
Avagacestat |
Colon adenocarcinoma |
0.036117063 |
Sensitive |
| ENSG00000243637.1 |
Avagacestat |
Colon adenocarcinoma |
0.045842226 |
Sensitive |
| ENSG00000243960.1 |
Avagacestat |
Colon adenocarcinoma |
0.009899274 |
Sensitive |
| ENSG00000244479.2 |
Avagacestat |
Colon adenocarcinoma |
0.043579128 |
Sensitive |
| ENSG00000244625.1 |
Avagacestat |
Colon adenocarcinoma |
0.020524029 |
Sensitive |
| ENSG00000246331.2 |
Avagacestat |
Colon adenocarcinoma |
0.012879594 |
Sensitive |
| ENSG00000247853.2 |
Avagacestat |
Colon adenocarcinoma |
0.016548022 |
Sensitive |
| ENSG00000248538.2 |
Avagacestat |
Colon adenocarcinoma |
0.017401791 |
Sensitive |
| ENSG00000248724.2 |
Avagacestat |
Colon adenocarcinoma |
0.006089803 |
Sensitive |
| ENSG00000249096.2 |
Avagacestat |
Colon adenocarcinoma |
0.03213866 |
Sensitive |
| ENSG00000249595.1 |
Avagacestat |
Colon adenocarcinoma |
0.04281146 |
Sensitive |
| ENSG00000249806.1 |
Avagacestat |
Colon adenocarcinoma |
0.044538642 |
Sensitive |
| ENSG00000250659.2 |
Avagacestat |
Colon adenocarcinoma |
0.047267945 |
Sensitive |
| ENSG00000250740.1 |
Avagacestat |
Colon adenocarcinoma |
0.00998989 |
Sensitive |
| ENSG00000250893.1 |
Avagacestat |
Colon adenocarcinoma |
0.03661789 |
Sensitive |
| ENSG00000250909.1 |
Avagacestat |
Colon adenocarcinoma |
0.04966371 |
Sensitive |
| ENSG00000253106.1 |
Avagacestat |
Colon adenocarcinoma |
0.010507799 |
Sensitive |
| ENSG00000253754.1 |
Avagacestat |
Colon adenocarcinoma |
0.035229993 |
Sensitive |
| ENSG00000254099.1 |
Avagacestat |
Colon adenocarcinoma |
0.02326968 |
Sensitive |
| ENSG00000254207.1 |
Avagacestat |
Colon adenocarcinoma |
0.046170358 |
Sensitive |
| ENSG00000254275.2 |
Avagacestat |
Colon adenocarcinoma |
0.018057364 |
Sensitive |
| ENSG00000254341.1 |
Avagacestat |
Colon adenocarcinoma |
0.032388699 |
Sensitive |
| ENSG00000254431.1 |
Avagacestat |
Colon adenocarcinoma |
0.02488919 |
Sensitive |
| ENSG00000254444.1 |
Avagacestat |
Colon adenocarcinoma |
0.013502473 |
Sensitive |
| ENSG00000254461.1 |
Avagacestat |
Colon adenocarcinoma |
0.039763458 |
Sensitive |
| ENSG00000254495.1 |
Avagacestat |
Colon adenocarcinoma |
0.032835077 |
Sensitive |
| ENSG00000254682.1 |
Avagacestat |
Colon adenocarcinoma |
0.009547436 |
Sensitive |
| ENSG00000254762.1 |
Avagacestat |
Colon adenocarcinoma |
0.013433717 |
Sensitive |
| ENSG00000254872.2 |
Avagacestat |
Colon adenocarcinoma |
0.000116504 |
Sensitive |
| ENSG00000255158.1 |
Avagacestat |
Colon adenocarcinoma |
0.008547082 |
Sensitive |
| ENSG00000255559.1 |
Avagacestat |
Colon adenocarcinoma |
0.004063823 |
Sensitive |
| ENSG00000255989.1 |
Avagacestat |
Colon adenocarcinoma |
0.002983139 |
Sensitive |
| ENSG00000256001.1 |
Avagacestat |
Colon adenocarcinoma |
0.0000574 |
Sensitive |
| ENSG00000256116.1 |
Avagacestat |
Colon adenocarcinoma |
0.003467237 |
Sensitive |
| ENSG00000256705.3 |
Avagacestat |
Colon adenocarcinoma |
0.021049446 |
Sensitive |
| ENSG00000256712.1 |
Avagacestat |
Colon adenocarcinoma |
0.00613521 |
Sensitive |
| ENSG00000256751.1 |
Avagacestat |
Colon adenocarcinoma |
0.011475177 |
Sensitive |
| ENSG00000256940.1 |
Avagacestat |
Colon adenocarcinoma |
0.047992885 |
Sensitive |
| ENSG00000257222.1 |
Avagacestat |
Colon adenocarcinoma |
0.005069364 |
Sensitive |
| ENSG00000257256.1 |
Avagacestat |
Colon adenocarcinoma |
0.010940353 |
Sensitive |
| ENSG00000257270.1 |
Avagacestat |
Colon adenocarcinoma |
0.037806407 |
Sensitive |
| ENSG00000257507.1 |
Avagacestat |
Colon adenocarcinoma |
0.001989398 |
Sensitive |
| ENSG00000257557.1 |
Avagacestat |
Colon adenocarcinoma |
0.00540128 |
Sensitive |
| ENSG00000257999.1 |
Avagacestat |
Colon adenocarcinoma |
0.022993189 |
Sensitive |
| ENSG00000258048.1 |
Avagacestat |
Colon adenocarcinoma |
0.003140023 |
Sensitive |
| ENSG00000258136.1 |
Avagacestat |
Colon adenocarcinoma |
0.001005872 |
Sensitive |
| ENSG00000258428.1 |
Avagacestat |
Colon adenocarcinoma |
0.005150555 |
Sensitive |
| ENSG00000258455.1 |
Avagacestat |
Colon adenocarcinoma |
0.0000322 |
Sensitive |
| ENSG00000258558.1 |
Avagacestat |
Colon adenocarcinoma |
0.024189628 |
Sensitive |
| ENSG00000258646.1 |
Avagacestat |
Colon adenocarcinoma |
0.044704114 |
Sensitive |
| ENSG00000258658.1 |
Avagacestat |
Colon adenocarcinoma |
0.048586696 |
Sensitive |
| ENSG00000258940.2 |
Avagacestat |
Colon adenocarcinoma |
0.0427787 |
Sensitive |
| ENSG00000258983.1 |
Avagacestat |
Colon adenocarcinoma |
0.044896147 |
Sensitive |
| ENSG00000259002.1 |
Avagacestat |
Colon adenocarcinoma |
0.026719042 |
Sensitive |
| ENSG00000259116.1 |
Avagacestat |
Colon adenocarcinoma |
0.040215555 |
Sensitive |
| ENSG00000259349.1 |
Avagacestat |
Colon adenocarcinoma |
0.021932831 |
Sensitive |
| ENSG00000259595.1 |
Avagacestat |
Colon adenocarcinoma |
0.028550207 |
Sensitive |
| ENSG00000259713.1 |
Avagacestat |
Colon adenocarcinoma |
0.019264848 |
Sensitive |
| ENSG00000259758.1 |
Avagacestat |
Colon adenocarcinoma |
0.047800872 |
Sensitive |
| ENSG00000259799.1 |
Avagacestat |
Colon adenocarcinoma |
0.002637939 |
Sensitive |
| ENSG00000259820.1 |
Avagacestat |
Colon adenocarcinoma |
0.012206938 |
Sensitive |
| ENSG00000259840.1 |
Avagacestat |
Colon adenocarcinoma |
0.023147707 |
Sensitive |
| ENSG00000259894.1 |
Avagacestat |
Colon adenocarcinoma |
0.007391393 |
Sensitive |
| ENSG00000259915.1 |
Avagacestat |
Colon adenocarcinoma |
0.038327265 |
Sensitive |
| ENSG00000259921.1 |
Avagacestat |
Colon adenocarcinoma |
0.013627827 |
Sensitive |
| ENSG00000260017.1 |
Avagacestat |
Colon adenocarcinoma |
0.002279591 |
Sensitive |
| ENSG00000260132.1 |
Avagacestat |
Colon adenocarcinoma |
0.03189786 |
Sensitive |
| ENSG00000260252.1 |
Avagacestat |
Colon adenocarcinoma |
0.026449848 |
Sensitive |
| ENSG00000260306.1 |
Avagacestat |
Colon adenocarcinoma |
0.034271239 |
Sensitive |
| ENSG00000260396.1 |
Avagacestat |
Colon adenocarcinoma |
0.048694528 |
Sensitive |
| ENSG00000260645.1 |
Avagacestat |
Colon adenocarcinoma |
0.042807816 |
Sensitive |
| ENSG00000260698.1 |
Avagacestat |
Colon adenocarcinoma |
0.010807131 |
Sensitive |
| ENSG00000260895.1 |
Avagacestat |
Colon adenocarcinoma |
0.008805716 |
Sensitive |
| ENSG00000260905.1 |
Avagacestat |
Colon adenocarcinoma |
0.011563366 |
Sensitive |
| ENSG00000260927.1 |
Avagacestat |
Colon adenocarcinoma |
0.004599475 |
Sensitive |
| ENSG00000260977.1 |
Avagacestat |
Colon adenocarcinoma |
0.030231439 |
Sensitive |
| ENSG00000261080.1 |
Avagacestat |
Colon adenocarcinoma |
0.0385105 |
Sensitive |
| ENSG00000261216.1 |
Avagacestat |
Colon adenocarcinoma |
0.034184019 |
Sensitive |
| ENSG00000261254.1 |
Avagacestat |
Colon adenocarcinoma |
0.041122265 |
Sensitive |
| ENSG00000261314.1 |
Avagacestat |
Colon adenocarcinoma |
0.021303189 |
Sensitive |
| ENSG00000261396.1 |
Avagacestat |
Colon adenocarcinoma |
0.001495839 |
Sensitive |
| ENSG00000261404.1 |
Avagacestat |
Colon adenocarcinoma |
0.008547581 |
Sensitive |
| ENSG00000261442.1 |
Avagacestat |
Colon adenocarcinoma |
0.045438881 |
Sensitive |
| ENSG00000261542.1 |
Avagacestat |
Colon adenocarcinoma |
0.048833536 |
Sensitive |
| ENSG00000261669.1 |
Avagacestat |
Colon adenocarcinoma |
0.039082803 |
Sensitive |
| ENSG00000261924.1 |
Avagacestat |
Colon adenocarcinoma |
0.000301377 |
Sensitive |
| ENSG00000261996.1 |
Avagacestat |
Colon adenocarcinoma |
0.029800053 |
Sensitive |
| ENSG00000263182.1 |
Avagacestat |
Colon adenocarcinoma |
0.036993258 |
Sensitive |
| ENSG00000263388.1 |
Avagacestat |
Colon adenocarcinoma |
0.022076259 |
Sensitive |
| ENSG00000263680.2 |
Avagacestat |
Colon adenocarcinoma |
0.000798496 |
Sensitive |
| ENSG00000264859.1 |
Avagacestat |
Colon adenocarcinoma |
0.001261162 |
Sensitive |
| ENSG00000265511.1 |
Avagacestat |
Colon adenocarcinoma |
0.002163593 |
Sensitive |
| ENSG00000266289.1 |
Avagacestat |
Colon adenocarcinoma |
0.011473849 |
Sensitive |
| ENSG00000266651.1 |
Avagacestat |
Colon adenocarcinoma |
0.028349628 |
Sensitive |
| ENSG00000266717.1 |
Avagacestat |
Colon adenocarcinoma |
0.028065197 |
Sensitive |
| ENSG00000266896.1 |
Avagacestat |
Colon adenocarcinoma |
0.041626674 |
Sensitive |
| ENSG00000266926.1 |
Avagacestat |
Colon adenocarcinoma |
0.026463291 |
Sensitive |
| ENSG00000267117.1 |
Avagacestat |
Colon adenocarcinoma |
0.002115139 |
Sensitive |
| ENSG00000267197.1 |
Avagacestat |
Colon adenocarcinoma |
0.048223295 |
Sensitive |
| ENSG00000267304.1 |
Avagacestat |
Colon adenocarcinoma |
0.043738914 |
Sensitive |
| ENSG00000267344.1 |
Avagacestat |
Colon adenocarcinoma |
0.013276157 |
Sensitive |
| ENSG00000267348.2 |
Avagacestat |
Colon adenocarcinoma |
0.035675355 |
Sensitive |
| ENSG00000267432.1 |
Avagacestat |
Colon adenocarcinoma |
0.040789082 |
Sensitive |
| ENSG00000267834.1 |
Avagacestat |
Colon adenocarcinoma |
0.034168446 |
Sensitive |
| ENSG00000268307.1 |
Avagacestat |
Colon adenocarcinoma |
0.014880947 |
Sensitive |
| ENSG00000268530.1 |
Avagacestat |
Colon adenocarcinoma |
0.044831919 |
Sensitive |
| ENSG00000268945.1 |
Avagacestat |
Colon adenocarcinoma |
0.006716424 |
Sensitive |
| ENSG00000269161.1 |
Avagacestat |
Colon adenocarcinoma |
0.010439519 |
Sensitive |
| ENSG00000269352.1 |
Avagacestat |
Colon adenocarcinoma |
0.005100605 |
Sensitive |
| ENSG00000269680.1 |
Avagacestat |
Colon adenocarcinoma |
0.021254252 |
Sensitive |
| ENSG00000269903.1 |
Avagacestat |
Colon adenocarcinoma |
0.040190595 |
Sensitive |
| ENSG00000269910.1 |
Avagacestat |
Colon adenocarcinoma |
0.029263895 |
Sensitive |
| ENSG00000269940.1 |
Avagacestat |
Colon adenocarcinoma |
0.029927784 |
Sensitive |
| ENSG00000269958.1 |
Avagacestat |
Colon adenocarcinoma |
0.026455217 |
Sensitive |
| ENSG00000270048.1 |
Avagacestat |
Colon adenocarcinoma |
0.013370467 |
Sensitive |
| ENSG00000270760.1 |
Avagacestat |
Colon adenocarcinoma |
0.005065415 |
Sensitive |
| ENSG00000271218.1 |
Avagacestat |
Colon adenocarcinoma |
0.001145028 |
Sensitive |
| ENSG00000271228.1 |
Avagacestat |
Colon adenocarcinoma |
0.022494071 |
Sensitive |
| ENSG00000272072.1 |
Avagacestat |
Colon adenocarcinoma |
0.049684346 |
Sensitive |
| ENSG00000272141.1 |
Avagacestat |
Colon adenocarcinoma |
0.002139398 |
Sensitive |
| ENSG00000272263.1 |
Avagacestat |
Colon adenocarcinoma |
0.005119766 |
Sensitive |
| ENSG00000272275.1 |
Avagacestat |
Colon adenocarcinoma |
0.003883431 |
Sensitive |
| ENSG00000272338.1 |
Avagacestat |
Colon adenocarcinoma |
0.049697125 |
Sensitive |
| ENSG00000272377.1 |
Avagacestat |
Colon adenocarcinoma |
0.008257282 |
Sensitive |
| ENSG00000272402.1 |
Avagacestat |
Colon adenocarcinoma |
0.042104447 |
Sensitive |
| ENSG00000272516.1 |
Avagacestat |
Colon adenocarcinoma |
0.012092895 |
Sensitive |
| ENSG00000272689.1 |
Avagacestat |
Colon adenocarcinoma |
0.018051431 |
Sensitive |
| ENSG00000272754.1 |
Avagacestat |
Colon adenocarcinoma |
0.016051644 |
Sensitive |
| ENSG00000272782.1 |
Avagacestat |
Colon adenocarcinoma |
0.027414214 |
Sensitive |
| ENSG00000272836.1 |
Avagacestat |
Colon adenocarcinoma |
0.04991031 |
Sensitive |
| ENSG00000273116.1 |
Avagacestat |
Colon adenocarcinoma |
0.029623832 |
Sensitive |
| ENSG00000273216.1 |
Avagacestat |
Colon adenocarcinoma |
0.022947891 |
Sensitive |
| ENSG00000273306.1 |
Avagacestat |
Colon adenocarcinoma |
0.018577236 |
Sensitive |
| ENSG00000273307.1 |
Avagacestat |
Colon adenocarcinoma |
0.004636199 |
Sensitive |
| ENSG00000273341.1 |
Avagacestat |
Colon adenocarcinoma |
0.010690592 |
Sensitive |
| ENSG00000273350.1 |
Avagacestat |
Colon adenocarcinoma |
0.003354325 |
Sensitive |
| ENSG00000273373.1 |
Avagacestat |
Colon adenocarcinoma |
0.043427251 |
Sensitive |
| ENSG00000225194.2 |
Avagacestat |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.049388386 |
Sensitive |
| ENSG00000227237.1 |
Avagacestat |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.01389799 |
Sensitive |
| ENSG00000228686.2 |
Avagacestat |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.035068823 |
Sensitive |
| ENSG00000228786.1 |
Avagacestat |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.027434418 |
Sensitive |
| ENSG00000230925.3 |
Avagacestat |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.014443493 |
Sensitive |
| ENSG00000232295.3 |
Avagacestat |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.039508735 |
Sensitive |
| ENSG00000232377.1 |
Avagacestat |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.013350162 |
Sensitive |
| ENSG00000234230.1 |
Avagacestat |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.036383679 |
Sensitive |
| ENSG00000234478.1 |
Avagacestat |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.0473522 |
Sensitive |
| ENSG00000237222.3 |
Avagacestat |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.020573287 |
Sensitive |
| ENSG00000237298.4 |
Avagacestat |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.01211997 |
Sensitive |
| ENSG00000239828.2 |
Avagacestat |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.01114863 |
Sensitive |
| ENSG00000246130.1 |
Avagacestat |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.028640192 |
Sensitive |
| ENSG00000247950.2 |
Avagacestat |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.001936194 |
Sensitive |
| ENSG00000248476.1 |
Avagacestat |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.049938221 |
Sensitive |
| ENSG00000250033.1 |
Avagacestat |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.023953734 |
Sensitive |
| ENSG00000251018.2 |
Avagacestat |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.035242307 |
Sensitive |
| ENSG00000253893.2 |
Avagacestat |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.011607718 |
Sensitive |
| ENSG00000254459.1 |
Avagacestat |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.02889982 |
Sensitive |
| ENSG00000255089.1 |
Avagacestat |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.019401083 |
Sensitive |
| ENSG00000256482.1 |
Avagacestat |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.022501706 |
Sensitive |
| ENSG00000256588.1 |
Avagacestat |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.037262397 |
Sensitive |
| ENSG00000257563.1 |
Avagacestat |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.036331304 |
Sensitive |
| ENSG00000258035.1 |
Avagacestat |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.04152237 |
Sensitive |
| ENSG00000258813.1 |
Avagacestat |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.001215393 |
Sensitive |
| ENSG00000260364.1 |
Avagacestat |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.022219504 |
Sensitive |
| ENSG00000260834.1 |
Avagacestat |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.022814537 |
Sensitive |
| ENSG00000260912.1 |
Avagacestat |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.012067627 |
Sensitive |
| ENSG00000261286.1 |
Avagacestat |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.031321972 |
Sensitive |
| ENSG00000261372.1 |
Avagacestat |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.023919767 |
Sensitive |
| ENSG00000269896.1 |
Avagacestat |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.012907431 |
Sensitive |
| ENSG00000269983.1 |
Avagacestat |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.040320206 |
Sensitive |
| ENSG00000271788.1 |
Avagacestat |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.035773508 |
Sensitive |
| ENSG00000271843.1 |
Avagacestat |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.020825837 |
Sensitive |
| ENSG00000272148.1 |
Avagacestat |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.032344389 |
Sensitive |
| ENSG00000272156.1 |
Avagacestat |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.024077012 |
Sensitive |
| ENSG00000272248.1 |
Avagacestat |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.034826136 |
Sensitive |
| ENSG00000272983.1 |
Avagacestat |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.032413867 |
Sensitive |
| ENSG00000272984.1 |
Avagacestat |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.044116369 |
Sensitive |
| ENSG00000273017.1 |
Avagacestat |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.042720227 |
Sensitive |
| ENSG00000224269.1 |
Avagacestat |
Esophageal cancer |
0.006773347 |
Sensitive |
| ENSG00000230368.2 |
Avagacestat |
Esophageal cancer |
0.007366831 |
Sensitive |
| ENSG00000230415.1 |
Avagacestat |
Esophageal cancer |
0.036783503 |
Sensitive |
| ENSG00000232224.1 |
Avagacestat |
Esophageal cancer |
0.023950905 |
Sensitive |
| ENSG00000236514.1 |
Avagacestat |
Esophageal cancer |
0.027730121 |
Sensitive |
| ENSG00000241679.2 |
Avagacestat |
Esophageal cancer |
0.043490065 |
Sensitive |
| ENSG00000245729.1 |
Avagacestat |
Esophageal cancer |
0.027420154 |
Sensitive |
| ENSG00000254389.2 |
Avagacestat |
Esophageal cancer |
0.014391816 |
Sensitive |
| ENSG00000254855.1 |
Avagacestat |
Esophageal cancer |
0.04783749 |
Sensitive |
| ENSG00000257135.1 |
Avagacestat |
Esophageal cancer |
0.041284647 |
Sensitive |
| ENSG00000261033.1 |
Avagacestat |
Esophageal cancer |
0.040502243 |
Sensitive |
| ENSG00000262155.1 |
Avagacestat |
Esophageal cancer |
0.038264235 |
Sensitive |
| ENSG00000271963.1 |
Avagacestat |
Esophageal cancer |
0.046227084 |
Sensitive |
| ENSG00000271967.1 |
Avagacestat |
Esophageal cancer |
0.035941445 |
Sensitive |
| ENSG00000273264.1 |
Avagacestat |
Esophageal cancer |
0.02765902 |
Sensitive |
| ENSG00000182366.5 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.009770615 |
Sensitive |
| ENSG00000203706.4 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.04376424 |
Sensitive |
| ENSG00000224577.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.014859635 |
Sensitive |
| ENSG00000226659.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.04381441 |
Sensitive |
| ENSG00000231742.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.026776579 |
Sensitive |
| ENSG00000237993.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.035833997 |
Sensitive |
| ENSG00000250551.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.015452179 |
Sensitive |
| ENSG00000259756.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.019386829 |
Sensitive |
| ENSG00000262202.3 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.0448053 |
Sensitive |
| ENSG00000157306.10 |
Avagacestat |
Kidney renal clear cell carcinoma |
0.037753206 |
Sensitive |
| ENSG00000188365.3 |
Avagacestat |
Kidney renal clear cell carcinoma |
0.014583434 |
Sensitive |
| ENSG00000203496.4 |
Avagacestat |
Kidney renal clear cell carcinoma |
0.005709384 |
Sensitive |
| ENSG00000224707.1 |
Avagacestat |
Kidney renal clear cell carcinoma |
0.04200657 |
Sensitive |
| ENSG00000225806.3 |
Avagacestat |
Kidney renal clear cell carcinoma |
0.043796158 |
Sensitive |
| ENSG00000228028.2 |
Avagacestat |
Kidney renal clear cell carcinoma |
0.002007622 |
Sensitive |
| ENSG00000231920.1 |
Avagacestat |
Kidney renal clear cell carcinoma |
0.049759161 |
Sensitive |
| ENSG00000232224.1 |
Avagacestat |
Kidney renal clear cell carcinoma |
0.01812689 |
Sensitive |
| ENSG00000234006.1 |
Avagacestat |
Kidney renal clear cell carcinoma |
0.039115844 |
Sensitive |
| ENSG00000234584.1 |
Avagacestat |
Kidney renal clear cell carcinoma |
0.046315322 |
Sensitive |
| ENSG00000235652.3 |
Avagacestat |
Kidney renal clear cell carcinoma |
0.035424577 |
Sensitive |
| ENSG00000241818.1 |
Avagacestat |
Kidney renal clear cell carcinoma |
0.004357138 |
Sensitive |
| ENSG00000253133.1 |
Avagacestat |
Kidney renal clear cell carcinoma |
0.039825596 |
Sensitive |
| ENSG00000254165.1 |
Avagacestat |
Kidney renal clear cell carcinoma |
0.031481695 |
Sensitive |
| ENSG00000255158.1 |
Avagacestat |
Kidney renal clear cell carcinoma |
0.024963721 |
Sensitive |
| ENSG00000255495.1 |
Avagacestat |
Kidney renal clear cell carcinoma |
0.032386124 |
Sensitive |
| ENSG00000256538.1 |
Avagacestat |
Kidney renal clear cell carcinoma |
0.022516299 |
Sensitive |
| ENSG00000258602.1 |
Avagacestat |
Kidney renal clear cell carcinoma |
0.047384972 |
Sensitive |
| ENSG00000260261.1 |
Avagacestat |
Kidney renal clear cell carcinoma |
0.027387965 |
Sensitive |
| ENSG00000260645.1 |
Avagacestat |
Kidney renal clear cell carcinoma |
0.005068326 |
Sensitive |
| ENSG00000260671.1 |
Avagacestat |
Kidney renal clear cell carcinoma |
0.019430601 |
Sensitive |
| ENSG00000260837.1 |
Avagacestat |
Kidney renal clear cell carcinoma |
0.00028547 |
Sensitive |
| ENSG00000267082.1 |
Avagacestat |
Kidney renal clear cell carcinoma |
0.028040253 |
Sensitive |
| ENSG00000267249.1 |
Avagacestat |
Kidney renal clear cell carcinoma |
0.002735414 |
Sensitive |
| ENSG00000267565.1 |
Avagacestat |
Kidney renal clear cell carcinoma |
0.029994291 |
Sensitive |
| ENSG00000271344.1 |
Avagacestat |
Kidney renal clear cell carcinoma |
0.040433297 |
Sensitive |
| ENSG00000271551.1 |
Avagacestat |
Kidney renal clear cell carcinoma |
0.039840992 |
Sensitive |
| ENSG00000271825.1 |
Avagacestat |
Kidney renal clear cell carcinoma |
0.029343703 |
Sensitive |
| ENSG00000272079.1 |
Avagacestat |
Kidney renal clear cell carcinoma |
0.015308967 |
Sensitive |
| ENSG00000272316.1 |
Avagacestat |
Kidney renal clear cell carcinoma |
0.017671215 |
Sensitive |
| ENSG00000273139.1 |
Avagacestat |
Kidney renal clear cell carcinoma |
0.023670702 |
Sensitive |
| ENSG00000203520.3 |
Avagacestat |
Chronic Lymphocytic Leukemia |
0.013714816 |
Sensitive |
| ENSG00000226883.1 |
Avagacestat |
Chronic Lymphocytic Leukemia |
0.018046444 |
Sensitive |
| ENSG00000245526.4 |
Avagacestat |
Chronic Lymphocytic Leukemia |
0.026762841 |
Sensitive |
| ENSG00000248115.1 |
Avagacestat |
Chronic Lymphocytic Leukemia |
0.014383142 |
Sensitive |
| ENSG00000248243.1 |
Avagacestat |
Chronic Lymphocytic Leukemia |
0.002324204 |
Sensitive |
| ENSG00000250786.1 |
Avagacestat |
Chronic Lymphocytic Leukemia |
0.040523842 |
Sensitive |
| ENSG00000271737.1 |
Avagacestat |
Chronic Lymphocytic Leukemia |
0.042629756 |
Sensitive |
| ENSG00000177406.4 |
Avagacestat |
Brain lower grade glioma |
0.008159498 |
Sensitive |
| ENSG00000188424.5 |
Avagacestat |
Brain lower grade glioma |
0.022950182 |
Sensitive |
| ENSG00000196668.3 |
Avagacestat |
Brain lower grade glioma |
0.010370971 |
Sensitive |
| ENSG00000204929.7 |
Avagacestat |
Brain lower grade glioma |
0.019175948 |
Sensitive |
| ENSG00000214407.3 |
Avagacestat |
Brain lower grade glioma |
0.009632938 |
Sensitive |
| ENSG00000214773.1 |
Avagacestat |
Brain lower grade glioma |
0.04148784 |
Sensitive |
| ENSG00000215159.3 |
Avagacestat |
Brain lower grade glioma |
0.004779552 |
Sensitive |
| ENSG00000215498.4 |
Avagacestat |
Brain lower grade glioma |
0.013372319 |
Sensitive |
| ENSG00000217258.2 |
Avagacestat |
Brain lower grade glioma |
0.008195221 |
Sensitive |
| ENSG00000218018.2 |
Avagacestat |
Brain lower grade glioma |
0.046035893 |
Sensitive |
| ENSG00000223579.2 |
Avagacestat |
Brain lower grade glioma |
0.040112038 |
Sensitive |
| ENSG00000224174.2 |
Avagacestat |
Brain lower grade glioma |
0.012200825 |
Sensitive |
| ENSG00000224292.1 |
Avagacestat |
Brain lower grade glioma |
0.026274313 |
Sensitive |
| ENSG00000224671.1 |
Avagacestat |
Brain lower grade glioma |
0.042530726 |
Sensitive |
| ENSG00000224945.1 |
Avagacestat |
Brain lower grade glioma |
0.043400753 |
Sensitive |
| ENSG00000225602.1 |
Avagacestat |
Brain lower grade glioma |
0.028441649 |
Sensitive |
| ENSG00000226053.1 |
Avagacestat |
Brain lower grade glioma |
0.032082381 |
Sensitive |
| ENSG00000226312.3 |
Avagacestat |
Brain lower grade glioma |
0.008162458 |
Sensitive |
| ENSG00000226334.1 |
Avagacestat |
Brain lower grade glioma |
0.029821808 |
Sensitive |
| ENSG00000226375.1 |
Avagacestat |
Brain lower grade glioma |
0.047983806 |
Sensitive |
| ENSG00000227005.1 |
Avagacestat |
Brain lower grade glioma |
0.023140458 |
Sensitive |
| ENSG00000227028.2 |
Avagacestat |
Brain lower grade glioma |
0.029128746 |
Sensitive |
| ENSG00000227695.1 |
Avagacestat |
Brain lower grade glioma |
0.013904771 |
Sensitive |
| ENSG00000227764.1 |
Avagacestat |
Brain lower grade glioma |
0.04852666 |
Sensitive |
| ENSG00000228176.1 |
Avagacestat |
Brain lower grade glioma |
0.044015008 |
Sensitive |
| ENSG00000228242.3 |
Avagacestat |
Brain lower grade glioma |
0.036260503 |
Sensitive |
| ENSG00000229021.2 |
Avagacestat |
Brain lower grade glioma |
0.011266048 |
Sensitive |
| ENSG00000229666.1 |
Avagacestat |
Brain lower grade glioma |
0.021531562 |
Sensitive |
| ENSG00000230155.2 |
Avagacestat |
Brain lower grade glioma |
0.034331772 |
Sensitive |
| ENSG00000230479.1 |
Avagacestat |
Brain lower grade glioma |
0.013773916 |
Sensitive |
| ENSG00000231092.1 |
Avagacestat |
Brain lower grade glioma |
0.03562592 |
Sensitive |
| ENSG00000231185.2 |
Avagacestat |
Brain lower grade glioma |
0.002652005 |
Sensitive |
| ENSG00000231298.2 |
Avagacestat |
Brain lower grade glioma |
0.049950245 |
Sensitive |
| ENSG00000231609.1 |
Avagacestat |
Brain lower grade glioma |
0.03525998 |
Sensitive |
| ENSG00000231742.1 |
Avagacestat |
Brain lower grade glioma |
0.008863612 |
Sensitive |
| ENSG00000232023.2 |
Avagacestat |
Brain lower grade glioma |
0.039691447 |
Sensitive |
| ENSG00000232310.2 |
Avagacestat |
Brain lower grade glioma |
0.035509781 |
Sensitive |
| ENSG00000232623.1 |
Avagacestat |
Brain lower grade glioma |
0.016501151 |
Sensitive |
| ENSG00000232693.2 |
Avagacestat |
Brain lower grade glioma |
0.010101552 |
Sensitive |
| ENSG00000232876.1 |
Avagacestat |
Brain lower grade glioma |
0.012891717 |
Sensitive |
| ENSG00000233384.1 |
Avagacestat |
Brain lower grade glioma |
0.030325501 |
Sensitive |
| ENSG00000233429.5 |
Avagacestat |
Brain lower grade glioma |
0.030126855 |
Sensitive |
| ENSG00000233818.1 |
Avagacestat |
Brain lower grade glioma |
0.018228877 |
Sensitive |
| ENSG00000233942.1 |
Avagacestat |
Brain lower grade glioma |
0.048874375 |
Sensitive |
| ENSG00000234197.1 |
Avagacestat |
Brain lower grade glioma |
0.022861856 |
Sensitive |
| ENSG00000234698.1 |
Avagacestat |
Brain lower grade glioma |
0.015274274 |
Sensitive |
| ENSG00000234703.1 |
Avagacestat |
Brain lower grade glioma |
0.02485382 |
Sensitive |
| ENSG00000234900.1 |
Avagacestat |
Brain lower grade glioma |
0.040038872 |
Sensitive |
| ENSG00000235884.2 |
Avagacestat |
Brain lower grade glioma |
0.020957023 |
Sensitive |
| ENSG00000236514.1 |
Avagacestat |
Brain lower grade glioma |
0.004657921 |
Sensitive |
| ENSG00000236520.2 |
Avagacestat |
Brain lower grade glioma |
0.022624159 |
Sensitive |
| ENSG00000236671.3 |
Avagacestat |
Brain lower grade glioma |
0.046255669 |
Sensitive |
| ENSG00000236673.1 |
Avagacestat |
Brain lower grade glioma |
0.023038571 |
Sensitive |
| ENSG00000236914.3 |
Avagacestat |
Brain lower grade glioma |
0.005636495 |
Sensitive |
| ENSG00000236935.1 |
Avagacestat |
Brain lower grade glioma |
0.017879136 |
Sensitive |
| ENSG00000238142.1 |
Avagacestat |
Brain lower grade glioma |
0.038266965 |
Sensitive |
| ENSG00000238178.2 |
Avagacestat |
Brain lower grade glioma |
0.043762622 |
Sensitive |
| ENSG00000240440.1 |
Avagacestat |
Brain lower grade glioma |
0.033088608 |
Sensitive |
| ENSG00000240571.1 |
Avagacestat |
Brain lower grade glioma |
0.04934718 |
Sensitive |
| ENSG00000241219.1 |
Avagacestat |
Brain lower grade glioma |
0.021721948 |
Sensitive |
| ENSG00000241280.1 |
Avagacestat |
Brain lower grade glioma |
0.011712922 |
Sensitive |
| ENSG00000243243.1 |
Avagacestat |
Brain lower grade glioma |
0.035463498 |
Sensitive |
| ENSG00000244380.1 |
Avagacestat |
Brain lower grade glioma |
0.017982198 |
Sensitive |
| ENSG00000244675.2 |
Avagacestat |
Brain lower grade glioma |
0.049808093 |
Sensitive |
| ENSG00000244791.2 |
Avagacestat |
Brain lower grade glioma |
0.029371856 |
Sensitive |
| ENSG00000245768.2 |
Avagacestat |
Brain lower grade glioma |
0.033252886 |
Sensitive |
| ENSG00000246228.2 |
Avagacestat |
Brain lower grade glioma |
0.048767268 |
Sensitive |
| ENSG00000246863.2 |
Avagacestat |
Brain lower grade glioma |
0.028382507 |
Sensitive |
| ENSG00000247151.2 |
Avagacestat |
Brain lower grade glioma |
0.009567416 |
Sensitive |
| ENSG00000248399.1 |
Avagacestat |
Brain lower grade glioma |
0.025989324 |
Sensitive |
| ENSG00000248629.1 |
Avagacestat |
Brain lower grade glioma |
0.030257726 |
Sensitive |
| ENSG00000248925.1 |
Avagacestat |
Brain lower grade glioma |
0.024846318 |
Sensitive |
| ENSG00000249867.1 |
Avagacestat |
Brain lower grade glioma |
0.021652745 |
Sensitive |
| ENSG00000250770.2 |
Avagacestat |
Brain lower grade glioma |
0.0450436 |
Sensitive |
| ENSG00000251173.1 |
Avagacestat |
Brain lower grade glioma |
0.042497798 |
Sensitive |
| ENSG00000251257.1 |
Avagacestat |
Brain lower grade glioma |
0.038142931 |
Sensitive |
| ENSG00000251460.1 |
Avagacestat |
Brain lower grade glioma |
0.040318583 |
Sensitive |
| ENSG00000253390.1 |
Avagacestat |
Brain lower grade glioma |
0.017548161 |
Sensitive |
| ENSG00000253519.1 |
Avagacestat |
Brain lower grade glioma |
0.039494891 |
Sensitive |
| ENSG00000253669.3 |
Avagacestat |
Brain lower grade glioma |
0.033377086 |
Sensitive |
| ENSG00000253848.1 |
Avagacestat |
Brain lower grade glioma |
0.039944909 |
Sensitive |
| ENSG00000253982.1 |
Avagacestat |
Brain lower grade glioma |
0.001839674 |
Sensitive |
| ENSG00000254142.2 |
Avagacestat |
Brain lower grade glioma |
0.03636949 |
Sensitive |
| ENSG00000254401.1 |
Avagacestat |
Brain lower grade glioma |
0.045561809 |
Sensitive |
| ENSG00000254526.1 |
Avagacestat |
Brain lower grade glioma |
0.040986249 |
Sensitive |
| ENSG00000254821.1 |
Avagacestat |
Brain lower grade glioma |
0.023859328 |
Sensitive |
| ENSG00000255029.1 |
Avagacestat |
Brain lower grade glioma |
0.03773602 |
Sensitive |
| ENSG00000255145.1 |
Avagacestat |
Brain lower grade glioma |
0.041486474 |
Sensitive |
| ENSG00000255186.1 |
Avagacestat |
Brain lower grade glioma |
0.037490615 |
Sensitive |
| ENSG00000255458.1 |
Avagacestat |
Brain lower grade glioma |
0.043217586 |
Sensitive |
| ENSG00000255507.1 |
Avagacestat |
Brain lower grade glioma |
0.005336844 |
Sensitive |
| ENSG00000255521.1 |
Avagacestat |
Brain lower grade glioma |
0.041408511 |
Sensitive |
| ENSG00000255992.1 |
Avagacestat |
Brain lower grade glioma |
0.019425466 |
Sensitive |
| ENSG00000256802.2 |
Avagacestat |
Brain lower grade glioma |
0.028536716 |
Sensitive |
| ENSG00000256940.1 |
Avagacestat |
Brain lower grade glioma |
0.032302988 |
Sensitive |
| ENSG00000257052.1 |
Avagacestat |
Brain lower grade glioma |
0.021365339 |
Sensitive |
| ENSG00000257086.1 |
Avagacestat |
Brain lower grade glioma |
0.038183246 |
Sensitive |
| ENSG00000257135.1 |
Avagacestat |
Brain lower grade glioma |
0.009302367 |
Sensitive |
| ENSG00000257202.1 |
Avagacestat |
Brain lower grade glioma |
0.04546493 |
Sensitive |
| ENSG00000257754.1 |
Avagacestat |
Brain lower grade glioma |
0.01237982 |
Sensitive |
| ENSG00000257953.1 |
Avagacestat |
Brain lower grade glioma |
0.002145731 |
Sensitive |
| ENSG00000258343.1 |
Avagacestat |
Brain lower grade glioma |
0.014283398 |
Sensitive |
| ENSG00000258413.1 |
Avagacestat |
Brain lower grade glioma |
0.015095002 |
Sensitive |
| ENSG00000258658.1 |
Avagacestat |
Brain lower grade glioma |
0.020706052 |
Sensitive |
| ENSG00000258884.1 |
Avagacestat |
Brain lower grade glioma |
0.027309935 |
Sensitive |
| ENSG00000258935.1 |
Avagacestat |
Brain lower grade glioma |
0.00588918 |
Sensitive |
| ENSG00000259093.1 |
Avagacestat |
Brain lower grade glioma |
0.025076719 |
Sensitive |
| ENSG00000259248.1 |
Avagacestat |
Brain lower grade glioma |
0.022730692 |
Sensitive |
| ENSG00000259251.2 |
Avagacestat |
Brain lower grade glioma |
0.016254467 |
Sensitive |
| ENSG00000259410.1 |
Avagacestat |
Brain lower grade glioma |
0.029454922 |
Sensitive |
| ENSG00000259561.1 |
Avagacestat |
Brain lower grade glioma |
0.031151577 |
Sensitive |
| ENSG00000259577.1 |
Avagacestat |
Brain lower grade glioma |
0.043142125 |
Sensitive |
| ENSG00000259617.1 |
Avagacestat |
Brain lower grade glioma |
0.031958322 |
Sensitive |
| ENSG00000259771.1 |
Avagacestat |
Brain lower grade glioma |
0.044923223 |
Sensitive |
| ENSG00000259792.1 |
Avagacestat |
Brain lower grade glioma |
0.024348332 |
Sensitive |
| ENSG00000260046.1 |
Avagacestat |
Brain lower grade glioma |
0.046051028 |
Sensitive |
| ENSG00000260063.1 |
Avagacestat |
Brain lower grade glioma |
0.019338464 |
Sensitive |
| ENSG00000260093.1 |
Avagacestat |
Brain lower grade glioma |
0.035931512 |
Sensitive |
| ENSG00000260441.1 |
Avagacestat |
Brain lower grade glioma |
0.026936797 |
Sensitive |
| ENSG00000260823.1 |
Avagacestat |
Brain lower grade glioma |
0.046163137 |
Sensitive |
| ENSG00000261430.1 |
Avagacestat |
Brain lower grade glioma |
0.042269148 |
Sensitive |
| ENSG00000261488.1 |
Avagacestat |
Brain lower grade glioma |
0.030374331 |
Sensitive |
| ENSG00000261707.1 |
Avagacestat |
Brain lower grade glioma |
0.011186909 |
Sensitive |
| ENSG00000261775.1 |
Avagacestat |
Brain lower grade glioma |
0.037511055 |
Sensitive |
| ENSG00000261838.1 |
Avagacestat |
Brain lower grade glioma |
0.025699037 |
Sensitive |
| ENSG00000262001.1 |
Avagacestat |
Brain lower grade glioma |
0.012926575 |
Sensitive |
| ENSG00000264125.1 |
Avagacestat |
Brain lower grade glioma |
0.037325482 |
Sensitive |
| ENSG00000264235.1 |
Avagacestat |
Brain lower grade glioma |
0.009316352 |
Sensitive |
| ENSG00000265342.1 |
Avagacestat |
Brain lower grade glioma |
0.012718166 |
Sensitive |
| ENSG00000265394.1 |
Avagacestat |
Brain lower grade glioma |
0.017865182 |
Sensitive |
| ENSG00000265399.1 |
Avagacestat |
Brain lower grade glioma |
0.033229518 |
Sensitive |
| ENSG00000265490.1 |
Avagacestat |
Brain lower grade glioma |
0.04854664 |
Sensitive |
| ENSG00000265845.2 |
Avagacestat |
Brain lower grade glioma |
0.012060879 |
Sensitive |
| ENSG00000266709.1 |
Avagacestat |
Brain lower grade glioma |
0.012776478 |
Sensitive |
| ENSG00000266783.1 |
Avagacestat |
Brain lower grade glioma |
0.016569467 |
Sensitive |
| ENSG00000266824.1 |
Avagacestat |
Brain lower grade glioma |
0.032648345 |
Sensitive |
| ENSG00000267175.1 |
Avagacestat |
Brain lower grade glioma |
0.040232783 |
Sensitive |
| ENSG00000267222.1 |
Avagacestat |
Brain lower grade glioma |
0.034181208 |
Sensitive |
| ENSG00000267279.1 |
Avagacestat |
Brain lower grade glioma |
0.048438199 |
Sensitive |
| ENSG00000267374.1 |
Avagacestat |
Brain lower grade glioma |
0.005103421 |
Sensitive |
| ENSG00000267551.3 |
Avagacestat |
Brain lower grade glioma |
0.047652362 |
Sensitive |
| ENSG00000267672.1 |
Avagacestat |
Brain lower grade glioma |
0.03265602 |
Sensitive |
| ENSG00000267852.1 |
Avagacestat |
Brain lower grade glioma |
0.047608353 |
Sensitive |
| ENSG00000267940.1 |
Avagacestat |
Brain lower grade glioma |
0.030505156 |
Sensitive |
| ENSG00000268518.1 |
Avagacestat |
Brain lower grade glioma |
0.026639883 |
Sensitive |
| ENSG00000268764.1 |
Avagacestat |
Brain lower grade glioma |
0.040046597 |
Sensitive |
| ENSG00000270036.1 |
Avagacestat |
Brain lower grade glioma |
0.049586803 |
Sensitive |
| ENSG00000270177.1 |
Avagacestat |
Brain lower grade glioma |
0.02793078 |
Sensitive |
| ENSG00000271840.1 |
Avagacestat |
Brain lower grade glioma |
0.034277076 |
Sensitive |
| ENSG00000271874.1 |
Avagacestat |
Brain lower grade glioma |
0.005616528 |
Sensitive |
| ENSG00000272121.1 |
Avagacestat |
Brain lower grade glioma |
0.048661932 |
Sensitive |
| ENSG00000272143.1 |
Avagacestat |
Brain lower grade glioma |
0.037538713 |
Sensitive |
| ENSG00000272273.1 |
Avagacestat |
Brain lower grade glioma |
0.005889455 |
Sensitive |
| ENSG00000272688.1 |
Avagacestat |
Brain lower grade glioma |
0.023694761 |
Sensitive |
| ENSG00000272699.1 |
Avagacestat |
Brain lower grade glioma |
0.009361116 |
Sensitive |
| ENSG00000272780.1 |
Avagacestat |
Brain lower grade glioma |
0.030207463 |
Sensitive |
| ENSG00000273107.1 |
Avagacestat |
Brain lower grade glioma |
0.012979298 |
Sensitive |
| ENSG00000273125.1 |
Avagacestat |
Brain lower grade glioma |
0.023353373 |
Sensitive |
| ENSG00000273365.1 |
Avagacestat |
Brain lower grade glioma |
0.045251257 |
Sensitive |
| ENSG00000273406.1 |
Avagacestat |
Brain lower grade glioma |
0.012933977 |
Sensitive |
| ENSG00000273481.1 |
Avagacestat |
Brain lower grade glioma |
0.040965227 |
Sensitive |
| ENSG00000224961.1 |
Avagacestat |
Lung squamous cell carcinoma |
0.047857183 |
Sensitive |
| ENSG00000225822.3 |
Avagacestat |
Lung squamous cell carcinoma |
0.01339767 |
Sensitive |
| ENSG00000226380.3 |
Avagacestat |
Lung squamous cell carcinoma |
0.039131894 |
Sensitive |
| ENSG00000227197.1 |
Avagacestat |
Lung squamous cell carcinoma |
0.04879873 |
Sensitive |
| ENSG00000227258.1 |
Avagacestat |
Lung squamous cell carcinoma |
0.03402514 |
Sensitive |
| ENSG00000228649.4 |
Avagacestat |
Lung squamous cell carcinoma |
0.000515347 |
Sensitive |
| ENSG00000229672.2 |
Avagacestat |
Lung squamous cell carcinoma |
0.023354064 |
Sensitive |
| ENSG00000229869.1 |
Avagacestat |
Lung squamous cell carcinoma |
0.021144427 |
Sensitive |
| ENSG00000230826.1 |
Avagacestat |
Lung squamous cell carcinoma |
0.048096288 |
Sensitive |
| ENSG00000235427.1 |
Avagacestat |
Lung squamous cell carcinoma |
0.034313611 |
Sensitive |
| ENSG00000235629.1 |
Avagacestat |
Lung squamous cell carcinoma |
0.004140405 |
Sensitive |
| ENSG00000235881.2 |
Avagacestat |
Lung squamous cell carcinoma |
0.030118902 |
Sensitive |
| ENSG00000236388.1 |
Avagacestat |
Lung squamous cell carcinoma |
0.016000859 |
Sensitive |
| ENSG00000238280.1 |
Avagacestat |
Lung squamous cell carcinoma |
0.015658922 |
Sensitive |
| ENSG00000242154.1 |
Avagacestat |
Lung squamous cell carcinoma |
0.0010864 |
Sensitive |
| ENSG00000244268.1 |
Avagacestat |
Lung squamous cell carcinoma |
0.030862365 |
Sensitive |
| ENSG00000246130.1 |
Avagacestat |
Lung squamous cell carcinoma |
0.03566498 |
Sensitive |
| ENSG00000251054.1 |
Avagacestat |
Lung squamous cell carcinoma |
0.049993136 |
Sensitive |
| ENSG00000253744.1 |
Avagacestat |
Lung squamous cell carcinoma |
0.026155321 |
Sensitive |
| ENSG00000253965.1 |
Avagacestat |
Lung squamous cell carcinoma |
0.04048303 |
Sensitive |
| ENSG00000255723.1 |
Avagacestat |
Lung squamous cell carcinoma |
0.001058413 |
Sensitive |
| ENSG00000255946.1 |
Avagacestat |
Lung squamous cell carcinoma |
0.004838965 |
Sensitive |
| ENSG00000258612.1 |
Avagacestat |
Lung squamous cell carcinoma |
0.023135221 |
Sensitive |
| ENSG00000259135.1 |
Avagacestat |
Lung squamous cell carcinoma |
0.001895874 |
Sensitive |
| ENSG00000259178.1 |
Avagacestat |
Lung squamous cell carcinoma |
0.040794232 |
Sensitive |
| ENSG00000259276.1 |
Avagacestat |
Lung squamous cell carcinoma |
0.013388028 |
Sensitive |
| ENSG00000260790.1 |
Avagacestat |
Lung squamous cell carcinoma |
0.036805663 |
Sensitive |
| ENSG00000261471.1 |
Avagacestat |
Lung squamous cell carcinoma |
0.02234696 |
Sensitive |
| ENSG00000261592.1 |
Avagacestat |
Lung squamous cell carcinoma |
0.048430915 |
Sensitive |
| ENSG00000261758.1 |
Avagacestat |
Lung squamous cell carcinoma |
0.024712539 |
Sensitive |
| ENSG00000264595.1 |
Avagacestat |
Lung squamous cell carcinoma |
0.044676223 |
Sensitive |
| ENSG00000267551.3 |
Avagacestat |
Lung squamous cell carcinoma |
0.04002939 |
Sensitive |
| ENSG00000272254.1 |
Avagacestat |
Lung squamous cell carcinoma |
0.043272534 |
Sensitive |
| ENSG00000272610.1 |
Avagacestat |
Lung squamous cell carcinoma |
0.024637091 |
Sensitive |
| ENSG00000272895.1 |
Avagacestat |
Lung squamous cell carcinoma |
0.036363683 |
Sensitive |
| ENSG00000273009.1 |
Avagacestat |
Lung squamous cell carcinoma |
0.026403513 |
Sensitive |
| ENSG00000177993.3 |
Avagacestat |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.028567663 |
Sensitive |
| ENSG00000203356.2 |
Avagacestat |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.007441863 |
Sensitive |
| ENSG00000223734.2 |
Avagacestat |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.046724212 |
Sensitive |
| ENSG00000223813.2 |
Avagacestat |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.022551737 |
Sensitive |
| ENSG00000226051.2 |
Avagacestat |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.007770988 |
Sensitive |
| ENSG00000226453.1 |
Avagacestat |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.035068735 |
Sensitive |
| ENSG00000226471.2 |
Avagacestat |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.019456051 |
Sensitive |
| ENSG00000226950.2 |
Avagacestat |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.013918937 |
Sensitive |
| ENSG00000229951.1 |
Avagacestat |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.006828509 |
Sensitive |
| ENSG00000230990.1 |
Avagacestat |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.02402437 |
Sensitive |
| ENSG00000231156.1 |
Avagacestat |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.032186122 |
Sensitive |
| ENSG00000232082.1 |
Avagacestat |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.005152605 |
Sensitive |
| ENSG00000254142.2 |
Avagacestat |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.037907337 |
Sensitive |
| ENSG00000254528.3 |
Avagacestat |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.005473021 |
Sensitive |
| ENSG00000257449.1 |
Avagacestat |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.044191155 |
Sensitive |
| ENSG00000258099.1 |
Avagacestat |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.032375062 |
Sensitive |
| ENSG00000258920.1 |
Avagacestat |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.02344316 |
Sensitive |
| ENSG00000261438.1 |
Avagacestat |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.022171778 |
Sensitive |
| ENSG00000265933.1 |
Avagacestat |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.002687965 |
Sensitive |
| ENSG00000272627.1 |
Avagacestat |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.014156436 |
Sensitive |
| ENSG00000273175.1 |
Avagacestat |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.018839191 |
Sensitive |
| ENSG00000182057.4 |
Avagacestat |
Pancreatic adenocarcinoma |
0.014036641 |
Sensitive |
| ENSG00000223356.1 |
Avagacestat |
Pancreatic adenocarcinoma |
0.004053438 |
Sensitive |
| ENSG00000225434.2 |
Avagacestat |
Pancreatic adenocarcinoma |
0.026525429 |
Sensitive |
| ENSG00000229848.1 |
Avagacestat |
Pancreatic adenocarcinoma |
0.046208921 |
Sensitive |
| ENSG00000231724.1 |
Avagacestat |
Pancreatic adenocarcinoma |
0.01974317 |
Sensitive |
| ENSG00000232233.1 |
Avagacestat |
Pancreatic adenocarcinoma |
0.043981187 |
Sensitive |
| ENSG00000232530.1 |
Avagacestat |
Pancreatic adenocarcinoma |
0.00941546 |
Sensitive |
| ENSG00000232811.1 |
Avagacestat |
Pancreatic adenocarcinoma |
0.047463604 |
Sensitive |
| ENSG00000233845.1 |
Avagacestat |
Pancreatic adenocarcinoma |
0.017885058 |
Sensitive |
| ENSG00000234350.1 |
Avagacestat |
Pancreatic adenocarcinoma |
0.000503056 |
Sensitive |
| ENSG00000234608.3 |
Avagacestat |
Pancreatic adenocarcinoma |
0.042626075 |
Sensitive |
| ENSG00000235560.3 |
Avagacestat |
Pancreatic adenocarcinoma |
0.041602899 |
Sensitive |
| ENSG00000235663.1 |
Avagacestat |
Pancreatic adenocarcinoma |
0.014436438 |
Sensitive |
| ENSG00000236081.1 |
Avagacestat |
Pancreatic adenocarcinoma |
0.033738671 |
Sensitive |
| ENSG00000236434.2 |
Avagacestat |
Pancreatic adenocarcinoma |
0.021210721 |
Sensitive |
| ENSG00000236753.1 |
Avagacestat |
Pancreatic adenocarcinoma |
0.044477168 |
Sensitive |
| ENSG00000237149.4 |
Avagacestat |
Pancreatic adenocarcinoma |
0.049086147 |
Sensitive |
| ENSG00000240291.1 |
Avagacestat |
Pancreatic adenocarcinoma |
0.003574645 |
Sensitive |
| ENSG00000240541.2 |
Avagacestat |
Pancreatic adenocarcinoma |
0.0247536 |
Sensitive |
| ENSG00000245498.2 |
Avagacestat |
Pancreatic adenocarcinoma |
0.010659081 |
Sensitive |
| ENSG00000249464.1 |
Avagacestat |
Pancreatic adenocarcinoma |
0.026204019 |
Sensitive |
| ENSG00000249825.1 |
Avagacestat |
Pancreatic adenocarcinoma |
0.041818464 |
Sensitive |
| ENSG00000250073.2 |
Avagacestat |
Pancreatic adenocarcinoma |
0.031678108 |
Sensitive |
| ENSG00000250295.2 |
Avagacestat |
Pancreatic adenocarcinoma |
0.001086654 |
Sensitive |
| ENSG00000253327.2 |
Avagacestat |
Pancreatic adenocarcinoma |
0.012787961 |
Sensitive |
| ENSG00000253671.1 |
Avagacestat |
Pancreatic adenocarcinoma |
0.018082337 |
Sensitive |
| ENSG00000255045.1 |
Avagacestat |
Pancreatic adenocarcinoma |
0.026635107 |
Sensitive |
| ENSG00000255568.2 |
Avagacestat |
Pancreatic adenocarcinoma |
0.034032446 |
Sensitive |
| ENSG00000257052.1 |
Avagacestat |
Pancreatic adenocarcinoma |
0.049900505 |
Sensitive |
| ENSG00000257252.1 |
Avagacestat |
Pancreatic adenocarcinoma |
0.016080693 |
Sensitive |
| ENSG00000258088.1 |
Avagacestat |
Pancreatic adenocarcinoma |
0.013581085 |
Sensitive |
| ENSG00000258486.2 |
Avagacestat |
Pancreatic adenocarcinoma |
0.019039958 |
Sensitive |
| ENSG00000258561.1 |
Avagacestat |
Pancreatic adenocarcinoma |
0.032051212 |
Sensitive |
| ENSG00000258940.2 |
Avagacestat |
Pancreatic adenocarcinoma |
0.012433912 |
Sensitive |
| ENSG00000259240.1 |
Avagacestat |
Pancreatic adenocarcinoma |
0.03033543 |
Sensitive |
| ENSG00000259264.1 |
Avagacestat |
Pancreatic adenocarcinoma |
0.002991081 |
Sensitive |
| ENSG00000259687.1 |
Avagacestat |
Pancreatic adenocarcinoma |
0.02020946 |
Sensitive |
| ENSG00000259768.3 |
Avagacestat |
Pancreatic adenocarcinoma |
0.043119141 |
Sensitive |
| ENSG00000260231.1 |
Avagacestat |
Pancreatic adenocarcinoma |
0.006374455 |
Sensitive |
| ENSG00000260377.1 |
Avagacestat |
Pancreatic adenocarcinoma |
0.023831842 |
Sensitive |
| ENSG00000260608.1 |
Avagacestat |
Pancreatic adenocarcinoma |
0.036398839 |
Sensitive |
| ENSG00000261173.1 |
Avagacestat |
Pancreatic adenocarcinoma |
0.013484746 |
Sensitive |
| ENSG00000262294.1 |
Avagacestat |
Pancreatic adenocarcinoma |
0.022669458 |
Sensitive |
| ENSG00000263214.1 |
Avagacestat |
Pancreatic adenocarcinoma |
0.033885871 |
Sensitive |
| ENSG00000269483.1 |
Avagacestat |
Pancreatic adenocarcinoma |
0.014518503 |
Sensitive |
| ENSG00000270640.1 |
Avagacestat |
Pancreatic adenocarcinoma |
0.03753975 |
Sensitive |
| ENSG00000271921.1 |
Avagacestat |
Pancreatic adenocarcinoma |
0.004934192 |
Sensitive |
| ENSG00000272129.1 |
Avagacestat |
Pancreatic adenocarcinoma |
0.043782324 |
Sensitive |
| ENSG00000272717.1 |
Avagacestat |
Pancreatic adenocarcinoma |
0.023719908 |
Sensitive |
| ENSG00000272761.1 |
Avagacestat |
Pancreatic adenocarcinoma |
0.031181486 |
Sensitive |
| ENSG00000273264.1 |
Avagacestat |
Pancreatic adenocarcinoma |
0.025487012 |
Sensitive |
| ENSG00000273265.1 |
Avagacestat |
Pancreatic adenocarcinoma |
0.036565461 |
Sensitive |
| ENSG00000273456.1 |
Avagacestat |
Pancreatic adenocarcinoma |
0.022576213 |
Sensitive |
| ENSG00000172250.10 |
Avagacestat |
Sarcoma |
0.046523373 |
Sensitive |
| ENSG00000188206.5 |
Avagacestat |
Sarcoma |
0.004187279 |
Sensitive |
| ENSG00000204241.3 |
Avagacestat |
Sarcoma |
0.018324732 |
Sensitive |
| ENSG00000215458.4 |
Avagacestat |
Sarcoma |
0.046564748 |
Sensitive |
| ENSG00000219665.4 |
Avagacestat |
Sarcoma |
0.015489011 |
Sensitive |
| ENSG00000224985.1 |
Avagacestat |
Sarcoma |
0.044394947 |
Sensitive |
| ENSG00000225113.1 |
Avagacestat |
Sarcoma |
0.00573305 |
Sensitive |
| ENSG00000225146.1 |
Avagacestat |
Sarcoma |
0.021483553 |
Sensitive |
| ENSG00000225611.1 |
Avagacestat |
Sarcoma |
0.045232809 |
Sensitive |
| ENSG00000225975.2 |
Avagacestat |
Sarcoma |
0.000517657 |
Sensitive |
| ENSG00000226913.1 |
Avagacestat |
Sarcoma |
0.006601482 |
Sensitive |
| ENSG00000227186.1 |
Avagacestat |
Sarcoma |
0.044360812 |
Sensitive |
| ENSG00000227218.3 |
Avagacestat |
Sarcoma |
0.029239641 |
Sensitive |
| ENSG00000228798.1 |
Avagacestat |
Sarcoma |
0.03130907 |
Sensitive |
| ENSG00000229587.2 |
Avagacestat |
Sarcoma |
0.003426437 |
Sensitive |
| ENSG00000230310.1 |
Avagacestat |
Sarcoma |
0.000710486 |
Sensitive |
| ENSG00000230606.6 |
Avagacestat |
Sarcoma |
0.021068949 |
Sensitive |
| ENSG00000234396.3 |
Avagacestat |
Sarcoma |
0.023152605 |
Sensitive |
| ENSG00000234740.1 |
Avagacestat |
Sarcoma |
0.004066026 |
Sensitive |
| ENSG00000235138.1 |
Avagacestat |
Sarcoma |
0.021937984 |
Sensitive |
| ENSG00000235527.2 |
Avagacestat |
Sarcoma |
0.01311391 |
Sensitive |
| ENSG00000237187.4 |
Avagacestat |
Sarcoma |
0.00040697 |
Sensitive |
| ENSG00000237857.2 |
Avagacestat |
Sarcoma |
0.043247483 |
Sensitive |
| ENSG00000240006.1 |
Avagacestat |
Sarcoma |
0.016159818 |
Sensitive |
| ENSG00000240137.1 |
Avagacestat |
Sarcoma |
0.010615884 |
Sensitive |
| ENSG00000241481.2 |
Avagacestat |
Sarcoma |
0.01405991 |
Sensitive |
| ENSG00000246877.1 |
Avagacestat |
Sarcoma |
0.022559199 |
Sensitive |
| ENSG00000248240.1 |
Avagacestat |
Sarcoma |
0.008781216 |
Sensitive |
| ENSG00000250107.1 |
Avagacestat |
Sarcoma |
0.046574597 |
Sensitive |
| ENSG00000250582.1 |
Avagacestat |
Sarcoma |
0.033323613 |
Sensitive |
| ENSG00000250900.2 |
Avagacestat |
Sarcoma |
0.012819896 |
Sensitive |
| ENSG00000251075.1 |
Avagacestat |
Sarcoma |
0.000847359 |
Sensitive |
| ENSG00000254648.1 |
Avagacestat |
Sarcoma |
0.012829964 |
Sensitive |
| ENSG00000255139.1 |
Avagacestat |
Sarcoma |
0.026145902 |
Sensitive |
| ENSG00000255989.1 |
Avagacestat |
Sarcoma |
0.021491037 |
Sensitive |
| ENSG00000257808.1 |
Avagacestat |
Sarcoma |
0.031492596 |
Sensitive |
| ENSG00000258048.1 |
Avagacestat |
Sarcoma |
0.003342424 |
Sensitive |
| ENSG00000258096.1 |
Avagacestat |
Sarcoma |
0.013056346 |
Sensitive |
| ENSG00000259635.1 |
Avagacestat |
Sarcoma |
0.022743932 |
Sensitive |
| ENSG00000260448.1 |
Avagacestat |
Sarcoma |
0.004391765 |
Sensitive |
| ENSG00000260735.1 |
Avagacestat |
Sarcoma |
0.04639528 |
Sensitive |
| ENSG00000260803.1 |
Avagacestat |
Sarcoma |
0.017775987 |
Sensitive |
| ENSG00000261101.1 |
Avagacestat |
Sarcoma |
0.00628753 |
Sensitive |
| ENSG00000261195.1 |
Avagacestat |
Sarcoma |
0.013782331 |
Sensitive |
| ENSG00000261226.1 |
Avagacestat |
Sarcoma |
0.040691505 |
Sensitive |
| ENSG00000261595.1 |
Avagacestat |
Sarcoma |
0.013924144 |
Sensitive |
| ENSG00000261744.1 |
Avagacestat |
Sarcoma |
0.000828169 |
Sensitive |
| ENSG00000261971.2 |
Avagacestat |
Sarcoma |
0.032829663 |
Sensitive |
| ENSG00000264304.1 |
Avagacestat |
Sarcoma |
0.03962085 |
Sensitive |
| ENSG00000266340.1 |
Avagacestat |
Sarcoma |
0.004494893 |
Sensitive |
| ENSG00000267108.1 |
Avagacestat |
Sarcoma |
0.049321056 |
Sensitive |
| ENSG00000267197.1 |
Avagacestat |
Sarcoma |
0.022040776 |
Sensitive |
| ENSG00000267439.1 |
Avagacestat |
Sarcoma |
0.035524784 |
Sensitive |
| ENSG00000267480.1 |
Avagacestat |
Sarcoma |
0.039881659 |
Sensitive |
| ENSG00000267658.1 |
Avagacestat |
Sarcoma |
0.0198 |
Sensitive |
| ENSG00000267666.1 |
Avagacestat |
Sarcoma |
0.045341137 |
Sensitive |
| ENSG00000267667.1 |
Avagacestat |
Sarcoma |
0.037400914 |
Sensitive |
| ENSG00000268366.1 |
Avagacestat |
Sarcoma |
0.045521529 |
Sensitive |
| ENSG00000268650.3 |
Avagacestat |
Sarcoma |
0.019314829 |
Sensitive |
| ENSG00000269172.1 |
Avagacestat |
Sarcoma |
0.026776244 |
Sensitive |
| ENSG00000272161.1 |
Avagacestat |
Sarcoma |
0.02500483 |
Sensitive |
| ENSG00000272420.1 |
Avagacestat |
Sarcoma |
0.016373155 |
Sensitive |
| ENSG00000273007.1 |
Avagacestat |
Sarcoma |
0.021899416 |
Sensitive |
| ENSG00000273203.1 |
Avagacestat |
Sarcoma |
0.005105038 |
Sensitive |
| ENSG00000273308.1 |
Avagacestat |
Sarcoma |
0.037038451 |
Sensitive |
| ENSG00000160336.10 |
Avagacestat |
Skin cutaneous melanoma |
0.001489885 |
Sensitive |
| ENSG00000197308.4 |
Avagacestat |
Skin cutaneous melanoma |
0.044075607 |
Sensitive |
| ENSG00000203325.3 |
Avagacestat |
Skin cutaneous melanoma |
0.038691736 |
Sensitive |
| ENSG00000225278.3 |
Avagacestat |
Skin cutaneous melanoma |
0.032261424 |
Sensitive |
| ENSG00000225353.2 |
Avagacestat |
Skin cutaneous melanoma |
0.03629758 |
Sensitive |
| ENSG00000225498.1 |
Avagacestat |
Skin cutaneous melanoma |
0.032906393 |
Sensitive |
| ENSG00000225511.2 |
Avagacestat |
Skin cutaneous melanoma |
0.047380848 |
Sensitive |
| ENSG00000225744.1 |
Avagacestat |
Skin cutaneous melanoma |
0.000472849 |
Sensitive |
| ENSG00000226944.1 |
Avagacestat |
Skin cutaneous melanoma |
0.000749445 |
Sensitive |
| ENSG00000227161.1 |
Avagacestat |
Skin cutaneous melanoma |
0.009295207 |
Sensitive |
| ENSG00000227197.1 |
Avagacestat |
Skin cutaneous melanoma |
0.000764933 |
Sensitive |
| ENSG00000227953.2 |
Avagacestat |
Skin cutaneous melanoma |
0.044035783 |
Sensitive |
| ENSG00000228288.2 |
Avagacestat |
Skin cutaneous melanoma |
0.011211698 |
Sensitive |
| ENSG00000228382.1 |
Avagacestat |
Skin cutaneous melanoma |
0.015335096 |
Sensitive |
| ENSG00000228389.1 |
Avagacestat |
Skin cutaneous melanoma |
0.042160509 |
Sensitive |
| ENSG00000229105.1 |
Avagacestat |
Skin cutaneous melanoma |
0.001993999 |
Sensitive |
| ENSG00000230005.2 |
Avagacestat |
Skin cutaneous melanoma |
0.020513818 |
Sensitive |
| ENSG00000230815.1 |
Avagacestat |
Skin cutaneous melanoma |
0.035638766 |
Sensitive |
| ENSG00000231134.1 |
Avagacestat |
Skin cutaneous melanoma |
0.000558547 |
Sensitive |
| ENSG00000231193.1 |
Avagacestat |
Skin cutaneous melanoma |
0.002653266 |
Sensitive |
| ENSG00000231401.1 |
Avagacestat |
Skin cutaneous melanoma |
0.038230585 |
Sensitive |
| ENSG00000231428.2 |
Avagacestat |
Skin cutaneous melanoma |
0.000131086 |
Sensitive |
| ENSG00000231527.1 |
Avagacestat |
Skin cutaneous melanoma |
0.030947025 |
Sensitive |
| ENSG00000231574.1 |
Avagacestat |
Skin cutaneous melanoma |
0.017598651 |
Sensitive |
| ENSG00000231724.1 |
Avagacestat |
Skin cutaneous melanoma |
0.019495674 |
Sensitive |
| ENSG00000232490.2 |
Avagacestat |
Skin cutaneous melanoma |
0.019523464 |
Sensitive |
| ENSG00000232564.1 |
Avagacestat |
Skin cutaneous melanoma |
0.000028 |
Sensitive |
| ENSG00000233143.1 |
Avagacestat |
Skin cutaneous melanoma |
0.024848862 |
Sensitive |
| ENSG00000233642.1 |
Avagacestat |
Skin cutaneous melanoma |
0.000905543 |
Sensitive |
| ENSG00000233785.1 |
Avagacestat |
Skin cutaneous melanoma |
0.017052674 |
Sensitive |
| ENSG00000234978.1 |
Avagacestat |
Skin cutaneous melanoma |
0.016402053 |
Sensitive |
| ENSG00000236206.1 |
Avagacestat |
Skin cutaneous melanoma |
0.022344265 |
Sensitive |
| ENSG00000237153.1 |
Avagacestat |
Skin cutaneous melanoma |
0.023490129 |
Sensitive |
| ENSG00000237310.1 |
Avagacestat |
Skin cutaneous melanoma |
0.018347011 |
Sensitive |
| ENSG00000237343.1 |
Avagacestat |
Skin cutaneous melanoma |
0.004905447 |
Sensitive |
| ENSG00000237613.2 |
Avagacestat |
Skin cutaneous melanoma |
0.032866664 |
Sensitive |
| ENSG00000238043.1 |
Avagacestat |
Skin cutaneous melanoma |
0.036129305 |
Sensitive |
| ENSG00000238217.1 |
Avagacestat |
Skin cutaneous melanoma |
0.007874867 |
Sensitive |
| ENSG00000239508.1 |
Avagacestat |
Skin cutaneous melanoma |
0.021693835 |
Sensitive |
| ENSG00000240541.2 |
Avagacestat |
Skin cutaneous melanoma |
0.033891876 |
Sensitive |
| ENSG00000241317.1 |
Avagacestat |
Skin cutaneous melanoma |
0.034950051 |
Sensitive |
| ENSG00000244649.2 |
Avagacestat |
Skin cutaneous melanoma |
0.027000518 |
Sensitive |
| ENSG00000249196.2 |
Avagacestat |
Skin cutaneous melanoma |
0.015320288 |
Sensitive |
| ENSG00000249426.1 |
Avagacestat |
Skin cutaneous melanoma |
0.0000632 |
Sensitive |
| ENSG00000250069.1 |
Avagacestat |
Skin cutaneous melanoma |
0.039727103 |
Sensitive |
| ENSG00000250402.1 |
Avagacestat |
Skin cutaneous melanoma |
0.044916937 |
Sensitive |
| ENSG00000250891.1 |
Avagacestat |
Skin cutaneous melanoma |
0.021651308 |
Sensitive |
| ENSG00000250958.1 |
Avagacestat |
Skin cutaneous melanoma |
0.021544361 |
Sensitive |
| ENSG00000253301.1 |
Avagacestat |
Skin cutaneous melanoma |
0.041435746 |
Sensitive |
| ENSG00000253526.1 |
Avagacestat |
Skin cutaneous melanoma |
0.006612461 |
Sensitive |
| ENSG00000253807.1 |
Avagacestat |
Skin cutaneous melanoma |
0.011764639 |
Sensitive |
| ENSG00000254027.1 |
Avagacestat |
Skin cutaneous melanoma |
0.012838503 |
Sensitive |
| ENSG00000254034.1 |
Avagacestat |
Skin cutaneous melanoma |
0.003894025 |
Sensitive |
| ENSG00000254718.2 |
Avagacestat |
Skin cutaneous melanoma |
0.048025483 |
Sensitive |
| ENSG00000255079.1 |
Avagacestat |
Skin cutaneous melanoma |
0.023437914 |
Sensitive |
| ENSG00000255354.1 |
Avagacestat |
Skin cutaneous melanoma |
0.000116691 |
Sensitive |
| ENSG00000257256.1 |
Avagacestat |
Skin cutaneous melanoma |
0.0000229 |
Sensitive |
| ENSG00000257322.1 |
Avagacestat |
Skin cutaneous melanoma |
0.005075552 |
Sensitive |
| ENSG00000257657.2 |
Avagacestat |
Skin cutaneous melanoma |
0.001124836 |
Sensitive |
| ENSG00000258486.2 |
Avagacestat |
Skin cutaneous melanoma |
0.003587118 |
Sensitive |
| ENSG00000258517.1 |
Avagacestat |
Skin cutaneous melanoma |
0.025726134 |
Sensitive |
| ENSG00000258857.1 |
Avagacestat |
Skin cutaneous melanoma |
0.014029847 |
Sensitive |
| ENSG00000258999.1 |
Avagacestat |
Skin cutaneous melanoma |
0.043713881 |
Sensitive |
| ENSG00000259048.1 |
Avagacestat |
Skin cutaneous melanoma |
0.028421246 |
Sensitive |
| ENSG00000259103.1 |
Avagacestat |
Skin cutaneous melanoma |
0.006454677 |
Sensitive |
| ENSG00000259521.1 |
Avagacestat |
Skin cutaneous melanoma |
0.037931888 |
Sensitive |
| ENSG00000260177.1 |
Avagacestat |
Skin cutaneous melanoma |
0.029788875 |
Sensitive |
| ENSG00000260288.2 |
Avagacestat |
Skin cutaneous melanoma |
0.001960131 |
Sensitive |
| ENSG00000260840.1 |
Avagacestat |
Skin cutaneous melanoma |
0.001991672 |
Sensitive |
| ENSG00000260880.2 |
Avagacestat |
Skin cutaneous melanoma |
0.000379665 |
Sensitive |
| ENSG00000261033.1 |
Avagacestat |
Skin cutaneous melanoma |
0.028183102 |
Sensitive |
| ENSG00000261632.1 |
Avagacestat |
Skin cutaneous melanoma |
0.038750004 |
Sensitive |
| ENSG00000261925.1 |
Avagacestat |
Skin cutaneous melanoma |
0.000847564 |
Sensitive |
| ENSG00000264012.1 |
Avagacestat |
Skin cutaneous melanoma |
0.015862675 |
Sensitive |
| ENSG00000264270.1 |
Avagacestat |
Skin cutaneous melanoma |
0.001496505 |
Sensitive |
| ENSG00000265542.1 |
Avagacestat |
Skin cutaneous melanoma |
0.039058969 |
Sensitive |
| ENSG00000266311.2 |
Avagacestat |
Skin cutaneous melanoma |
0.022024639 |
Sensitive |
| ENSG00000266340.1 |
Avagacestat |
Skin cutaneous melanoma |
0.002515199 |
Sensitive |
| ENSG00000266744.1 |
Avagacestat |
Skin cutaneous melanoma |
0.012615876 |
Sensitive |
| ENSG00000266844.1 |
Avagacestat |
Skin cutaneous melanoma |
0.033872222 |
Sensitive |
| ENSG00000267044.1 |
Avagacestat |
Skin cutaneous melanoma |
0.016516603 |
Sensitive |
| ENSG00000269535.1 |
Avagacestat |
Skin cutaneous melanoma |
0.021897287 |
Sensitive |
| ENSG00000270068.1 |
Avagacestat |
Skin cutaneous melanoma |
0.043712337 |
Sensitive |
| ENSG00000271204.1 |
Avagacestat |
Skin cutaneous melanoma |
0.000259005 |
Sensitive |
| ENSG00000271778.1 |
Avagacestat |
Skin cutaneous melanoma |
0.034001166 |
Sensitive |
| ENSG00000271931.1 |
Avagacestat |
Skin cutaneous melanoma |
0.021892686 |
Sensitive |
| ENSG00000273164.1 |
Avagacestat |
Skin cutaneous melanoma |
0.001948912 |
Sensitive |
| ENSG00000178977.3 |
Avagacestat |
Thyroid carcinoma |
0.007317344 |
Sensitive |
| ENSG00000182165.13 |
Avagacestat |
Thyroid carcinoma |
0.04601591 |
Sensitive |
| ENSG00000211683.3 |
Avagacestat |
Thyroid carcinoma |
0.00654207 |
Sensitive |
| ENSG00000223960.2 |
Avagacestat |
Thyroid carcinoma |
0.0373636 |
Sensitive |
| ENSG00000224376.1 |
Avagacestat |
Thyroid carcinoma |
0.035002709 |
Sensitive |
| ENSG00000228044.2 |
Avagacestat |
Thyroid carcinoma |
0.025325244 |
Sensitive |
| ENSG00000231081.1 |
Avagacestat |
Thyroid carcinoma |
0.012204416 |
Sensitive |
| ENSG00000233396.3 |
Avagacestat |
Thyroid carcinoma |
0.007806653 |
Sensitive |
| ENSG00000237073.1 |
Avagacestat |
Thyroid carcinoma |
0.01621144 |
Sensitive |
| ENSG00000241544.1 |
Avagacestat |
Thyroid carcinoma |
0.03266007 |
Sensitive |
| ENSG00000241570.4 |
Avagacestat |
Thyroid carcinoma |
0.033155406 |
Sensitive |
| ENSG00000248866.1 |
Avagacestat |
Thyroid carcinoma |
0.03736349 |
Sensitive |
| ENSG00000248932.1 |
Avagacestat |
Thyroid carcinoma |
0.006982208 |
Sensitive |
| ENSG00000253917.3 |
Avagacestat |
Thyroid carcinoma |
0.033573615 |
Sensitive |
| ENSG00000254615.2 |
Avagacestat |
Thyroid carcinoma |
0.001922013 |
Sensitive |
| ENSG00000255100.1 |
Avagacestat |
Thyroid carcinoma |
0.037637222 |
Sensitive |
| ENSG00000256546.1 |
Avagacestat |
Thyroid carcinoma |
0.035372842 |
Sensitive |
| ENSG00000258458.1 |
Avagacestat |
Thyroid carcinoma |
0.000826687 |
Sensitive |
| ENSG00000267711.1 |
Avagacestat |
Thyroid carcinoma |
0.034499039 |
Sensitive |
| ENSG00000267871.1 |
Avagacestat |
Thyroid carcinoma |
0.00631474 |
Sensitive |
| ENSG00000268049.1 |
Avagacestat |
Thyroid carcinoma |
0.026473429 |
Sensitive |
| ENSG00000268061.1 |
Avagacestat |
Thyroid carcinoma |
0.02939867 |
Sensitive |
| ENSG00000270426.1 |
Avagacestat |
Thyroid carcinoma |
0.03494558 |
Sensitive |
| ENSG00000272250.1 |
Avagacestat |
Thyroid carcinoma |
0.03921258 |
Sensitive |
| ENSG00000272482.1 |
Avagacestat |
Thyroid carcinoma |
0.006590017 |
Sensitive |
| ENSG00000272690.1 |
Avagacestat |
Thyroid carcinoma |
0.033895828 |
Sensitive |
